data_1kvi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kvi _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 53' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.582 HG12 ' CD2' ' A' ' 37' ' ' HIS . 1.9 t -143.92 165.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.054 -1.262 . . . . 0.0 110.079 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 6.5 m-20 -138.36 161.9 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.495 -0.753 . . . . 0.0 109.437 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 t -126.01 139.11 53.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.677 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.482 ' CG1' ' CD2' ' A' ' 62' ' ' LEU . 1.5 t -127.99 127.58 68.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.671 -0.643 . . . . 0.0 110.061 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -109.66 143.05 39.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.483 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 2.2 pp -138.59 154.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.624 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.01 166.16 11.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.691 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.457 HG12 ' SD ' ' A' ' 17' ' ' MET . 58.7 t -144.08 148.75 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -152.58 19.7 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.17 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' HA3' ' OD2' ' A' ' 72' ' ' ASP . . . -148.25 80.88 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.53 ' O ' ' CG2' ' A' ' 18' ' ' THR . 63.4 mtm -130.68 -143.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.402 -1.058 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER 174.73 -71.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.321 -0.862 . . . . 0.0 109.735 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ASN . 33.5 m -112.76 160.66 17.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 14.5 p30 -42.73 -43.86 4.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.019 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.503 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 83.2 p -45.99 -21.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 110.694 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.515 ' O ' ' CD1' ' A' ' 26' ' ' ILE . 4.4 m -56.73 -86.17 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.917 -1.114 . . . . 0.0 111.375 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.6 ' CG2' ' CG1' ' A' ' 41' ' ' VAL . 12.0 p -72.34 -37.62 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.399 -0.813 . . . . 0.0 111.819 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.632 ' CZ2' ' CG2' ' A' ' 41' ' ' VAL . 9.2 m-90 -62.29 -47.43 84.35 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.517 -0.739 . . . . 0.0 110.485 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 21' ' ' SER . 14.7 m -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.611 -1.306 . . . . 0.0 108.16 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.632 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 48.0 mt -68.0 -42.66 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.517 ' CA ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -66.13 -28.23 68.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.818 . . . . 0.0 109.874 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -49.19 65.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.37 -55.5 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.776 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -52.8 -29.43 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.586 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.539 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . -86.69 -21.29 51.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -101.75 10.98 39.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -1.108 . . . . 0.0 109.76 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 30' ' ' ILE . 6.3 p -83.03 -28.88 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 110.839 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.542 ' CB ' ' HG3' ' A' ' 57' ' ' GLN . 6.0 t-20 -165.88 -135.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.941 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.13 38.67 2.73 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.22 -0.991 . . . . 0.0 110.684 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.539 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 3.5 t -67.33 115.19 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.926 -1.337 . . . . 0.0 109.446 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.582 ' CD2' HG12 ' A' ' 7' ' ' VAL . 39.6 m-70 -64.07 -85.38 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.427 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.533 ' N ' HD12 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -132.33 174.65 10.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.068 . . . . 0.0 110.907 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -157.66 173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.531 -0.731 . . . . 0.0 109.44 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 39' ' ' ILE . 12.6 mttm -166.43 148.28 6.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.055 -1.028 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.632 ' CG2' ' CZ2' ' A' ' 24' ' ' TRP . 4.2 m -123.23 159.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.965 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.03 85.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -25.21 4.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -42.14 67.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.036 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.53 12.74 22.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? 49.53 69.19 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.268 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 18.3 p-10 -170.08 -177.68 2.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.43 137.85 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 110.106 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.461 ' HA ' HG22 ' A' ' 11' ' ' THR . 15.0 t -109.98 130.33 55.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 49' ' ' THR . 2.0 pp -143.1 151.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.543 ' CD1' ' C ' ' A' ' 51' ' ' ILE . 1.1 pp -109.79 -177.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 23.5 p90 -174.33 133.26 0.39 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.122 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 0.4 OUTLIER -71.3 117.34 55.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.521 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.6 Cg_endo -72.65 -26.66 16.07 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.901 1.474 . . . . 0.0 109.5 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -14.36 62.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.691 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.99 -32.51 3.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.542 ' HG3' ' CB ' ' A' ' 34' ' ' ASN . 25.0 mm100 -134.72 -154.61 0.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.418 -0.802 . . . . 0.0 109.708 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.536 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.33 -179.17 0.64 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.013 -1.054 . . . . 0.0 110.306 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 42.3 Cg_endo -69.96 -17.9 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.796 1.419 . . . . 0.0 110.293 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.13 -49.04 71.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.543 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 m -50.19 -44.08 52.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.202 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.482 ' CD2' ' CG1' ' A' ' 10' ' ' VAL . 6.2 mp -57.07 -43.66 82.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 108.68 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -45.16 92.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.09 -31.6 70.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.475 -0.766 . . . . 0.0 109.543 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -57.4 -59.42 5.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.485 -0.759 . . . . 0.0 110.087 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.18 -45.35 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.86 -16.83 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.818 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 63.6 t0 -81.08 -42.64 20.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -66.32 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 136.83 -26.03 3.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.632 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 92.3 m-85 -42.15 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -1.101 . . . . 0.0 110.2 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.442 ' OD2' ' HA3' ' A' ' 16' ' ' GLY . 1.2 p30 -56.99 83.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.85 . . . . 0.0 110.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -116.78 135.94 53.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 0.0 109.984 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 74' ' ' VAL . 14.7 p -111.67 142.6 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 110.502 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 5.8 mt -85.21 166.9 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.037 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.554 ' CG2' ' NE2' ' A' ' 37' ' ' HIS . 27.8 m -64.42 132.47 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.235 . . . . 0.0 110.486 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.448 ' O ' HG23 ' A' ' 51' ' ' ILE . 4.9 m-20 -95.5 -174.42 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.42 -0.8 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 95.5 p -131.28 132.14 44.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.942 -1.099 . . . . 0.0 111.153 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.66 129.12 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.765 -0.584 . . . . 0.0 109.546 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 12' ' ' ILE . 82.5 p -112.01 159.32 18.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.221 -0.925 . . . . 0.0 110.646 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.501 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 2.7 pp -139.8 157.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.359 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -88.61 168.14 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 109.694 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.509 ' CG1' ' SD ' ' A' ' 17' ' ' MET . 70.5 t -140.11 147.49 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.991 -1.068 . . . . 0.0 110.585 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' HG12 ' A' ' 14' ' ' VAL . 1.6 mt-10 -170.61 42.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 17' ' ' MET . . . -171.69 -34.06 0.03 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.551 ' HB2' ' CB ' ' A' ' 22' ' ' CYS . 19.3 ptt? -42.88 151.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -1.118 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.523 ' N ' ' HB3' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -72.01 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -0.825 . . . . 0.0 110.716 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -107.24 -31.48 8.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -125.31 -67.19 0.91 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.192 -0.943 . . . . 0.0 109.974 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.492 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 2.7 t -49.96 -19.44 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.834 -1.166 . . . . 0.0 109.971 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.551 ' CB ' ' HB2' ' A' ' 17' ' ' MET . 0.8 OUTLIER -46.04 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.665 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 7.3 p -85.32 -31.64 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 111.461 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.665 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 17.1 m-90 -60.84 -32.18 71.59 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.165 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.492 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 14.7 m -80.4 -44.93 18.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.55 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 9.0 mt -63.64 -59.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.599 ' N ' ' O ' ' A' ' 23' ' ' VAL . 42.9 tt0 -42.91 -41.93 3.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.487 -0.758 . . . . 0.0 109.292 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.27 -43.79 83.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' A' ' 32' ' ' LYS . 1.9 mt-30 -74.98 -63.0 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.08 -1.012 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.541 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 24.3 pt -51.45 -34.57 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 109.473 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 30' ' ' ILE . . . -77.19 -22.33 71.23 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.409 -1.877 . . . . 0.0 108.409 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 12.3 tttm -101.02 3.17 41.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -1.007 . . . . 0.0 110.013 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 34' ' ' ASN . 1.8 t -59.94 -76.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.534 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 2.3 t30 -177.25 -75.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.941 -1.099 . . . . 0.0 110.95 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.61 -26.73 74.26 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 30' ' ' ILE . 35.9 m -50.81 123.77 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -1.146 . . . . 0.0 110.54 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.645 ' CD2' ' CD1' ' A' ' 51' ' ' ILE . 5.2 p80 -129.54 10.89 5.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.614 ' N ' HD11 ' A' ' 51' ' ' ILE . 14.9 t60 -171.85 143.66 1.66 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 109.934 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 38' ' ' HIS . 3.9 mp -141.2 149.59 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.41 108.51 4.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.554 ' CG1' HG21 ' A' ' 23' ' ' VAL . 4.8 p -125.89 140.4 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 0.0 110.476 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 p -112.54 150.94 30.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.987 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 -2.91 22.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 110.136 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -102.51 -32.55 9.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.3 -3.08 37.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' C ' ' HB ' ' A' ' 14' ' ' VAL . 4.8 mttp 53.75 65.06 1.62 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.321 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.55 176.01 12.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 0.0 109.707 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -152.63 146.56 25.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 0.0 110.781 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 11' ' ' THR . 88.3 m -132.8 100.34 4.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.742 . . . . 0.0 109.435 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -119.23 156.5 21.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 110.231 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.645 ' CD1' ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -109.86 174.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 8.1 p90 -159.28 128.71 5.44 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.583 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 6.6 t0 -68.52 115.13 26.91 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 110.014 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 42.9 Cg_endo -69.44 -44.89 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.906 1.477 . . . . 0.0 110.138 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HG2' ' OD1' ' A' ' 53' ' ' ASP . 11.1 ptmt -42.56 -26.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -123.93 -22.69 4.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.372 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 49.3 mm-40 -131.01 -158.64 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.527 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -170.72 179.42 0.71 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 43.1 Cg_endo -69.46 -12.27 33.1 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.719 1.379 . . . . 0.0 110.291 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' THR . 11.1 mttt -74.14 -51.97 13.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.649 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' LYS . 7.4 m -45.2 -48.63 12.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 109.227 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.545 HD11 ' CG ' ' A' ' 52' ' ' TYR . 2.1 mt -57.91 -48.88 78.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 109.263 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.9 -37.99 72.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.001 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 68' ' ' ASP . 47.1 tt0 -73.53 -31.76 63.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.251 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' LEU . . . -55.78 -58.22 8.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.485 -0.759 . . . . 0.0 109.548 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.7 mt -61.37 -37.62 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.489 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.89 -12.24 60.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 64' ' ' GLU . 25.0 t70 -85.59 -39.82 16.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.4 mmt -87.59 -56.13 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 123.56 -10.16 8.61 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.55 ' CZ ' HD13 ' A' ' 26' ' ' ILE . 8.0 m-85 -42.76 143.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -1.179 . . . . 0.0 110.347 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.14 74.09 2.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -119.81 162.15 19.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.645 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HB ' ' OG ' ' A' ' 13' ' ' SER . 40.8 t -144.07 108.59 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.458 ' HA ' HG23 ' A' ' 12' ' ' ILE . 14.4 pt -46.26 146.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.598 HG13 ' CE1' ' A' ' 37' ' ' HIS . 6.2 m -82.14 142.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -108.09 166.64 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.073 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.3 p -114.37 131.64 56.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.525 ' CG1' HD21 ' A' ' 62' ' ' LEU . 1.3 t -117.8 137.38 51.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.642 -0.661 . . . . 0.0 110.351 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.467 ' O ' HG21 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -114.64 152.67 31.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.573 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.495 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -145.35 139.83 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.003 -1.06 . . . . 0.0 110.764 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.433 ' C ' HD12 ' A' ' 12' ' ' ILE . 44.7 m -90.55 122.28 33.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.492 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 10.2 p -111.45 153.84 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 110.494 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -139.98 -59.74 0.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.48 75.77 0.52 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.45 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -98.36 -146.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.205 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 m -156.93 -67.11 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.208 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.7 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.21 -0.931 . . . . 0.0 110.12 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.555 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -140.8 -68.92 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.841 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -45.38 -22.73 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.103 -0.998 . . . . 0.0 109.975 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 16.0 t -49.83 -83.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.796 -1.19 . . . . 0.0 110.398 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' CG1' ' A' ' 41' ' ' VAL . 15.0 p -81.13 -42.22 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 111.531 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.555 ' CE3' ' HA ' ' A' ' 20' ' ' ASN . 9.8 m-90 -52.55 -33.75 47.07 Favored 'General case' 0 C--N 1.285 -2.223 0 O-C-N 121.127 -0.983 . . . . 0.0 109.725 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.513 ' CB ' ' O ' ' A' ' 21' ' ' SER . 25.7 m -77.8 -43.04 31.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.633 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 63.0 mt -64.22 -58.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.7 tm-20 -42.76 -39.72 2.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.529 -0.732 . . . . 0.0 109.407 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.34 -47.74 82.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.77 -56.53 5.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.212 -0.93 . . . . 0.0 110.129 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.493 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 2.5 tp -48.81 -30.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.49 -32.86 32.98 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -89.14 6.3 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -1.121 . . . . 0.0 110.05 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 30' ' ' ILE . 6.1 p -81.81 -18.73 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -161.35 -132.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 109.985 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -115.05 47.99 0.98 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 51' ' ' ILE . 9.9 p -45.77 135.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -1.156 . . . . 0.0 110.415 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.598 ' CE1' HG13 ' A' ' 7' ' ' VAL . 15.1 m-70 -105.63 -10.54 16.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.959 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 25.4 t60 -163.87 145.25 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.416 -0.802 . . . . 0.0 109.822 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.49 ' CD1' HG23 ' A' ' 30' ' ' ILE . 6.8 tt -162.27 124.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.049 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -145.23 140.1 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 110.399 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.557 ' CG1' HG23 ' A' ' 23' ' ' VAL . 4.6 p -131.9 148.03 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.497 ' N ' HG21 ' A' ' 41' ' ' VAL . 6.2 m -126.88 168.47 14.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.07 -1.82 14.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 17.6 pt-20 -95.57 -34.12 12.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 9.6 mt-10 -102.04 4.97 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' CG ' ' O ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER 45.65 58.69 4.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.464 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -169.63 166.15 10.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.049 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.61 148.24 29.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.455 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.434 HG22 ' CG2' ' A' ' 11' ' ' THR . 3.4 m -109.89 152.82 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.791 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -165.79 157.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.989 -1.069 . . . . 0.0 110.593 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.584 HG21 ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.59 169.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.547 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 9.7 p90 -165.1 118.73 1.24 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.883 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.481 ' OD2' ' HD3' ' A' ' 55' ' ' LYS . 3.9 t0 -63.65 117.98 40.18 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.158 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.53 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.7 Cg_endo -70.68 -43.11 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.864 1.455 . . . . 0.0 109.841 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HD3' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.93 -26.04 0.37 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 tp -117.31 -34.89 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 110.07 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.409 ' C ' ' OG1' ' A' ' 58' ' ' THR . 1.9 tp-100 -124.39 -150.95 0.46 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.955 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.543 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.11 -179.36 0.35 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.294 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 41.7 Cg_endo -69.81 -30.43 22.04 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.917 1.483 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -36.2 83.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.863 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -57.75 -56.7 18.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.785 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.525 HD21 ' CG1' ' A' ' 10' ' ' VAL . 2.2 mp -50.16 -41.94 50.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.17 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 75' ' ' ILE . 13.9 tt0 -61.49 -44.5 96.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.103 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -27.36 66.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.518 -0.739 . . . . 0.0 109.459 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.35 -62.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 109.942 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mm -51.63 -38.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.608 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -68.94 -26.15 64.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -70.88 -32.34 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.81 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.408 ' HE2' ' HA ' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -89.66 -50.49 6.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.266 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 121.72 -25.68 6.79 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.633 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 39.7 m-85 -43.01 116.7 0.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 110.281 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.03 83.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 110.398 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' CB ' ' CD1' ' A' ' 12' ' ' ILE . . . -129.26 137.04 50.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 74' ' ' VAL . 11.4 p -117.93 133.93 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.226 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.467 HG21 ' O ' ' A' ' 11' ' ' THR . 6.1 mt -73.94 162.61 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.01 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.123 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.542 HG12 ' CD2' ' A' ' 37' ' ' HIS . 2.5 t -64.58 168.24 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -1.092 . . . . 0.0 110.805 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.4 m-20 -149.95 173.97 13.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.659 -0.651 . . . . 0.0 109.29 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 11.2 p -127.41 147.72 50.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.941 -1.099 . . . . 0.0 110.771 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.512 ' CG1' HD21 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -136.38 125.55 38.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.547 -0.72 . . . . 0.0 110.208 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -109.55 144.93 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.527 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.452 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 2.3 pp -144.1 169.65 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.551 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.34 138.24 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.393 -0.817 . . . . 0.0 109.809 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.85 146.68 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.528 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -145.94 27.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.868 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.36 80.42 0.12 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.468 ' O ' ' CG2' ' A' ' 18' ' ' THR . 0.0 OUTLIER -122.94 -138.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -1.141 . . . . 0.0 110.026 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.468 ' CG2' ' O ' ' A' ' 17' ' ' MET . 19.2 p -156.32 -94.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.346 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.5 p -142.51 -40.56 0.34 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.082 -1.011 . . . . 0.0 110.029 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 16.7 t-20 -145.34 -47.45 0.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.544 ' HA ' ' CG2' ' A' ' 25' ' ' THR . 0.8 OUTLIER -49.32 -20.47 0.66 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.925 -1.109 . . . . 0.0 110.325 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.465 ' HA ' ' CE1' ' A' ' 71' ' ' PHE . 14.3 t -52.44 -81.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.939 -1.101 . . . . 0.0 111.381 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.685 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 7.5 p -81.16 -34.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.187 -0.946 . . . . 0.0 111.986 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.685 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.7 m-90 -60.2 -38.01 82.02 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 121.12 -0.988 . . . . 0.0 110.534 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.544 ' CG2' ' HA ' ' A' ' 21' ' ' SER . 16.4 p -80.49 -44.92 18.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.634 -1.291 . . . . 0.0 107.832 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.463 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 50.4 mt -61.42 -56.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' VAL . 7.3 tt0 -43.22 -48.91 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.124 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -53.14 -41.8 65.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -75.83 -51.87 11.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.799 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.497 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 9.8 mm -51.24 -39.43 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 36' ' ' VAL . . . -72.15 -30.95 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -82.89 -1.8 53.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -1.089 . . . . 0.0 110.126 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 t -80.95 -47.31 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -155.66 -147.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.43 42.71 3.17 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 30' ' ' ILE . 41.4 t -46.73 100.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 110.109 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.545 ' N ' HD13 ' A' ' 51' ' ' ILE . 50.9 m-70 -57.83 -85.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.293 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.541 ' N ' HD13 ' A' ' 51' ' ' ILE . 14.0 p80 -111.54 161.64 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.095 -1.003 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.502 HG13 ' CG2' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -162.01 140.45 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.412 -0.805 . . . . 0.0 109.623 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.69 155.43 35.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.605 ' CG1' ' CG2' ' A' ' 23' ' ' VAL . 14.0 m -133.86 151.52 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.842 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 t -114.39 162.42 16.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.45 -18.08 11.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 110.342 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.86 -44.8 12.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.94 -5.32 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.355 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 54.68 79.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -168.07 -172.45 1.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.25 134.11 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 m -122.31 118.04 27.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 109.563 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 1.3 pp -143.76 167.43 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.758 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.545 HD13 ' N ' ' A' ' 37' ' ' HIS . 1.1 pp -115.57 -173.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.484 -0.76 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 20.5 p90 -175.5 152.18 1.31 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.875 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' A' ' 55' ' ' LYS . 4.6 t0 -92.85 105.23 14.02 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.526 ' CG ' ' O ' ' A' ' 6' ' ' GLY . 42.6 Cg_endo -69.25 -10.07 27.97 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.0 1.526 . . . . 0.0 109.479 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 7.2 mtpt -57.01 -32.03 65.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.44 -0.787 . . . . 0.0 109.149 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.417 HD12 ' HB2' ' A' ' 55' ' ' LYS . 5.0 mp -118.35 -44.5 2.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.656 . . . . 0.0 109.381 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 58' ' ' THR . 3.3 pt20 -107.84 -141.59 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 109.509 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.553 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.33 -178.35 0.31 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.008 . . . . 0.0 110.279 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 43.9 Cg_endo -70.9 -17.68 32.23 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.905 1.476 . . . . 0.0 110.11 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HE3' ' HG2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -73.07 -36.46 66.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.768 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.5 m -53.43 -52.81 58.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.536 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.563 ' CD2' ' CD1' ' A' ' 50' ' ' ILE . 2.0 mp -52.27 -41.23 62.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.026 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -45.31 84.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -33.69 74.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.386 -0.821 . . . . 0.0 109.181 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.78 -52.1 66.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.52 -44.65 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.636 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.15 -17.65 58.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.86 -34.49 21.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.408 -0.807 . . . . 0.0 110.101 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 mmm -85.77 -57.79 2.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 128.61 -17.98 5.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 22' ' ' CYS . 33.7 m-85 -42.73 115.62 0.75 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -1.187 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.02 82.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.281 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -132.55 144.36 50.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.02 128.78 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.521 HG12 ' N ' ' A' ' 76' ' ' HIS . 2.6 tt -54.52 161.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.521 ' N ' HG12 ' A' ' 75' ' ' ILE . 46.1 t-80 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.476 ' HA3' ' HD2' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.518 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 3.4 m -141.9 131.64 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.279 . . . . 0.0 110.583 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -96.9 -165.37 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.519 -0.738 . . . . 0.0 109.076 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.516 ' CB ' ' CG2' ' A' ' 51' ' ' ILE . 49.5 p -148.43 141.95 25.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.799 -1.188 . . . . 0.0 111.129 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 52' ' ' TYR . 2.2 t -142.89 141.31 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.708 -0.62 . . . . 0.0 109.944 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.458 HG23 HG21 ' A' ' 49' ' ' THR . 66.9 p -117.89 156.31 28.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.495 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 2.6 pp -133.61 -175.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.267 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 97.5 p -117.88 131.78 56.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 14' ' ' VAL . 3.4 p -116.98 125.56 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -134.05 -40.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.29 85.66 1.2 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.465 ' O ' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -110.75 -151.02 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 19' ' ' CYS . 8.9 t -179.06 -138.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.85 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.479 ' N ' HG23 ' A' ' 18' ' ' THR . 8.0 p -56.67 163.22 1.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.066 -1.021 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 5.4 t-20 -37.79 -30.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 110.846 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -51.24 -20.74 1.72 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.809 -1.182 . . . . 0.0 110.056 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -46.31 -74.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 111.835 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.629 HG11 ' CZ3' ' A' ' 24' ' ' TRP . 2.0 m -88.42 -38.68 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.629 ' CZ3' HG11 ' A' ' 23' ' ' VAL . 25.9 m-90 -59.44 -31.73 69.57 Favored 'General case' 0 C--N 1.28 -2.438 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.278 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.523 ' CB ' ' O ' ' A' ' 21' ' ' SER . 7.6 m -84.42 -48.23 9.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 0.0 107.911 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.618 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 33.9 mt -59.9 -44.31 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 23' ' ' VAL . 35.2 tt0 -57.55 -45.87 84.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.602 -0.686 . . . . 0.0 109.523 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 11.8 tt0 -54.84 -42.33 71.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.429 -0.795 . . . . 0.0 109.948 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -74.98 -63.62 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 31' ' ' GLY . 22.7 pt -50.44 -38.86 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.025 -1.047 . . . . 0.0 108.972 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' HG13 ' A' ' 30' ' ' ILE . . . -69.18 -24.71 75.87 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -102.83 9.24 39.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.655 -0.909 . . . . 0.0 109.918 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 1.2 p -66.13 -161.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.553 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.74 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -118.13 87.73 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.29 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.543 ' CG2' ' CG2' ' A' ' 39' ' ' ILE . 7.6 p -121.31 82.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.673 ' CD2' ' CD1' ' A' ' 51' ' ' ILE . 8.2 p80 -73.89 7.04 2.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 111.985 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.526 ' N ' HD12 ' A' ' 51' ' ' ILE . 15.9 t60 -173.34 149.81 1.79 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.773 -1.204 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.543 ' CG2' ' CG2' ' A' ' 36' ' ' VAL . 2.8 pp -157.8 158.01 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.457 -0.777 . . . . 0.0 109.575 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -154.35 163.69 39.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.832 -1.168 . . . . 0.0 111.11 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.54 ' CG1' HG13 ' A' ' 23' ' ' VAL . 73.4 t -136.96 138.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.483 -0.761 . . . . 0.0 110.019 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -124.85 76.2 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.21 -33.19 69.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -53.01 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.421 -0.8 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.54 58.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.315 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 60.51 70.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.38 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 14.6 t-20 -170.26 163.39 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 47' ' ' ASN . . . -129.81 137.25 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 110.318 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.458 HG21 HG23 ' A' ' 11' ' ' THR . 1.6 m -113.17 108.25 17.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.862 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 pp -136.77 154.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.316 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.673 ' CD1' ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -116.98 -166.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.583 ' CE1' HG22 ' A' ' 10' ' ' VAL . 22.5 p90 -174.52 155.13 2.19 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.292 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 3.0 p-10 -95.06 117.96 66.69 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 110.464 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 44.7 Cg_endo -70.89 -6.2 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.684 1.36 . . . . 0.0 109.305 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HD2' ' HA3' ' A' ' 6' ' ' GLY . 0.7 OUTLIER -66.73 -43.38 84.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.652 . . . . 0.0 109.544 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 1.2 tt -129.16 -8.28 4.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.37 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.436 ' OE1' HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -127.61 -165.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.537 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.481 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -163.86 177.81 1.68 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 110.1 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 45.6 Cg_endo -72.11 -7.98 22.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.017 1.535 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -33.96 21.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.348 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' LEU . 3.5 m -55.61 -68.16 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.831 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -45.45 -32.96 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 109.084 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -45.71 63.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 108.814 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -68.12 -29.9 68.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.2 -68.54 0.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.727 . . . . 0.0 110.153 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 66' ' ' ILE . 27.6 pt -50.56 -34.2 12.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.102 -0.999 . . . . 0.0 109.88 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.415 ' N ' HG13 ' A' ' 66' ' ' ILE . 11.4 t70 -74.25 -22.26 59.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.738 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.3 t0 -76.68 -34.82 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.528 ' CE ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -75.34 -46.22 34.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.78 9.97 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.618 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 9.3 m-85 -64.15 134.23 54.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 7.4 m-20 -69.29 58.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.377 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -109.94 143.88 39.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 110.008 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 75' ' ' ILE . 25.6 t -139.6 146.7 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 0.0 110.288 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.495 ' N ' HG12 ' A' ' 74' ' ' VAL . 9.4 tt -59.89 147.18 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 83.1 t60 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.477 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 7' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.57 ' CG1' ' CD2' ' A' ' 37' ' ' HIS . 1.4 t -153.43 162.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -1.145 . . . . 0.0 110.318 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.59 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 5.9 m-20 -150.53 147.1 27.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -0.782 . . . . 0.0 109.872 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 t -106.56 138.31 42.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.325 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.539 ' CB ' HD21 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -124.76 131.21 72.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.571 -0.706 . . . . 0.0 110.381 -178.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -114.97 139.71 49.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 109.91 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 75' ' ' ILE . 2.5 pp -141.07 167.2 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.674 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 4.6 m -90.08 140.85 29.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.348 -0.845 . . . . 0.0 108.803 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.462 HG13 ' SD ' ' A' ' 17' ' ' MET . 38.0 t -110.56 143.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.893 -1.13 . . . . 0.0 111.013 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -168.67 28.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 72' ' ' ASP . . . -153.08 57.64 0.42 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.462 ' SD ' HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.92 -153.91 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -1.206 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.8 m -148.5 -83.59 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -0.918 . . . . 0.0 109.912 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 1.2 t -137.77 -141.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.496 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 5.1 m120 -46.41 -25.06 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.993 -1.067 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.527 ' CA ' ' OG1' ' A' ' 25' ' ' THR . 67.9 p -57.84 -11.05 1.99 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.013 -1.055 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' O ' HD13 ' A' ' 26' ' ' ILE . 93.9 m -52.9 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.846 -1.159 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.68 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 8.2 p -80.58 -30.09 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 111.252 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.68 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 18.2 m-90 -67.16 -43.34 82.55 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.671 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.527 ' OG1' ' CA ' ' A' ' 21' ' ' SER . 12.4 m -71.27 -45.22 63.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.496 -1.377 . . . . 0.0 107.867 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.651 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 mp -61.17 -58.52 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 82.4 tt0 -49.52 -32.89 13.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -68.95 -56.54 7.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 32' ' ' LYS . 5.8 tp60 -73.41 -61.62 1.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.503 HG22 ' CG1' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -49.13 -34.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.288 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.58 -27.45 67.41 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 29' ' ' GLN . 2.1 tttp -92.44 0.57 57.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -1.065 . . . . 0.0 110.088 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 34' ' ' ASN . 1.7 p -82.75 -146.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.351 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.535 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 95.6 m-20 -49.06 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.32 61.75 0.33 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.145 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.503 ' CG1' HG22 ' A' ' 30' ' ' ILE . 25.8 m -59.92 135.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.128 -1.219 . . . . 0.0 109.818 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.57 ' CD2' ' CG1' ' A' ' 7' ' ' VAL . 31.0 m-70 -92.88 -24.44 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.136 -0.977 . . . . 0.0 111.017 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.406 ' CG ' ' C ' ' A' ' 37' ' ' HIS . 85.6 m-70 -147.04 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.952 -1.093 . . . . 0.0 110.778 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.516 ' CD1' ' CG2' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -167.07 123.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.133 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.95 140.09 24.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.555 ' CG2' ' HB ' ' A' ' 23' ' ' VAL . 8.0 m -109.85 139.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.399 -0.813 . . . . 0.0 110.112 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.39 112.27 23.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.038 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 -16.46 38.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.301 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.77 -10.45 20.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.269 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -121.3 -1.53 9.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.215 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 50.75 67.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 1.2 t-20 -169.98 170.32 7.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 110.022 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -153.68 144.81 22.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.216 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.446 ' C ' ' CG2' ' A' ' 50' ' ' ILE . 88.1 m -120.31 129.76 54.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -0.821 . . . . 0.0 109.662 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.446 ' CG2' ' C ' ' A' ' 49' ' ' THR . 1.5 pp -147.33 161.27 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.07 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -114.49 170.72 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.902 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 10.6 p90 -168.45 126.52 1.11 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 20.4 p-10 -68.85 118.83 64.87 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 110.434 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 42.4 Cg_endo -69.73 -29.59 23.74 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.901 1.474 . . . . 0.0 110.058 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.37 -26.44 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.725 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.403 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.4 -57.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.871 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.498 ' C ' ' CG2' ' A' ' 58' ' ' THR . 2.5 tt0 -158.58 -178.64 7.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.562 HG22 ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -168.86 -60.19 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.791 -1.193 . . . . 0.0 111.603 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.562 ' CD ' HG22 ' A' ' 58' ' ' THR . 53.7 Cg_endo -75.59 -48.42 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.227 1.119 . . . . 0.0 111.745 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -76.22 -37.05 58.24 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.216 -0.927 . . . . 0.0 111.665 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 57' ' ' GLN . 12.7 m -64.19 -59.63 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 110.233 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.539 HD21 ' CB ' ' A' ' 10' ' ' VAL . 5.4 mp -52.28 -40.99 62.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -65.55 -46.09 80.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.272 -0.893 . . . . 0.0 109.087 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -66.96 -28.78 68.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.355 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.66 -53.2 58.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.499 -0.751 . . . . 0.0 109.666 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 71' ' ' PHE . 30.0 mt -58.37 -50.06 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.35 -22.62 32.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -79.23 -31.09 43.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 110.025 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.547 ' CG ' HD11 ' A' ' 26' ' ' ILE . 26.2 mmt -106.27 12.46 29.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.0 22.15 5.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.651 ' CZ ' ' CD1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -72.52 78.43 1.06 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.723 -0.869 . . . . 0.0 110.422 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.459 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.038 . . . . 0.0 109.562 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -125.68 167.95 14.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 111.062 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.66 120.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.753 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.532 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 15.8 tt -80.95 140.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 0.0 110.764 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.7 p80 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.84 . . . . 0.0 109.98 179.636 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.495 ' CA ' ' HD2' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.582 ' CG2' ' N ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -167.61 170.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.168 -1.195 . . . . 0.0 111.056 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.582 ' N ' ' CG2' ' A' ' 7' ' ' VAL . 1.3 m-20 -155.17 163.19 40.55 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 p -104.15 161.59 13.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.82 -1.175 . . . . 0.0 110.848 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG2' HD23 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -151.99 126.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 110.18 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.484 ' C ' ' CG2' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -116.19 161.63 18.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.32 -0.863 . . . . 0.0 109.574 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -150.35 162.59 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.483 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 3.1 m -97.7 126.37 43.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.443 ' CG1' ' HG2' ' A' ' 17' ' ' MET . 91.8 t -111.54 134.12 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.554 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.8 -40.61 0.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 17' ' ' MET . . . -50.73 -30.83 22.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.466 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -52.69 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -1.139 . . . . 0.0 110.102 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.461 HG22 ' SG ' ' A' ' 22' ' ' CYS . 2.4 t -164.21 -37.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.8 p -118.0 -138.89 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.552 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 7.1 m-20 -99.84 -57.3 2.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.512 ' O ' ' HB ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -45.72 -20.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 110.814 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.511 ' O ' ' CD1' ' A' ' 26' ' ' ILE . 3.4 m -58.46 -87.25 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.816 -1.178 . . . . 0.0 111.336 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.63 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 12.1 p -70.56 -36.61 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.912 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.63 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.3 m-90 -63.69 -43.07 97.71 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.299 -0.876 . . . . 0.0 110.751 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 21' ' ' SER . 43.7 m -65.52 -38.82 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.449 -1.407 . . . . 0.0 107.914 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.651 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 52.1 mt -68.24 -48.66 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -27.42 64.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.596 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -67.82 -54.16 21.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 109.936 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 33' ' ' VAL . 11.5 tt0 -64.11 -48.92 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.665 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.481 ' HA ' ' CG2' ' A' ' 33' ' ' VAL . 56.8 mt -52.73 -38.91 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.564 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.521 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . -69.97 -27.18 73.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.64 5.48 41.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.515 -0.991 . . . . 0.0 109.729 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.491 HG11 ' N ' ' A' ' 34' ' ' ASN . 1.3 t -51.84 -69.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.491 ' N ' HG11 ' A' ' 33' ' ' VAL . 2.5 m120 -142.76 -98.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.077 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' HA3' ' OD2' ' A' ' 53' ' ' ASP . . . -106.04 62.63 0.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.521 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 42.1 t -89.12 118.34 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.26 . . . . 0.0 110.221 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.548 ' CD2' HG22 ' A' ' 7' ' ' VAL . 49.7 m-70 -65.91 -75.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 110.313 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.19 164.81 16.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.431 HD11 ' HB ' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -155.04 142.49 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -166.6 142.84 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.601 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.581 ' CG2' ' CG2' ' A' ' 23' ' ' VAL . 2.7 p -123.14 140.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.988 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.64 168.22 16.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mt -110.14 -28.91 8.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.226 -0.921 . . . . 0.0 109.979 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.23 -22.54 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.232 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.507 ' HB2' ' ND2' ' A' ' 47' ' ' ASN . 27.5 mt-10 -134.38 8.2 3.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mttt 46.92 74.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 0.0 110.507 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.507 ' ND2' ' HB2' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -170.26 -170.88 1.02 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.477 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 12' ' ' ILE . . . -155.91 141.41 17.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.033 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.484 ' HA ' ' CG2' ' A' ' 11' ' ' THR . 2.9 m -110.99 128.38 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -153.06 147.84 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.61 HG21 ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -113.17 171.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.312 -0.868 . . . . 0.0 110.265 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 5.3 p90 -157.35 127.59 6.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.695 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.707 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 1.4 p30 -107.24 18.57 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.352 -0.842 . . . . 0.0 111.757 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 52.1 Cg_endo -79.62 65.42 8.88 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 N-CA-C 108.141 -1.523 . . . . 0.0 108.141 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HD2' ' CA ' ' A' ' 6' ' ' GLY . 0.9 OUTLIER -40.15 -27.15 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.636 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.511 HD22 ' CA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -54.07 -22.32 10.57 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.473 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 12.6 mm100 -154.77 178.17 10.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -175.05 -65.05 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 49.6 Cg_endo -73.09 -49.07 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.648 1.341 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HB3' ' NE2' ' A' ' 57' ' ' GLN . 2.5 tppp? -67.85 -32.6 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 110.781 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 57' ' ' GLN . 12.6 m -68.9 -58.35 4.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 4.0 mp -55.65 -46.79 77.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.296 -0.878 . . . . 0.0 109.117 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 1.4 tp60 -61.17 -41.21 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 108.83 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' ASP . 84.3 tt0 -68.62 -39.65 80.7 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.654 0.74 . . . . 0.0 109.093 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.88 -52.12 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.56 -0.713 . . . . 0.0 109.781 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.467 HD11 HG23 ' A' ' 66' ' ' ILE . 34.3 mm -64.93 -55.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.581 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.53 -24.1 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 64' ' ' GLU . 2.7 t70 -75.89 -38.83 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -65.95 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.19 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.12 41.38 0.76 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.651 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 19.9 m-85 -119.89 143.27 48.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -1.126 . . . . 0.0 110.243 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.62 74.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.456 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -117.69 148.89 41.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.096 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 13' ' ' SER . 27.1 m -132.55 120.15 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.351 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.74 152.39 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.3 -0.875 . . . . 0.0 110.021 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 t60 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.262 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.417 ' HA3' ' CE ' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.544 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -141.79 135.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -1.168 . . . . 0.0 110.599 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -110.14 -177.78 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 51' ' ' ILE . 57.9 m -131.6 135.08 46.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.761 -1.212 . . . . 0.0 110.776 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.565 HG21 ' CE1' ' A' ' 52' ' ' TYR . 2.1 t -127.91 145.23 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.415 HG21 ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -110.91 173.35 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.089 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.506 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -163.2 130.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.279 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 74' ' ' VAL . 8.5 t -84.5 135.65 34.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.221 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 8.1 p -123.76 166.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.655 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.02 -39.27 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.437 -0.789 . . . . 0.0 109.927 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.83 97.85 2.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.418 ' O ' ' C ' ' A' ' 18' ' ' THR . 0.9 OUTLIER -150.33 100.22 2.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.15 . . . . 0.0 110.238 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.538 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -42.0 -68.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.845 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 20' ' ' ASN . 6.0 m -154.68 -162.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.959 -1.088 . . . . 0.0 110.841 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.574 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.4 t30 -39.36 -50.13 2.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 110.806 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' HB ' ' A' ' 25' ' ' THR . 42.7 m -43.69 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 18' ' ' THR . 97.2 m -75.31 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.597 -1.315 . . . . 0.0 111.831 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.607 HG12 ' CZ3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -43.1 -38.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.382 -0.824 . . . . 0.0 110.773 -178.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.607 ' CZ3' HG12 ' A' ' 23' ' ' VAL . 21.4 m-90 -69.8 -50.18 45.5 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.141 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 21' ' ' SER . 49.4 m -60.06 -38.19 82.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.464 -1.398 . . . . 0.0 107.827 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.638 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 17.0 mt -69.29 -54.23 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.476 ' O ' HG22 ' A' ' 30' ' ' ILE . 3.7 tt0 -54.89 -20.76 9.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -57.77 3.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.461 ' OE1' ' HE1' ' A' ' 69' ' ' MET . 0.6 OUTLIER -61.12 -52.07 66.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 109.721 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 27' ' ' GLU . 11.8 tt -51.39 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.555 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . -77.92 -15.69 80.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -116.78 18.82 14.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.852 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.522 ' CG1' ' N ' ' A' ' 34' ' ' ASN . 5.0 p -82.51 -42.6 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.725 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.522 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 2.3 t30 -170.69 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.065 -1.022 . . . . 0.0 110.867 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 53' ' ' ASP . . . -67.91 55.31 0.38 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.163 -0.96 . . . . 0.0 110.841 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' A' ' 51' ' ' ILE . 5.7 p -95.39 151.55 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.914 -1.345 . . . . 0.0 108.476 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.646 ' NE2' ' HB ' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -115.32 -68.63 0.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.069 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.555 ' O ' ' CD1' ' A' ' 51' ' ' ILE . 9.4 p80 -124.66 168.76 12.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.593 -1.317 . . . . 0.0 111.091 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 38' ' ' HIS . 1.8 mp -145.75 150.01 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 110.571 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -125.87 149.96 48.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 109.814 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.582 ' CG2' ' CG2' ' A' ' 23' ' ' VAL . 7.7 p -164.08 137.4 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.001 -1.062 . . . . 0.0 110.49 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.18 127.8 17.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.9 -3.45 51.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 110.45 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.45 -33.01 32.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 110.087 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.74 -1.41 21.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.068 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 3.1 mptt 58.86 58.34 3.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -170.38 167.81 8.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 109.69 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -150.35 142.71 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.306 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 33.1 m -110.0 105.08 14.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 109.28 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -118.69 153.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.672 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.646 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -108.99 -177.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.438 -0.788 . . . . 0.0 110.591 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.565 ' CE1' HG21 ' A' ' 10' ' ' VAL . 20.3 p90 -178.34 141.51 0.23 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.618 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 6.3 p-10 -79.68 111.91 25.04 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.677 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HA ' HG22 ' A' ' 58' ' ' THR . 46.5 Cg_endo -73.5 0.76 7.65 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.724 1.381 . . . . 0.0 110.477 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' CE ' ' HA3' ' A' ' 6' ' ' GLY . 3.4 mttm -70.34 -19.39 63.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 0.0 110.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.05 3.1 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.955 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.552 ' HB2' ' CB ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -177.71 137.01 0.19 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 110.078 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.57 HG21 ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -169.05 -60.34 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.948 -1.095 . . . . 0.0 112.054 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.57 ' CD ' HG21 ' A' ' 58' ' ' THR . 51.8 Cg_endo -74.45 -52.1 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.159 1.084 . . . . 0.0 111.499 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -86.92 -50.57 6.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 111.396 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.552 ' CB ' ' HB2' ' A' ' 57' ' ' GLN . 63.9 m -46.15 -61.8 1.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.915 -1.116 . . . . 0.0 110.336 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.1 mp -52.23 -44.18 64.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.339 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -44.3 93.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.216 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -69.12 -19.95 64.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.544 -0.723 . . . . 0.0 109.329 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 62' ' ' LEU . . . -69.93 -65.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.787 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.49 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 1.3 tp -53.75 -35.3 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.46 ' N ' HG23 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -78.59 -30.18 46.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 6.7 t0 -64.71 -36.11 83.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 109.929 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.461 ' HE1' ' OE1' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -89.64 -68.6 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.017 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.44 -9.06 10.96 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.165 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.638 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 30.6 m-85 -49.79 124.7 10.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.942 -1.328 . . . . 0.0 110.122 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.68 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.273 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -133.11 178.39 6.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.972 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' SER . 58.5 t -135.49 95.69 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 110.166 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.49 ' CG2' ' HB ' ' A' ' 66' ' ' ILE . 50.1 pt -56.62 162.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.227 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.571 ' CG1' ' NE2' ' A' ' 37' ' ' HIS . 11.4 m -66.87 143.32 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -1.214 . . . . 0.0 110.669 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -118.06 167.55 11.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.805 . . . . 0.0 109.927 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.3 t -112.11 136.81 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.063 -1.023 . . . . 0.0 110.287 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.56 ' CG1' ' CD2' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -120.65 126.2 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.627 -0.671 . . . . 0.0 110.438 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.495 ' C ' ' CG2' ' A' ' 12' ' ' ILE . 12.3 p -116.88 161.01 19.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 0.0 109.603 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.495 ' CG2' ' C ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -152.38 166.98 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.411 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -98.21 159.99 14.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.497 HG13 ' CG ' ' A' ' 17' ' ' MET . 58.4 t -145.27 147.34 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.079 . . . . 0.0 110.705 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 3.3 tp10 -146.15 -41.36 0.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 109.706 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.05 88.81 1.49 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.497 ' CG ' HG13 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -114.5 -160.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -1.163 . . . . 0.0 110.614 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' C ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -167.04 -144.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.546 -0.721 . . . . 0.0 109.711 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -58.74 153.29 17.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 109.764 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -27.88 -44.26 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.65 0.738 . . . . 0.0 111.535 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.51 ' O ' ' HB ' ' A' ' 25' ' ' THR . 96.0 p -50.18 -15.9 0.27 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.745 -1.222 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 1.2 p -49.56 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.838 -1.164 . . . . 0.0 111.058 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.609 HG11 ' CE3' ' A' ' 24' ' ' TRP . 7.9 p -82.84 -23.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 111.374 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.609 ' CE3' HG11 ' A' ' 23' ' ' VAL . 14.4 m-90 -69.34 -28.46 66.24 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.264 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 21' ' ' SER . 28.4 m -82.29 -41.69 19.81 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.621 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 83.4 mt -65.1 -45.86 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.401 ' OE2' HG13 ' A' ' 41' ' ' VAL . 19.1 tt0 -60.32 -36.45 77.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.459 -0.776 . . . . 0.0 109.659 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -45.11 80.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.149 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.428 ' O ' HG21 ' A' ' 33' ' ' VAL . 2.0 mm100 -54.23 -42.54 69.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.534 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 75.2 mt -61.36 -46.93 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.466 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . -62.78 -14.65 52.3 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -107.26 -9.86 15.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -1.043 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' A' ' 30' ' ' ILE . 3.2 t -49.02 -64.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.506 ' ND2' ' OE1' ' A' ' 57' ' ' GLN . 48.1 t-20 -169.66 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.095 . . . . 0.0 110.812 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.13 34.84 4.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 30' ' ' ILE . 29.0 t -70.61 115.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.055 -1.262 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.576 ' CD2' HG21 ' A' ' 51' ' ' ILE . 52.3 m-70 -65.27 -87.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 110.691 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.571 ' CD2' HG13 ' A' ' 51' ' ' ILE . 19.5 p80 -120.52 163.07 18.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.89 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 2.3 pp -148.42 153.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.449 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.83 141.54 5.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.95 -1.094 . . . . 0.0 111.096 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.537 HG22 ' CG2' ' A' ' 23' ' ' VAL . 1.2 p -124.32 135.34 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.416 ' C ' HD21 ' A' ' 43' ' ' LEU . 15.2 p -109.52 172.73 6.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 110.213 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 3.9 mm? -117.62 -29.06 5.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.998 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -66.04 -29.11 69.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 110.352 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.447 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 35.2 mt-10 -116.08 5.08 13.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.503 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER 43.01 65.61 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 45' ' ' GLU . 15.1 p-10 -155.59 171.89 19.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.463 ' HB1' HD12 ' A' ' 12' ' ' ILE . . . -141.22 154.78 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 110.372 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.417 ' C ' HG21 ' A' ' 50' ' ' ILE . 10.1 t -136.83 127.61 27.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 110.02 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.526 ' HB ' ' CG2' ' A' ' 39' ' ' ILE . 2.3 pp -144.62 161.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.138 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.609 HG23 ' N ' ' A' ' 52' ' ' TYR . 0.5 OUTLIER -112.41 168.17 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 110.509 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.609 ' N ' HG23 ' A' ' 51' ' ' ILE . 9.8 p90 -166.2 130.68 2.2 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.338 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 56' ' ' LEU . 18.1 p-10 -77.34 125.85 85.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.368 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 42.2 Cg_endo -68.93 -30.16 26.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.87 1.458 . . . . 0.0 109.597 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -20.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.961 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -135.86 -40.9 0.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.506 ' OE1' ' ND2' ' A' ' 34' ' ' ASN . 5.2 mp0 -106.77 -166.1 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 0.0 110.677 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.492 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.01 179.73 0.8 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 0.0 110.169 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 45.7 Cg_endo -73.44 -11.88 24.75 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.959 1.505 . . . . 0.0 110.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -76.29 -51.34 12.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 65' ' ' ALA . 54.3 m -44.37 -47.25 9.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.455 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.56 ' CD2' ' CG1' ' A' ' 10' ' ' VAL . 1.3 mp -57.32 -45.95 83.73 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.317 -0.865 . . . . 0.0 108.871 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HG3' HD11 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -62.74 -51.09 68.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.489 -0.757 . . . . 0.0 109.203 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.2 -34.66 78.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.389 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' THR . . . -56.5 -55.86 28.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 109.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 mm -55.2 -42.82 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -29.46 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.32 -23.96 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.945 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.78 -47.94 5.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.04 74.07 1.0 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.621 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 8.4 m-85 -146.48 135.52 22.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -1.139 . . . . 0.0 110.213 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.26 81.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.501 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -113.0 171.24 7.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.3 t -147.51 79.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.383 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.418 HD11 ' HG3' ' A' ' 63' ' ' GLN . 8.2 tt -56.93 141.77 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.876 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.548 ' CG1' ' NE2' ' A' ' 37' ' ' HIS . 16.1 m -53.64 131.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.326 . . . . 0.0 110.698 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 51' ' ' ILE . 3.0 t-20 -118.77 -177.81 3.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.55 -0.719 . . . . 0.0 109.759 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -117.5 140.56 49.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.084 -1.01 . . . . 0.0 110.399 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.575 HG22 ' CZ ' ' A' ' 52' ' ' TYR . 1.4 t -139.83 141.12 35.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.613 -0.68 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.3 p -114.35 159.39 20.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.233 -0.917 . . . . 0.0 110.186 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.521 ' O ' ' CD1' ' A' ' 12' ' ' ILE . 2.4 pp -135.99 136.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 110.196 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.423 ' HA ' ' CG ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -84.73 135.5 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 110.058 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.484 ' CG2' ' CD1' ' A' ' 12' ' ' ILE . 71.1 t -117.33 142.42 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.26 52.77 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.2 51.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.499 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -97.19 -139.79 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.392 -1.063 . . . . 0.0 110.15 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.532 HG22 ' N ' ' A' ' 19' ' ' CYS . 1.4 t -179.43 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.203 -0.936 . . . . 0.0 110.42 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.532 ' N ' HG22 ' A' ' 18' ' ' THR . 0.8 OUTLIER -159.28 -139.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -89.32 -51.19 5.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 25' ' ' THR . 1.8 t -48.04 -17.75 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.667 -1.271 . . . . 0.0 110.619 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.536 ' O ' ' CD1' ' A' ' 26' ' ' ILE . 2.0 m -59.96 -87.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.73 -1.231 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.648 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 12.4 p -72.47 -17.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 112.044 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.648 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 8.0 m-90 -86.39 -40.87 14.96 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.02 -1.05 . . . . 0.0 110.522 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -68.41 -40.27 81.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.536 -1.353 . . . . 0.0 107.909 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.662 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 60.8 mt -60.7 -44.47 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.49 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -60.48 -28.8 68.64 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -42.87 88.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.515 ' HG3' ' CE ' ' A' ' 69' ' ' MET . 0.2 OUTLIER -67.09 -56.81 8.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.653 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 31' ' ' GLY . 1.5 tt -47.57 -28.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.23 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 30' ' ' ILE . . . -83.6 -28.24 36.26 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -83.31 -0.26 48.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.015 . . . . 0.0 109.86 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' CG1' HG22 ' A' ' 61' ' ' THR . 13.2 t -102.49 -62.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -105.46 154.16 20.72 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -66.85 62.49 0.19 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.525 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 35.6 m -52.15 125.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.186 -1.185 . . . . 0.0 110.521 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.566 ' CD2' ' O ' ' A' ' 35' ' ' GLY . 32.2 m-70 -93.24 -20.47 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.301 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.508 ' NE2' HG23 ' A' ' 49' ' ' THR . 2.2 t60 -136.95 138.61 40.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.859 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 27' ' ' GLU . 7.5 tt -139.27 123.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.58 148.19 35.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 110.417 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 24' ' ' TRP . 24.7 t -126.94 151.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.296 -0.877 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 47' ' ' ASN . 15.0 p -122.4 145.91 47.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.442 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -106.67 -66.09 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.372 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -15.19 4.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.649 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.61 -9.07 13.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 110.362 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 48.72 73.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.168 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -163.79 178.73 7.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.71 151.96 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.416 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.508 HG23 ' NE2' ' A' ' 38' ' ' HIS . 8.9 t -140.89 122.36 15.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.494 ' HA ' ' CD2' ' A' ' 38' ' ' HIS . 2.3 pp -145.64 172.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.687 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.601 HG21 ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.36 170.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 109.755 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 7.4 p90 -164.0 126.22 2.41 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 4.5 p-10 -68.31 121.08 79.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.568 -0.707 . . . . 0.0 110.017 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 42.4 Cg_endo -67.77 -7.01 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.731 1.385 . . . . 0.0 110.084 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.9 -48.14 11.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.838 . . . . 0.0 109.81 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 8.9 mp -82.09 -63.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.541 ' O ' ' CG2' ' A' ' 58' ' ' THR . 0.3 OUTLIER -156.76 -154.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 109.25 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.601 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -175.53 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 110.627 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 47.8 Cg_endo -73.02 -28.66 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.419 1.221 . . . . 0.0 109.159 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.34 -29.43 17.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.514 -0.741 . . . . 0.0 110.859 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 57' ' ' GLN . 27.6 m -73.42 -63.41 1.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.738 -1.226 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD2' HG13 ' A' ' 10' ' ' VAL . 5.7 mp -46.84 -39.06 11.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 108.956 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -67.11 -48.0 69.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.533 -0.73 . . . . 0.0 109.272 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 68' ' ' ASP . 35.7 tt0 -66.75 -23.45 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.376 -0.828 . . . . 0.0 109.367 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 62' ' ' LEU . . . -65.67 -69.56 0.29 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.802 . . . . 0.0 109.705 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.56 -30.43 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 109.158 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 10.7 t0 -78.58 -39.88 36.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 64' ' ' GLU . 18.0 t0 -53.15 -35.92 60.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.785 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.515 ' CE ' ' HG3' ' A' ' 29' ' ' GLN . 6.1 mmt -84.89 -68.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.193 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -12.42 7.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.662 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 15.4 m-85 -51.9 142.16 16.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.278 -1.13 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -68.62 70.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.71 164.36 27.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.414 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.49 152.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.126 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.424 ' HA ' HG23 ' A' ' 12' ' ' ILE . 1.7 pp -111.58 143.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.122 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 110.083 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.348 0.594 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -150.55 60.01 3.88 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.86 -1.34 10.68 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.121 1.59 . . . . 0.0 109.812 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 5' ' ' MET . 0.2 OUTLIER 58.01 48.22 13.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.291 -0.88 . . . . 0.0 109.839 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.536 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 6.9 ttm 65.52 34.99 7.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.163 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 53' ' ' ASP . . . 44.51 67.66 1.07 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.582 HG12 ' CD2' ' A' ' 37' ' ' HIS . 1.9 t -143.92 165.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.054 -1.262 . . . . 0.0 110.079 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 6.5 m-20 -138.36 161.9 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.495 -0.753 . . . . 0.0 109.437 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 t -126.01 139.11 53.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.677 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.482 ' CG1' ' CD2' ' A' ' 62' ' ' LEU . 1.5 t -127.99 127.58 68.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.671 -0.643 . . . . 0.0 110.061 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -109.66 143.05 39.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.483 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 2.2 pp -138.59 154.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.624 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.01 166.16 11.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.691 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.457 HG12 ' SD ' ' A' ' 17' ' ' MET . 58.7 t -144.08 148.75 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -152.58 19.7 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.17 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' HA3' ' OD2' ' A' ' 72' ' ' ASP . . . -148.25 80.88 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.53 ' O ' ' CG2' ' A' ' 18' ' ' THR . 63.4 mtm -130.68 -143.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.402 -1.058 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER 174.73 -71.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.321 -0.862 . . . . 0.0 109.735 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ASN . 33.5 m -112.76 160.66 17.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 14.5 p30 -42.73 -43.86 4.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.019 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.503 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 83.2 p -45.99 -21.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 110.694 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.515 ' O ' ' CD1' ' A' ' 26' ' ' ILE . 4.4 m -56.73 -86.17 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.917 -1.114 . . . . 0.0 111.375 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.6 ' CG2' ' CG1' ' A' ' 41' ' ' VAL . 12.0 p -72.34 -37.62 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.399 -0.813 . . . . 0.0 111.819 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.632 ' CZ2' ' CG2' ' A' ' 41' ' ' VAL . 9.2 m-90 -62.29 -47.43 84.35 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.517 -0.739 . . . . 0.0 110.485 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 21' ' ' SER . 14.7 m -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.611 -1.306 . . . . 0.0 108.16 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.632 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 48.0 mt -68.0 -42.66 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.517 ' CA ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -66.13 -28.23 68.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.818 . . . . 0.0 109.874 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -49.19 65.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.37 -55.5 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.776 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -52.8 -29.43 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.586 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.539 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . -86.69 -21.29 51.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -101.75 10.98 39.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -1.108 . . . . 0.0 109.76 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 30' ' ' ILE . 6.3 p -83.03 -28.88 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 110.839 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.542 ' CB ' ' HG3' ' A' ' 57' ' ' GLN . 6.0 t-20 -165.88 -135.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.941 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.13 38.67 2.73 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.22 -0.991 . . . . 0.0 110.684 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.539 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 3.5 t -67.33 115.19 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.926 -1.337 . . . . 0.0 109.446 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.582 ' CD2' HG12 ' A' ' 7' ' ' VAL . 39.6 m-70 -64.07 -85.38 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.427 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.533 ' N ' HD12 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -132.33 174.65 10.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.068 . . . . 0.0 110.907 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -157.66 173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.531 -0.731 . . . . 0.0 109.44 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 39' ' ' ILE . 12.6 mttm -166.43 148.28 6.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.055 -1.028 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.632 ' CG2' ' CZ2' ' A' ' 24' ' ' TRP . 4.2 m -123.23 159.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.965 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.03 85.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -25.21 4.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -42.14 67.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.036 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.53 12.74 22.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? 49.53 69.19 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.268 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 18.3 p-10 -170.08 -177.68 2.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.43 137.85 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 110.106 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.461 ' HA ' HG22 ' A' ' 11' ' ' THR . 15.0 t -109.98 130.33 55.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 49' ' ' THR . 2.0 pp -143.1 151.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.543 ' CD1' ' C ' ' A' ' 51' ' ' ILE . 1.1 pp -109.79 -177.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 23.5 p90 -174.33 133.26 0.39 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.122 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 0.4 OUTLIER -71.3 117.34 55.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.521 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.6 Cg_endo -72.65 -26.66 16.07 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.901 1.474 . . . . 0.0 109.5 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -14.36 62.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.691 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.99 -32.51 3.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.542 ' HG3' ' CB ' ' A' ' 34' ' ' ASN . 25.0 mm100 -134.72 -154.61 0.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.418 -0.802 . . . . 0.0 109.708 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.536 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.33 -179.17 0.64 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.013 -1.054 . . . . 0.0 110.306 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 42.3 Cg_endo -69.96 -17.9 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.796 1.419 . . . . 0.0 110.293 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.13 -49.04 71.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.543 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 m -50.19 -44.08 52.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.202 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.482 ' CD2' ' CG1' ' A' ' 10' ' ' VAL . 6.2 mp -57.07 -43.66 82.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 108.68 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -45.16 92.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.09 -31.6 70.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.475 -0.766 . . . . 0.0 109.543 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -57.4 -59.42 5.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.485 -0.759 . . . . 0.0 110.087 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.18 -45.35 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.86 -16.83 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.818 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 63.6 t0 -81.08 -42.64 20.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -66.32 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 136.83 -26.03 3.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.632 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 92.3 m-85 -42.15 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -1.101 . . . . 0.0 110.2 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.442 ' OD2' ' HA3' ' A' ' 16' ' ' GLY . 1.2 p30 -56.99 83.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.85 . . . . 0.0 110.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -116.78 135.94 53.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 0.0 109.984 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 74' ' ' VAL . 14.7 p -111.67 142.6 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 110.502 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 5.8 mt -85.21 166.9 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.79 9.45 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.037 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.471 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 1.6 m-20 -115.55 128.84 25.62 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 0.0 109.979 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.58 -38.23 4.64 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.811 1.427 . . . . 0.0 110.559 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.276 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.495 ' O ' ' HD3' ' A' ' 3' ' ' PRO . 6.9 mmm . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' A' ' 1' ' ' MET . 29.2 m-20 -33.08 94.49 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.827 -0.546 . . . . 0.0 111.37 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 1' ' ' MET . 47.7 Cg_endo -75.52 -4.7 15.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.302 1.685 . . . . 0.0 108.606 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -80.82 -72.65 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 44.62 47.14 8.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 110.232 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.6 -41.23 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.554 ' CG2' ' NE2' ' A' ' 37' ' ' HIS . 27.8 m -64.42 132.47 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.235 . . . . 0.0 110.486 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.448 ' O ' HG23 ' A' ' 51' ' ' ILE . 4.9 m-20 -95.5 -174.42 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.42 -0.8 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 95.5 p -131.28 132.14 44.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.942 -1.099 . . . . 0.0 111.153 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.422 ' HA ' ' OD1' ' A' ' 77' ' ' ASN . 2.1 t -128.66 129.12 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.765 -0.584 . . . . 0.0 109.546 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 12' ' ' ILE . 82.5 p -112.01 159.32 18.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.221 -0.925 . . . . 0.0 110.646 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.501 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 2.7 pp -139.8 157.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.359 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -88.61 168.14 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 109.694 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.509 ' CG1' ' SD ' ' A' ' 17' ' ' MET . 70.5 t -140.11 147.49 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.991 -1.068 . . . . 0.0 110.585 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' HG12 ' A' ' 14' ' ' VAL . 1.6 mt-10 -170.61 42.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 17' ' ' MET . . . -171.69 -34.06 0.03 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.551 ' HB2' ' CB ' ' A' ' 22' ' ' CYS . 19.3 ptt? -42.88 151.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -1.118 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.523 ' N ' ' HB3' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -72.01 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -0.825 . . . . 0.0 110.716 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -107.24 -31.48 8.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -125.31 -67.19 0.91 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.192 -0.943 . . . . 0.0 109.974 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.492 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 2.7 t -49.96 -19.44 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.834 -1.166 . . . . 0.0 109.971 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.551 ' CB ' ' HB2' ' A' ' 17' ' ' MET . 0.8 OUTLIER -46.04 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.665 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 7.3 p -85.32 -31.64 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 111.461 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.665 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 17.1 m-90 -60.84 -32.18 71.59 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.165 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.492 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 14.7 m -80.4 -44.93 18.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.55 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 9.0 mt -63.64 -59.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.599 ' N ' ' O ' ' A' ' 23' ' ' VAL . 42.9 tt0 -42.91 -41.93 3.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.487 -0.758 . . . . 0.0 109.292 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.27 -43.79 83.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' A' ' 32' ' ' LYS . 1.9 mt-30 -74.98 -63.0 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.08 -1.012 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.541 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 24.3 pt -51.45 -34.57 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 109.473 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 30' ' ' ILE . . . -77.19 -22.33 71.23 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.409 -1.877 . . . . 0.0 108.409 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 12.3 tttm -101.02 3.17 41.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -1.007 . . . . 0.0 110.013 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 34' ' ' ASN . 1.8 t -59.94 -76.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.534 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 2.3 t30 -177.25 -75.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.941 -1.099 . . . . 0.0 110.95 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.61 -26.73 74.26 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 30' ' ' ILE . 35.9 m -50.81 123.77 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -1.146 . . . . 0.0 110.54 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.645 ' CD2' ' CD1' ' A' ' 51' ' ' ILE . 5.2 p80 -129.54 10.89 5.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.614 ' N ' HD11 ' A' ' 51' ' ' ILE . 14.9 t60 -171.85 143.66 1.66 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 109.934 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 38' ' ' HIS . 3.9 mp -141.2 149.59 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.41 108.51 4.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.554 ' CG1' HG21 ' A' ' 23' ' ' VAL . 4.8 p -125.89 140.4 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 0.0 110.476 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 p -112.54 150.94 30.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.987 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 -2.91 22.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 110.136 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -102.51 -32.55 9.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.3 -3.08 37.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' C ' ' HB ' ' A' ' 14' ' ' VAL . 4.8 mttp 53.75 65.06 1.62 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.321 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.55 176.01 12.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 0.0 109.707 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -152.63 146.56 25.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 0.0 110.781 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 11' ' ' THR . 88.3 m -132.8 100.34 4.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.742 . . . . 0.0 109.435 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -119.23 156.5 21.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 110.231 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.645 ' CD1' ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -109.86 174.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 8.1 p90 -159.28 128.71 5.44 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.583 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 6.6 t0 -68.52 115.13 26.91 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 110.014 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 42.9 Cg_endo -69.44 -44.89 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.906 1.477 . . . . 0.0 110.138 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HG2' ' OD1' ' A' ' 53' ' ' ASP . 11.1 ptmt -42.56 -26.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -123.93 -22.69 4.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.372 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 49.3 mm-40 -131.01 -158.64 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.527 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -170.72 179.42 0.71 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 43.1 Cg_endo -69.46 -12.27 33.1 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.719 1.379 . . . . 0.0 110.291 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' THR . 11.1 mttt -74.14 -51.97 13.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.649 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' LYS . 7.4 m -45.2 -48.63 12.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 109.227 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.545 HD11 ' CG ' ' A' ' 52' ' ' TYR . 2.1 mt -57.91 -48.88 78.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 109.263 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.9 -37.99 72.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.001 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 68' ' ' ASP . 47.1 tt0 -73.53 -31.76 63.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.251 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 62' ' ' LEU . . . -55.78 -58.22 8.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.485 -0.759 . . . . 0.0 109.548 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.7 mt -61.37 -37.62 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.489 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.89 -12.24 60.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 64' ' ' GLU . 25.0 t70 -85.59 -39.82 16.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.4 mmt -87.59 -56.13 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 123.56 -10.16 8.61 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.55 ' CZ ' HD13 ' A' ' 26' ' ' ILE . 8.0 m-85 -42.76 143.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -1.179 . . . . 0.0 110.347 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.14 74.09 2.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -119.81 162.15 19.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.645 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HB ' ' OG ' ' A' ' 13' ' ' SER . 40.8 t -144.07 108.59 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.458 ' HA ' HG23 ' A' ' 12' ' ' ILE . 14.4 pt -46.26 146.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -122.34 45.99 2.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 10' ' ' VAL . 32.7 m-80 -109.88 108.85 59.39 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.251 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.25 -44.67 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.012 1.533 . . . . 0.0 110.437 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.231 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.249 0.547 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.56 61.22 36.05 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' O ' ' CB ' ' A' ' 4' ' ' SER . 49.4 Cg_endo -75.92 2.81 6.66 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.17 1.616 . . . . 0.0 109.822 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 1.1 m 71.29 30.61 2.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 110.172 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.471 ' HG3' ' O ' ' A' ' 5' ' ' MET . 6.5 ptm -68.7 100.36 1.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 110.276 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 137.96 -19.43 3.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.598 HG13 ' CE1' ' A' ' 37' ' ' HIS . 6.2 m -82.14 142.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -108.09 166.64 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.073 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.3 p -114.37 131.64 56.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.525 ' CG1' HD21 ' A' ' 62' ' ' LEU . 1.3 t -117.8 137.38 51.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.642 -0.661 . . . . 0.0 110.351 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.467 ' O ' HG21 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -114.64 152.67 31.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.573 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.495 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -145.35 139.83 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.003 -1.06 . . . . 0.0 110.764 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.433 ' C ' HD12 ' A' ' 12' ' ' ILE . 44.7 m -90.55 122.28 33.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.492 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 10.2 p -111.45 153.84 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 110.494 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -139.98 -59.74 0.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.48 75.77 0.52 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.45 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -98.36 -146.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.205 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 m -156.93 -67.11 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.208 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.7 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.21 -0.931 . . . . 0.0 110.12 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.555 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -140.8 -68.92 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.841 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -45.38 -22.73 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.103 -0.998 . . . . 0.0 109.975 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 16.0 t -49.83 -83.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.796 -1.19 . . . . 0.0 110.398 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' CG1' ' A' ' 41' ' ' VAL . 15.0 p -81.13 -42.22 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 111.531 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.555 ' CE3' ' HA ' ' A' ' 20' ' ' ASN . 9.8 m-90 -52.55 -33.75 47.07 Favored 'General case' 0 C--N 1.285 -2.223 0 O-C-N 121.127 -0.983 . . . . 0.0 109.725 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.513 ' CB ' ' O ' ' A' ' 21' ' ' SER . 25.7 m -77.8 -43.04 31.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.633 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 63.0 mt -64.22 -58.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.7 tm-20 -42.76 -39.72 2.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.529 -0.732 . . . . 0.0 109.407 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.34 -47.74 82.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.77 -56.53 5.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.212 -0.93 . . . . 0.0 110.129 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.493 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 2.5 tp -48.81 -30.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.49 -32.86 32.98 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -89.14 6.3 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -1.121 . . . . 0.0 110.05 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 30' ' ' ILE . 6.1 p -81.81 -18.73 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -161.35 -132.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 109.985 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -115.05 47.99 0.98 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 51' ' ' ILE . 9.9 p -45.77 135.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -1.156 . . . . 0.0 110.415 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.598 ' CE1' HG13 ' A' ' 7' ' ' VAL . 15.1 m-70 -105.63 -10.54 16.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.959 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 25.4 t60 -163.87 145.25 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.416 -0.802 . . . . 0.0 109.822 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.49 ' CD1' HG23 ' A' ' 30' ' ' ILE . 6.8 tt -162.27 124.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.049 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -145.23 140.1 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 110.399 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.557 ' CG1' HG23 ' A' ' 23' ' ' VAL . 4.6 p -131.9 148.03 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.497 ' N ' HG21 ' A' ' 41' ' ' VAL . 6.2 m -126.88 168.47 14.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.07 -1.82 14.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 17.6 pt-20 -95.57 -34.12 12.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 9.6 mt-10 -102.04 4.97 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' CG ' ' O ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER 45.65 58.69 4.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.464 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -169.63 166.15 10.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.049 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.61 148.24 29.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.455 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.434 HG22 ' CG2' ' A' ' 11' ' ' THR . 3.4 m -109.89 152.82 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.791 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -165.79 157.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.989 -1.069 . . . . 0.0 110.593 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.584 HG21 ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.59 169.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.547 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 9.7 p90 -165.1 118.73 1.24 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.883 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.481 ' OD2' ' HD3' ' A' ' 55' ' ' LYS . 3.9 t0 -63.65 117.98 40.18 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.158 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.53 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.7 Cg_endo -70.68 -43.11 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.864 1.455 . . . . 0.0 109.841 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HD3' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.93 -26.04 0.37 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 tp -117.31 -34.89 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 110.07 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.409 ' C ' ' OG1' ' A' ' 58' ' ' THR . 1.9 tp-100 -124.39 -150.95 0.46 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.955 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.543 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.11 -179.36 0.35 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.294 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 41.7 Cg_endo -69.81 -30.43 22.04 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.917 1.483 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -36.2 83.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.863 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.2 m -57.75 -56.7 18.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.785 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.525 HD21 ' CG1' ' A' ' 10' ' ' VAL . 2.2 mp -50.16 -41.94 50.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.17 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 75' ' ' ILE . 13.9 tt0 -61.49 -44.5 96.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.103 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -27.36 66.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.518 -0.739 . . . . 0.0 109.459 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.35 -62.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 109.942 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mm -51.63 -38.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.608 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -68.94 -26.15 64.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -70.88 -32.34 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.81 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.408 ' HE2' ' HA ' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -89.66 -50.49 6.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.266 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 121.72 -25.68 6.79 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.633 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 39.7 m-85 -43.01 116.7 0.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 110.281 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.03 83.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 110.398 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' CB ' ' CD1' ' A' ' 12' ' ' ILE . . . -129.26 137.04 50.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 74' ' ' VAL . 11.4 p -117.93 133.93 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.226 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.467 HG21 ' O ' ' A' ' 11' ' ' THR . 6.1 mt -73.94 162.61 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.01 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.22 23.75 5.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.123 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.93 85.7 0.84 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.65 -90.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.084 1.571 . . . . 0.0 110.347 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t0 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.085 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.5 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.241 0.543 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -158.37 60.35 1.77 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 110.491 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.92 -3.3 13.36 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.114 1.586 . . . . 0.0 109.526 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m -159.61 79.38 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.49 -0.756 . . . . 0.0 109.842 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.06 62.59 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.321 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' PRO . . . 172.45 -64.8 0.13 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.542 HG12 ' CD2' ' A' ' 37' ' ' HIS . 2.5 t -64.58 168.24 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -1.092 . . . . 0.0 110.805 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.4 m-20 -149.95 173.97 13.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.659 -0.651 . . . . 0.0 109.29 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 11.2 p -127.41 147.72 50.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.941 -1.099 . . . . 0.0 110.771 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.512 ' CG1' HD21 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -136.38 125.55 38.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.547 -0.72 . . . . 0.0 110.208 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -109.55 144.93 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.527 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.452 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 2.3 pp -144.1 169.65 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.551 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.34 138.24 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.393 -0.817 . . . . 0.0 109.809 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.85 146.68 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.528 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -145.94 27.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.868 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.36 80.42 0.12 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.468 ' O ' ' CG2' ' A' ' 18' ' ' THR . 0.0 OUTLIER -122.94 -138.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -1.141 . . . . 0.0 110.026 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.468 ' CG2' ' O ' ' A' ' 17' ' ' MET . 19.2 p -156.32 -94.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.346 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.5 p -142.51 -40.56 0.34 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.082 -1.011 . . . . 0.0 110.029 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 16.7 t-20 -145.34 -47.45 0.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.544 ' HA ' ' CG2' ' A' ' 25' ' ' THR . 0.8 OUTLIER -49.32 -20.47 0.66 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.925 -1.109 . . . . 0.0 110.325 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.465 ' HA ' ' CE1' ' A' ' 71' ' ' PHE . 14.3 t -52.44 -81.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.939 -1.101 . . . . 0.0 111.381 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.685 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 7.5 p -81.16 -34.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.187 -0.946 . . . . 0.0 111.986 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.685 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.7 m-90 -60.2 -38.01 82.02 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 121.12 -0.988 . . . . 0.0 110.534 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.544 ' CG2' ' HA ' ' A' ' 21' ' ' SER . 16.4 p -80.49 -44.92 18.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.634 -1.291 . . . . 0.0 107.832 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.463 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 50.4 mt -61.42 -56.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' VAL . 7.3 tt0 -43.22 -48.91 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.124 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -53.14 -41.8 65.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -75.83 -51.87 11.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.799 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.497 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 9.8 mm -51.24 -39.43 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' HA2' ' HB ' ' A' ' 36' ' ' VAL . . . -72.15 -30.95 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -82.89 -1.8 53.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -1.089 . . . . 0.0 110.126 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 t -80.95 -47.31 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -155.66 -147.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.43 42.71 3.17 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 30' ' ' ILE . 41.4 t -46.73 100.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 110.109 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.545 ' N ' HD13 ' A' ' 51' ' ' ILE . 50.9 m-70 -57.83 -85.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.293 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.541 ' N ' HD13 ' A' ' 51' ' ' ILE . 14.0 p80 -111.54 161.64 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.095 -1.003 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.502 HG13 ' CG2' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -162.01 140.45 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.412 -0.805 . . . . 0.0 109.623 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.69 155.43 35.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.605 ' CG1' ' CG2' ' A' ' 23' ' ' VAL . 14.0 m -133.86 151.52 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.842 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 t -114.39 162.42 16.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.45 -18.08 11.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 110.342 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.86 -44.8 12.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.94 -5.32 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.355 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 54.68 79.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -168.07 -172.45 1.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.25 134.11 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 m -122.31 118.04 27.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 109.563 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.563 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 1.3 pp -143.76 167.43 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.758 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.545 HD13 ' N ' ' A' ' 37' ' ' HIS . 1.1 pp -115.57 -173.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.484 -0.76 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 20.5 p90 -175.5 152.18 1.31 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.875 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' A' ' 55' ' ' LYS . 4.6 t0 -92.85 105.23 14.02 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.526 ' CG ' ' O ' ' A' ' 6' ' ' GLY . 42.6 Cg_endo -69.25 -10.07 27.97 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.0 1.526 . . . . 0.0 109.479 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 7.2 mtpt -57.01 -32.03 65.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.44 -0.787 . . . . 0.0 109.149 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.417 HD12 ' HB2' ' A' ' 55' ' ' LYS . 5.0 mp -118.35 -44.5 2.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.656 . . . . 0.0 109.381 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' HG3' ' N ' ' A' ' 58' ' ' THR . 3.3 pt20 -107.84 -141.59 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 109.509 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.553 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.33 -178.35 0.31 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.008 . . . . 0.0 110.279 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 43.9 Cg_endo -70.9 -17.68 32.23 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.905 1.476 . . . . 0.0 110.11 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HE3' ' HG2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -73.07 -36.46 66.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.768 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.5 m -53.43 -52.81 58.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.536 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.563 ' CD2' ' CD1' ' A' ' 50' ' ' ILE . 2.0 mp -52.27 -41.23 62.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.026 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -45.31 84.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -33.69 74.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.386 -0.821 . . . . 0.0 109.181 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.78 -52.1 66.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.52 -44.65 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.636 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.15 -17.65 58.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.86 -34.49 21.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.408 -0.807 . . . . 0.0 110.101 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 mmm -85.77 -57.79 2.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 128.61 -17.98 5.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 22' ' ' CYS . 33.7 m-85 -42.73 115.62 0.75 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -1.187 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.02 82.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.281 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -132.55 144.36 50.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.02 128.78 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.521 HG12 ' N ' ' A' ' 76' ' ' HIS . 2.6 tt -54.52 161.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.521 ' N ' HG12 ' A' ' 75' ' ' ILE . 46.1 t-80 -158.96 59.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.431 ' OD1' HD13 ' A' ' 75' ' ' ILE . 25.1 p-10 -117.66 109.41 41.69 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.305 -0.872 . . . . 0.0 110.24 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -75.15 -81.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.987 1.52 . . . . 0.0 110.528 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.216 179.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.247 0.546 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.453 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.7 p30 -161.45 54.9 0.56 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.278 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 44.9 Cg_endo -73.42 -2.69 12.49 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.039 1.547 . . . . 0.0 109.557 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.41 ' OG ' ' C ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER 174.04 63.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.453 -0.779 . . . . 0.0 109.724 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.49 65.85 9.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 110.62 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.476 ' HA3' ' HD2' ' A' ' 55' ' ' LYS . . . 120.96 47.17 0.31 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.518 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 3.4 m -141.9 131.64 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.279 . . . . 0.0 110.583 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -96.9 -165.37 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.519 -0.738 . . . . 0.0 109.076 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.516 ' CB ' ' CG2' ' A' ' 51' ' ' ILE . 49.5 p -148.43 141.95 25.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.799 -1.188 . . . . 0.0 111.129 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 52' ' ' TYR . 2.2 t -142.89 141.31 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.708 -0.62 . . . . 0.0 109.944 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.458 HG23 HG21 ' A' ' 49' ' ' THR . 66.9 p -117.89 156.31 28.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.495 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 2.6 pp -133.61 -175.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.267 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 97.5 p -117.88 131.78 56.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 14' ' ' VAL . 3.4 p -116.98 125.56 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -134.05 -40.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.29 85.66 1.2 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.465 ' O ' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -110.75 -151.02 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 19' ' ' CYS . 8.9 t -179.06 -138.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.85 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.479 ' N ' HG23 ' A' ' 18' ' ' THR . 8.0 p -56.67 163.22 1.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.066 -1.021 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 5.4 t-20 -37.79 -30.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 110.846 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -51.24 -20.74 1.72 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.809 -1.182 . . . . 0.0 110.056 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -46.31 -74.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 111.835 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.629 HG11 ' CZ3' ' A' ' 24' ' ' TRP . 2.0 m -88.42 -38.68 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.629 ' CZ3' HG11 ' A' ' 23' ' ' VAL . 25.9 m-90 -59.44 -31.73 69.57 Favored 'General case' 0 C--N 1.28 -2.438 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.278 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.523 ' CB ' ' O ' ' A' ' 21' ' ' SER . 7.6 m -84.42 -48.23 9.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 0.0 107.911 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.618 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 33.9 mt -59.9 -44.31 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 23' ' ' VAL . 35.2 tt0 -57.55 -45.87 84.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.602 -0.686 . . . . 0.0 109.523 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.42 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 11.8 tt0 -54.84 -42.33 71.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.429 -0.795 . . . . 0.0 109.948 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -74.98 -63.62 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 31' ' ' GLY . 22.7 pt -50.44 -38.86 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.025 -1.047 . . . . 0.0 108.972 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' HG13 ' A' ' 30' ' ' ILE . . . -69.18 -24.71 75.87 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -102.83 9.24 39.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.655 -0.909 . . . . 0.0 109.918 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 1.2 p -66.13 -161.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.553 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.74 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -118.13 87.73 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.29 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.543 ' CG2' ' CG2' ' A' ' 39' ' ' ILE . 7.6 p -121.31 82.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.673 ' CD2' ' CD1' ' A' ' 51' ' ' ILE . 8.2 p80 -73.89 7.04 2.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 111.985 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.526 ' N ' HD12 ' A' ' 51' ' ' ILE . 15.9 t60 -173.34 149.81 1.79 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.773 -1.204 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.543 ' CG2' ' CG2' ' A' ' 36' ' ' VAL . 2.8 pp -157.8 158.01 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.457 -0.777 . . . . 0.0 109.575 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -154.35 163.69 39.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.832 -1.168 . . . . 0.0 111.11 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.54 ' CG1' HG13 ' A' ' 23' ' ' VAL . 73.4 t -136.96 138.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.483 -0.761 . . . . 0.0 110.019 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -124.85 76.2 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.21 -33.19 69.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -53.01 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.421 -0.8 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.54 58.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.315 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 60.51 70.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.38 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 14.6 t-20 -170.26 163.39 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.51 ' N ' ' OD1' ' A' ' 47' ' ' ASN . . . -129.81 137.25 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 110.318 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.458 HG21 HG23 ' A' ' 11' ' ' THR . 1.6 m -113.17 108.25 17.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.862 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 pp -136.77 154.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.316 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.673 ' CD1' ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -116.98 -166.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.583 ' CE1' HG22 ' A' ' 10' ' ' VAL . 22.5 p90 -174.52 155.13 2.19 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.292 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 3.0 p-10 -95.06 117.96 66.69 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 110.464 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 44.7 Cg_endo -70.89 -6.2 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.684 1.36 . . . . 0.0 109.305 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HD2' ' HA3' ' A' ' 6' ' ' GLY . 0.7 OUTLIER -66.73 -43.38 84.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.652 . . . . 0.0 109.544 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 1.2 tt -129.16 -8.28 4.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.37 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.436 ' OE1' HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -127.61 -165.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.537 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.481 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -163.86 177.81 1.68 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 110.1 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 45.6 Cg_endo -72.11 -7.98 22.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.017 1.535 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -33.96 21.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.348 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' LEU . 3.5 m -55.61 -68.16 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.831 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -45.45 -32.96 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 109.084 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -45.71 63.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 108.814 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -68.12 -29.9 68.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.2 -68.54 0.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.727 . . . . 0.0 110.153 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 66' ' ' ILE . 27.6 pt -50.56 -34.2 12.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.102 -0.999 . . . . 0.0 109.88 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.415 ' N ' HG13 ' A' ' 66' ' ' ILE . 11.4 t70 -74.25 -22.26 59.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.738 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.3 t0 -76.68 -34.82 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.528 ' CE ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -75.34 -46.22 34.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.78 9.97 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.618 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 9.3 m-85 -64.15 134.23 54.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 7.4 m-20 -69.29 58.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.377 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -109.94 143.88 39.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 110.008 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 75' ' ' ILE . 25.6 t -139.6 146.7 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 0.0 110.288 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.495 ' N ' HG12 ' A' ' 74' ' ' VAL . 9.4 tt -59.89 147.18 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -122.03 -43.27 2.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.477 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -129.11 95.6 30.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 110.325 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.36 -159.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.017 1.536 . . . . 0.0 110.258 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.258 0.551 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -132.3 54.34 13.67 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.288 -0.882 . . . . 0.0 110.16 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 46.8 Cg_endo -73.45 -1.61 10.92 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.1 1.579 . . . . 0.0 109.818 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -165.87 -62.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.383 -0.823 . . . . 0.0 109.961 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.65 72.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -0.865 . . . . 0.0 110.591 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 7' ' ' VAL . . . 124.43 5.32 7.24 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.57 ' CG1' ' CD2' ' A' ' 37' ' ' HIS . 1.4 t -153.43 162.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -1.145 . . . . 0.0 110.318 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.59 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 5.9 m-20 -150.53 147.1 27.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -0.782 . . . . 0.0 109.872 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 t -106.56 138.31 42.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.325 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.539 ' CB ' HD21 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -124.76 131.21 72.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.571 -0.706 . . . . 0.0 110.381 -178.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -114.97 139.71 49.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 109.91 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 75' ' ' ILE . 2.5 pp -141.07 167.2 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.674 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 4.6 m -90.08 140.85 29.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.348 -0.845 . . . . 0.0 108.803 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.462 HG13 ' SD ' ' A' ' 17' ' ' MET . 38.0 t -110.56 143.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.893 -1.13 . . . . 0.0 111.013 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -168.67 28.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 72' ' ' ASP . . . -153.08 57.64 0.42 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.462 ' SD ' HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.92 -153.91 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -1.206 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.8 m -148.5 -83.59 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -0.918 . . . . 0.0 109.912 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 1.2 t -137.77 -141.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.496 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 5.1 m120 -46.41 -25.06 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.993 -1.067 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.527 ' CA ' ' OG1' ' A' ' 25' ' ' THR . 67.9 p -57.84 -11.05 1.99 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.013 -1.055 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' O ' HD13 ' A' ' 26' ' ' ILE . 93.9 m -52.9 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.846 -1.159 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.68 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 8.2 p -80.58 -30.09 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 111.252 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.68 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 18.2 m-90 -67.16 -43.34 82.55 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.671 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.527 ' OG1' ' CA ' ' A' ' 21' ' ' SER . 12.4 m -71.27 -45.22 63.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.496 -1.377 . . . . 0.0 107.867 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.651 ' CD1' ' CZ ' ' A' ' 71' ' ' PHE . 1.1 mp -61.17 -58.52 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.555 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 82.4 tt0 -49.52 -32.89 13.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -68.95 -56.54 7.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 32' ' ' LYS . 5.8 tp60 -73.41 -61.62 1.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.503 HG22 ' CG1' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -49.13 -34.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.288 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.58 -27.45 67.41 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 29' ' ' GLN . 2.1 tttp -92.44 0.57 57.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -1.065 . . . . 0.0 110.088 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 34' ' ' ASN . 1.7 p -82.75 -146.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.351 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.535 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 95.6 m-20 -49.06 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.32 61.75 0.33 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.145 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.503 ' CG1' HG22 ' A' ' 30' ' ' ILE . 25.8 m -59.92 135.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.128 -1.219 . . . . 0.0 109.818 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.57 ' CD2' ' CG1' ' A' ' 7' ' ' VAL . 31.0 m-70 -92.88 -24.44 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.136 -0.977 . . . . 0.0 111.017 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.406 ' CG ' ' C ' ' A' ' 37' ' ' HIS . 85.6 m-70 -147.04 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.952 -1.093 . . . . 0.0 110.778 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.516 ' CD1' ' CG2' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -167.07 123.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.133 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.95 140.09 24.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.555 ' CG2' ' HB ' ' A' ' 23' ' ' VAL . 8.0 m -109.85 139.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.399 -0.813 . . . . 0.0 110.112 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.39 112.27 23.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.038 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 -16.46 38.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.301 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.77 -10.45 20.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.269 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -121.3 -1.53 9.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.215 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 50.75 67.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 1.2 t-20 -169.98 170.32 7.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 110.022 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -153.68 144.81 22.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.216 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.446 ' C ' ' CG2' ' A' ' 50' ' ' ILE . 88.1 m -120.31 129.76 54.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -0.821 . . . . 0.0 109.662 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.446 ' CG2' ' C ' ' A' ' 49' ' ' THR . 1.5 pp -147.33 161.27 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.07 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -114.49 170.72 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.902 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 10.6 p90 -168.45 126.52 1.11 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 20.4 p-10 -68.85 118.83 64.87 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 110.434 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 42.4 Cg_endo -69.73 -29.59 23.74 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.901 1.474 . . . . 0.0 110.058 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.37 -26.44 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.725 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.403 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.4 -57.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.871 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.498 ' C ' ' CG2' ' A' ' 58' ' ' THR . 2.5 tt0 -158.58 -178.64 7.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.562 HG22 ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -168.86 -60.19 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.791 -1.193 . . . . 0.0 111.603 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.562 ' CD ' HG22 ' A' ' 58' ' ' THR . 53.7 Cg_endo -75.59 -48.42 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.227 1.119 . . . . 0.0 111.745 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -76.22 -37.05 58.24 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.216 -0.927 . . . . 0.0 111.665 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 57' ' ' GLN . 12.7 m -64.19 -59.63 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 110.233 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.539 HD21 ' CB ' ' A' ' 10' ' ' VAL . 5.4 mp -52.28 -40.99 62.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -65.55 -46.09 80.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.272 -0.893 . . . . 0.0 109.087 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -66.96 -28.78 68.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.355 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.66 -53.2 58.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.499 -0.751 . . . . 0.0 109.666 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 71' ' ' PHE . 30.0 mt -58.37 -50.06 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.35 -22.62 32.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -79.23 -31.09 43.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 110.025 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.547 ' CG ' HD11 ' A' ' 26' ' ' ILE . 26.2 mmt -106.27 12.46 29.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.0 22.15 5.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.651 ' CZ ' ' CD1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -72.52 78.43 1.06 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.723 -0.869 . . . . 0.0 110.422 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.459 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.038 . . . . 0.0 109.562 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -125.68 167.95 14.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 111.062 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.66 120.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.753 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.532 ' HA ' ' CG2' ' A' ' 12' ' ' ILE . 15.8 tt -80.95 140.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 0.0 110.764 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -127.53 20.04 6.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.84 . . . . 0.0 109.98 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.98 102.42 34.58 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.291 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.13 -89.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.013 1.533 . . . . 0.0 110.309 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 p30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.189 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 tpt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.347 0.594 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 20.5 p30 -147.46 54.18 1.84 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 45.3 Cg_endo -73.15 -2.74 12.5 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.078 1.567 . . . . 0.0 109.684 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 6' ' ' GLY . 50.6 m -148.4 70.43 1.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.136 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.2 59.22 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.495 ' CA ' ' HD2' ' A' ' 55' ' ' LYS . . . 83.72 71.13 1.32 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.582 ' CG2' ' N ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -167.61 170.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.168 -1.195 . . . . 0.0 111.056 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.582 ' N ' ' CG2' ' A' ' 7' ' ' VAL . 1.3 m-20 -155.17 163.19 40.55 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 p -104.15 161.59 13.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.82 -1.175 . . . . 0.0 110.848 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.549 ' CG2' HD23 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -151.99 126.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 110.18 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.484 ' C ' ' CG2' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -116.19 161.63 18.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.32 -0.863 . . . . 0.0 109.574 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -150.35 162.59 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.483 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 3.1 m -97.7 126.37 43.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.443 ' CG1' ' HG2' ' A' ' 17' ' ' MET . 91.8 t -111.54 134.12 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.554 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.8 -40.61 0.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 17' ' ' MET . . . -50.73 -30.83 22.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.466 ' HB2' ' HB3' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -52.69 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -1.139 . . . . 0.0 110.102 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.461 HG22 ' SG ' ' A' ' 22' ' ' CYS . 2.4 t -164.21 -37.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.8 p -118.0 -138.89 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.552 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 7.1 m-20 -99.84 -57.3 2.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.512 ' O ' ' HB ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -45.72 -20.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 110.814 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.511 ' O ' ' CD1' ' A' ' 26' ' ' ILE . 3.4 m -58.46 -87.25 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.816 -1.178 . . . . 0.0 111.336 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.63 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 12.1 p -70.56 -36.61 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.912 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.63 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.3 m-90 -63.69 -43.07 97.71 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.299 -0.876 . . . . 0.0 110.751 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 21' ' ' SER . 43.7 m -65.52 -38.82 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.449 -1.407 . . . . 0.0 107.914 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.651 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 52.1 mt -68.24 -48.66 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -27.42 64.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.596 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -67.82 -54.16 21.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 109.936 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 33' ' ' VAL . 11.5 tt0 -64.11 -48.92 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.665 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.481 ' HA ' ' CG2' ' A' ' 33' ' ' VAL . 56.8 mt -52.73 -38.91 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.564 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.521 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . -69.97 -27.18 73.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.64 5.48 41.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.515 -0.991 . . . . 0.0 109.729 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.491 HG11 ' N ' ' A' ' 34' ' ' ASN . 1.3 t -51.84 -69.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.491 ' N ' HG11 ' A' ' 33' ' ' VAL . 2.5 m120 -142.76 -98.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.077 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' HA3' ' OD2' ' A' ' 53' ' ' ASP . . . -106.04 62.63 0.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.521 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 42.1 t -89.12 118.34 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.26 . . . . 0.0 110.221 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.548 ' CD2' HG22 ' A' ' 7' ' ' VAL . 49.7 m-70 -65.91 -75.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 110.313 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.19 164.81 16.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.431 HD11 ' HB ' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -155.04 142.49 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -166.6 142.84 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.601 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.581 ' CG2' ' CG2' ' A' ' 23' ' ' VAL . 2.7 p -123.14 140.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.988 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.64 168.22 16.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mt -110.14 -28.91 8.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.226 -0.921 . . . . 0.0 109.979 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.23 -22.54 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.232 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.507 ' HB2' ' ND2' ' A' ' 47' ' ' ASN . 27.5 mt-10 -134.38 8.2 3.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mttt 46.92 74.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 0.0 110.507 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.507 ' ND2' ' HB2' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -170.26 -170.88 1.02 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.477 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 12' ' ' ILE . . . -155.91 141.41 17.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.033 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.484 ' HA ' ' CG2' ' A' ' 11' ' ' THR . 2.9 m -110.99 128.38 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -153.06 147.84 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.61 HG21 ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -113.17 171.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.312 -0.868 . . . . 0.0 110.265 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 5.3 p90 -157.35 127.59 6.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.695 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.707 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 1.4 p30 -107.24 18.57 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.352 -0.842 . . . . 0.0 111.757 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 52.1 Cg_endo -79.62 65.42 8.88 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 N-CA-C 108.141 -1.523 . . . . 0.0 108.141 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HD2' ' CA ' ' A' ' 6' ' ' GLY . 0.9 OUTLIER -40.15 -27.15 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.636 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.511 HD22 ' CA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -54.07 -22.32 10.57 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.473 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 12.6 mm100 -154.77 178.17 10.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -175.05 -65.05 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 49.6 Cg_endo -73.09 -49.07 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.648 1.341 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HB3' ' NE2' ' A' ' 57' ' ' GLN . 2.5 tppp? -67.85 -32.6 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 110.781 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 57' ' ' GLN . 12.6 m -68.9 -58.35 4.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 4.0 mp -55.65 -46.79 77.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.296 -0.878 . . . . 0.0 109.117 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 1.4 tp60 -61.17 -41.21 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 108.83 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' ASP . 84.3 tt0 -68.62 -39.65 80.7 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.654 0.74 . . . . 0.0 109.093 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -47.88 -52.12 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.56 -0.713 . . . . 0.0 109.781 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.467 HD11 HG23 ' A' ' 66' ' ' ILE . 34.3 mm -64.93 -55.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.581 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.53 -24.1 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 64' ' ' GLU . 2.7 t70 -75.89 -38.83 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.99 -65.95 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.19 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.12 41.38 0.76 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.651 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 19.9 m-85 -119.89 143.27 48.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -1.126 . . . . 0.0 110.243 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.62 74.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.456 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -117.69 148.89 41.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.096 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.483 ' CG2' ' HB2' ' A' ' 13' ' ' SER . 27.1 m -132.55 120.15 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.351 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.437 HG12 ' OD1' ' A' ' 77' ' ' ASN . 18.5 tt -63.74 152.39 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.3 -0.875 . . . . 0.0 110.021 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -148.99 61.32 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.262 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.437 ' OD1' HG12 ' A' ' 75' ' ' ILE . 15.7 p-10 -112.13 110.67 53.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.999 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -5.24 16.85 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.018 1.536 . . . . 0.0 110.513 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 27.4 p-10 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.251 0.548 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 47.45 61.17 14.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 110.287 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.5 -3.22 13.34 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.129 1.594 . . . . 0.0 109.534 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' GLY . 60.0 p -166.34 74.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.094 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.404 ' C ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -59.96 83.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.434 -0.791 . . . . 0.0 110.21 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 4' ' ' SER . . . 54.19 51.4 50.88 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.544 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -141.79 135.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -1.168 . . . . 0.0 110.599 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -110.14 -177.78 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 51' ' ' ILE . 57.9 m -131.6 135.08 46.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.761 -1.212 . . . . 0.0 110.776 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.565 HG21 ' CE1' ' A' ' 52' ' ' TYR . 2.1 t -127.91 145.23 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.415 HG21 ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -110.91 173.35 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.089 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.506 ' CD1' ' C ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -163.2 130.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.279 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 74' ' ' VAL . 8.5 t -84.5 135.65 34.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.221 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 8.1 p -123.76 166.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.655 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.02 -39.27 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.437 -0.789 . . . . 0.0 109.927 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.83 97.85 2.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.418 ' O ' ' C ' ' A' ' 18' ' ' THR . 0.9 OUTLIER -150.33 100.22 2.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.15 . . . . 0.0 110.238 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.538 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -42.0 -68.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.845 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 20' ' ' ASN . 6.0 m -154.68 -162.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.959 -1.088 . . . . 0.0 110.841 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.574 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.4 t30 -39.36 -50.13 2.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 110.806 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.505 ' O ' ' HB ' ' A' ' 25' ' ' THR . 42.7 m -43.69 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 18' ' ' THR . 97.2 m -75.31 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.597 -1.315 . . . . 0.0 111.831 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.607 HG12 ' CZ3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -43.1 -38.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.382 -0.824 . . . . 0.0 110.773 -178.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.607 ' CZ3' HG12 ' A' ' 23' ' ' VAL . 21.4 m-90 -69.8 -50.18 45.5 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.141 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 21' ' ' SER . 49.4 m -60.06 -38.19 82.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.464 -1.398 . . . . 0.0 107.827 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.638 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 17.0 mt -69.29 -54.23 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.476 ' O ' HG22 ' A' ' 30' ' ' ILE . 3.7 tt0 -54.89 -20.76 9.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -57.77 3.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.461 ' OE1' ' HE1' ' A' ' 69' ' ' MET . 0.6 OUTLIER -61.12 -52.07 66.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 109.721 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 27' ' ' GLU . 11.8 tt -51.39 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.555 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' HA2' HG12 ' A' ' 36' ' ' VAL . . . -77.92 -15.69 80.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -116.78 18.82 14.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.852 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' CG1' ' N ' ' A' ' 34' ' ' ASN . 5.0 p -82.51 -42.6 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.725 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.522 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 2.3 t30 -170.69 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.065 -1.022 . . . . 0.0 110.867 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 53' ' ' ASP . . . -67.91 55.31 0.38 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.163 -0.96 . . . . 0.0 110.841 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' A' ' 51' ' ' ILE . 5.7 p -95.39 151.55 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.914 -1.345 . . . . 0.0 108.476 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.646 ' NE2' ' HB ' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -115.32 -68.63 0.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.069 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.555 ' O ' ' CD1' ' A' ' 51' ' ' ILE . 9.4 p80 -124.66 168.76 12.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.593 -1.317 . . . . 0.0 111.091 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 38' ' ' HIS . 1.8 mp -145.75 150.01 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 110.571 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -125.87 149.96 48.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 109.814 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.582 ' CG2' ' CG2' ' A' ' 23' ' ' VAL . 7.7 p -164.08 137.4 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.001 -1.062 . . . . 0.0 110.49 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.18 127.8 17.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.9 -3.45 51.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 110.45 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.45 -33.01 32.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 110.087 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.74 -1.41 21.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.068 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 3.1 mptt 58.86 58.34 3.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -170.38 167.81 8.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 109.69 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -150.35 142.71 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.306 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 33.1 m -110.0 105.08 14.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 109.28 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -118.69 153.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.672 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.646 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -108.99 -177.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.438 -0.788 . . . . 0.0 110.591 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.565 ' CE1' HG21 ' A' ' 10' ' ' VAL . 20.3 p90 -178.34 141.51 0.23 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.618 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 6.3 p-10 -79.68 111.91 25.04 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.677 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HA ' HG22 ' A' ' 58' ' ' THR . 46.5 Cg_endo -73.5 0.76 7.65 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.724 1.381 . . . . 0.0 110.477 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' CE ' ' HA3' ' A' ' 6' ' ' GLY . 3.4 mttm -70.34 -19.39 63.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 0.0 110.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.05 3.1 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.955 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.552 ' HB2' ' CB ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -177.71 137.01 0.19 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 110.078 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.57 HG21 ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -169.05 -60.34 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.948 -1.095 . . . . 0.0 112.054 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.57 ' CD ' HG21 ' A' ' 58' ' ' THR . 51.8 Cg_endo -74.45 -52.1 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.159 1.084 . . . . 0.0 111.499 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -86.92 -50.57 6.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 111.396 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.552 ' CB ' ' HB2' ' A' ' 57' ' ' GLN . 63.9 m -46.15 -61.8 1.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.915 -1.116 . . . . 0.0 110.336 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.1 mp -52.23 -44.18 64.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.339 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -44.3 93.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.216 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -69.12 -19.95 64.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.544 -0.723 . . . . 0.0 109.329 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 62' ' ' LEU . . . -69.93 -65.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.787 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.49 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 1.3 tp -53.75 -35.3 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.46 ' N ' HG23 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -78.59 -30.18 46.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 6.7 t0 -64.71 -36.11 83.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 109.929 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.461 ' HE1' ' OE1' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -89.64 -68.6 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.017 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.44 -9.06 10.96 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.165 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.638 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 30.6 m-85 -49.79 124.7 10.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.942 -1.328 . . . . 0.0 110.122 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.68 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.273 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -133.11 178.39 6.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.972 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' SER . 58.5 t -135.49 95.69 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 110.166 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.49 ' CG2' ' HB ' ' A' ' 66' ' ' ILE . 50.1 pt -56.62 162.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.227 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -145.17 87.75 1.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -117.93 137.46 24.43 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.047 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.57 -9.38 23.95 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.945 1.497 . . . . 0.0 110.84 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.201 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.278 0.561 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.9 65.86 6.11 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.508 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 4' ' ' SER . 47.0 Cg_endo -74.38 -0.5 9.76 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.036 1.545 . . . . 0.0 109.581 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 0.7 OUTLIER 65.37 58.07 0.87 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.333 -0.854 . . . . 0.0 110.278 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.18 85.31 3.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.72 -33.81 0.05 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.571 ' CG1' ' NE2' ' A' ' 37' ' ' HIS . 11.4 m -66.87 143.32 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -1.214 . . . . 0.0 110.669 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -118.06 167.55 11.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.805 . . . . 0.0 109.927 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.3 t -112.11 136.81 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.063 -1.023 . . . . 0.0 110.287 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.56 ' CG1' ' CD2' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -120.65 126.2 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.627 -0.671 . . . . 0.0 110.438 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.495 ' C ' ' CG2' ' A' ' 12' ' ' ILE . 12.3 p -116.88 161.01 19.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 0.0 109.603 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.495 ' CG2' ' C ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -152.38 166.98 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.411 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -98.21 159.99 14.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.497 HG13 ' CG ' ' A' ' 17' ' ' MET . 58.4 t -145.27 147.34 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.079 . . . . 0.0 110.705 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 3.3 tp10 -146.15 -41.36 0.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 109.706 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.05 88.81 1.49 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.497 ' CG ' HG13 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -114.5 -160.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -1.163 . . . . 0.0 110.614 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' C ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -167.04 -144.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.546 -0.721 . . . . 0.0 109.711 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -58.74 153.29 17.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 109.764 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -27.88 -44.26 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.65 0.738 . . . . 0.0 111.535 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.51 ' O ' ' HB ' ' A' ' 25' ' ' THR . 96.0 p -50.18 -15.9 0.27 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.745 -1.222 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 1.2 p -49.56 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.838 -1.164 . . . . 0.0 111.058 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.609 HG11 ' CE3' ' A' ' 24' ' ' TRP . 7.9 p -82.84 -23.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 111.374 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.609 ' CE3' HG11 ' A' ' 23' ' ' VAL . 14.4 m-90 -69.34 -28.46 66.24 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.264 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 21' ' ' SER . 28.4 m -82.29 -41.69 19.81 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.621 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 83.4 mt -65.1 -45.86 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.401 ' OE2' HG13 ' A' ' 41' ' ' VAL . 19.1 tt0 -60.32 -36.45 77.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.459 -0.776 . . . . 0.0 109.659 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -45.11 80.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.149 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.428 ' O ' HG21 ' A' ' 33' ' ' VAL . 2.0 mm100 -54.23 -42.54 69.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.534 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 75.2 mt -61.36 -46.93 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.466 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . -62.78 -14.65 52.3 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -107.26 -9.86 15.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -1.043 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' A' ' 30' ' ' ILE . 3.2 t -49.02 -64.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.506 ' ND2' ' OE1' ' A' ' 57' ' ' GLN . 48.1 t-20 -169.66 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.095 . . . . 0.0 110.812 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.13 34.84 4.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 30' ' ' ILE . 29.0 t -70.61 115.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.055 -1.262 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.576 ' CD2' HG21 ' A' ' 51' ' ' ILE . 52.3 m-70 -65.27 -87.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 110.691 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.571 ' CD2' HG13 ' A' ' 51' ' ' ILE . 19.5 p80 -120.52 163.07 18.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.89 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 2.3 pp -148.42 153.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.449 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.83 141.54 5.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.95 -1.094 . . . . 0.0 111.096 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.537 HG22 ' CG2' ' A' ' 23' ' ' VAL . 1.2 p -124.32 135.34 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.416 ' C ' HD21 ' A' ' 43' ' ' LEU . 15.2 p -109.52 172.73 6.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 110.213 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 3.9 mm? -117.62 -29.06 5.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.998 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -66.04 -29.11 69.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 110.352 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 35.2 mt-10 -116.08 5.08 13.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.503 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER 43.01 65.61 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 45' ' ' GLU . 15.1 p-10 -155.59 171.89 19.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.463 ' HB1' HD12 ' A' ' 12' ' ' ILE . . . -141.22 154.78 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 110.372 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.417 ' C ' HG21 ' A' ' 50' ' ' ILE . 10.1 t -136.83 127.61 27.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 110.02 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.526 ' HB ' ' CG2' ' A' ' 39' ' ' ILE . 2.3 pp -144.62 161.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.138 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.609 HG23 ' N ' ' A' ' 52' ' ' TYR . 0.5 OUTLIER -112.41 168.17 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 110.509 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.609 ' N ' HG23 ' A' ' 51' ' ' ILE . 9.8 p90 -166.2 130.68 2.2 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.338 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 56' ' ' LEU . 18.1 p-10 -77.34 125.85 85.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.368 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 42.2 Cg_endo -68.93 -30.16 26.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.87 1.458 . . . . 0.0 109.597 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -20.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.961 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -135.86 -40.9 0.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.506 ' OE1' ' ND2' ' A' ' 34' ' ' ASN . 5.2 mp0 -106.77 -166.1 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 0.0 110.677 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.492 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.01 179.73 0.8 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 0.0 110.169 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 45.7 Cg_endo -73.44 -11.88 24.75 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.959 1.505 . . . . 0.0 110.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -76.29 -51.34 12.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 65' ' ' ALA . 54.3 m -44.37 -47.25 9.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.455 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.56 ' CD2' ' CG1' ' A' ' 10' ' ' VAL . 1.3 mp -57.32 -45.95 83.73 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.317 -0.865 . . . . 0.0 108.871 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HG3' HD11 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -62.74 -51.09 68.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.489 -0.757 . . . . 0.0 109.203 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.2 -34.66 78.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.389 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' THR . . . -56.5 -55.86 28.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 109.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 mm -55.2 -42.82 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -29.46 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.32 -23.96 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.945 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.78 -47.94 5.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.04 74.07 1.0 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.621 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 8.4 m-85 -146.48 135.52 22.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -1.139 . . . . 0.0 110.213 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.26 81.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.501 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -113.0 171.24 7.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.3 t -147.51 79.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.383 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.418 HD11 ' HG3' ' A' ' 63' ' ' GLN . 8.2 tt -56.93 141.77 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -159.72 92.89 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.408 ' N ' ' CD ' ' A' ' 78' ' ' PRO . 1.1 p30 -157.25 57.01 1.22 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 45.8 Cg_endo -73.43 162.15 40.84 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.998 1.525 . . . . 0.0 110.37 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.265 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 2.1 mmt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.207 0.527 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.436 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 58.1 t0 -165.81 56.35 0.42 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.955 . . . . 0.0 110.415 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 46.3 Cg_endo -73.97 -1.58 11.06 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.069 1.562 . . . . 0.0 109.742 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 5.8 m -67.17 -8.85 34.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.957 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 70.12 41.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.486 -0.758 . . . . 0.0 110.612 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.46 -46.56 3.0 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.605 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.548 ' CG1' ' NE2' ' A' ' 37' ' ' HIS . 16.1 m -53.64 131.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.326 . . . . 0.0 110.698 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 51' ' ' ILE . 3.0 t-20 -118.77 -177.81 3.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.55 -0.719 . . . . 0.0 109.759 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -117.5 140.56 49.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.084 -1.01 . . . . 0.0 110.399 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.575 HG22 ' CZ ' ' A' ' 52' ' ' TYR . 1.4 t -139.83 141.12 35.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.613 -0.68 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.3 p -114.35 159.39 20.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.233 -0.917 . . . . 0.0 110.186 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.521 ' O ' ' CD1' ' A' ' 12' ' ' ILE . 2.4 pp -135.99 136.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 110.196 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.423 ' HA ' ' CG ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -84.73 135.5 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 110.058 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.484 ' CG2' ' CD1' ' A' ' 12' ' ' ILE . 71.1 t -117.33 142.42 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.26 52.77 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.2 51.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.499 ' HB3' ' CB ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -97.19 -139.79 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.392 -1.063 . . . . 0.0 110.15 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.532 HG22 ' N ' ' A' ' 19' ' ' CYS . 1.4 t -179.43 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.203 -0.936 . . . . 0.0 110.42 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.532 ' N ' HG22 ' A' ' 18' ' ' THR . 0.8 OUTLIER -159.28 -139.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -89.32 -51.19 5.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 25' ' ' THR . 1.8 t -48.04 -17.75 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.667 -1.271 . . . . 0.0 110.619 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' O ' ' CD1' ' A' ' 26' ' ' ILE . 2.0 m -59.96 -87.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.73 -1.231 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.648 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 12.4 p -72.47 -17.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 112.044 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.648 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 8.0 m-90 -86.39 -40.87 14.96 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.02 -1.05 . . . . 0.0 110.522 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -68.41 -40.27 81.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.536 -1.353 . . . . 0.0 107.909 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.662 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 60.8 mt -60.7 -44.47 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.49 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -60.48 -28.8 68.64 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -42.87 88.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.515 ' HG3' ' CE ' ' A' ' 69' ' ' MET . 0.2 OUTLIER -67.09 -56.81 8.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.653 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 31' ' ' GLY . 1.5 tt -47.57 -28.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.23 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 30' ' ' ILE . . . -83.6 -28.24 36.26 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -83.31 -0.26 48.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.015 . . . . 0.0 109.86 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' CG1' HG22 ' A' ' 61' ' ' THR . 13.2 t -102.49 -62.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -105.46 154.16 20.72 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -66.85 62.49 0.19 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.525 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 35.6 m -52.15 125.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.186 -1.185 . . . . 0.0 110.521 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.566 ' CD2' ' O ' ' A' ' 35' ' ' GLY . 32.2 m-70 -93.24 -20.47 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.301 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.508 ' NE2' HG23 ' A' ' 49' ' ' THR . 2.2 t60 -136.95 138.61 40.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.859 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 27' ' ' GLU . 7.5 tt -139.27 123.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.58 148.19 35.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 110.417 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.572 HG13 ' CE2' ' A' ' 24' ' ' TRP . 24.7 t -126.94 151.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.296 -0.877 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 47' ' ' ASN . 15.0 p -122.4 145.91 47.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.442 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -106.67 -66.09 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.372 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -15.19 4.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.649 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.61 -9.07 13.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 110.362 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 48.72 73.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.168 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -163.79 178.73 7.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.71 151.96 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.416 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.508 HG23 ' NE2' ' A' ' 38' ' ' HIS . 8.9 t -140.89 122.36 15.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.494 ' HA ' ' CD2' ' A' ' 38' ' ' HIS . 2.3 pp -145.64 172.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.687 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.601 HG21 ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.36 170.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 109.755 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 7.4 p90 -164.0 126.22 2.41 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 4.5 p-10 -68.31 121.08 79.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.568 -0.707 . . . . 0.0 110.017 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 42.4 Cg_endo -67.77 -7.01 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.731 1.385 . . . . 0.0 110.084 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.9 -48.14 11.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.838 . . . . 0.0 109.81 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 8.9 mp -82.09 -63.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.541 ' O ' ' CG2' ' A' ' 58' ' ' THR . 0.3 OUTLIER -156.76 -154.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 109.25 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.601 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -175.53 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 110.627 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 47.8 Cg_endo -73.02 -28.66 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.419 1.221 . . . . 0.0 109.159 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.34 -29.43 17.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.514 -0.741 . . . . 0.0 110.859 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 57' ' ' GLN . 27.6 m -73.42 -63.41 1.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.738 -1.226 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD2' HG13 ' A' ' 10' ' ' VAL . 5.7 mp -46.84 -39.06 11.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 108.956 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -67.11 -48.0 69.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.533 -0.73 . . . . 0.0 109.272 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 68' ' ' ASP . 35.7 tt0 -66.75 -23.45 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.376 -0.828 . . . . 0.0 109.367 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 62' ' ' LEU . . . -65.67 -69.56 0.29 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.802 . . . . 0.0 109.705 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.56 -30.43 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 109.158 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 10.7 t0 -78.58 -39.88 36.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 64' ' ' GLU . 18.0 t0 -53.15 -35.92 60.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.785 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.515 ' CE ' ' HG3' ' A' ' 29' ' ' GLN . 6.1 mmt -84.89 -68.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.193 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -12.42 7.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.662 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 15.4 m-85 -51.9 142.16 16.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.278 -1.13 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -68.62 70.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.71 164.36 27.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.414 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.49 152.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.126 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.424 ' HA ' HG23 ' A' ' 12' ' ' ILE . 1.7 pp -111.58 143.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.122 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.407 ' C ' ' CG ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -129.24 -171.82 2.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 110.083 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.536 ' OD1' ' CD ' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -164.27 -61.2 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.199 -0.938 . . . . 0.0 110.275 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.536 ' CD ' ' OD1' ' A' ' 77' ' ' ASN . 46.6 Cg_endo -72.98 57.64 3.26 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.449 1.237 . . . . 0.0 110.151 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.235 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 53' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.551 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 1.9 t -143.92 165.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.054 -1.262 . . . . 0.0 110.079 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 6.5 m-20 -138.36 161.9 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.495 -0.753 . . . . 0.0 109.437 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 t -126.01 139.11 53.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.677 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.792 HG11 ' CD2' ' A' ' 62' ' ' LEU . 1.5 t -127.99 127.58 68.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.671 -0.643 . . . . 0.0 110.061 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.66 143.05 39.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.752 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.2 pp -138.59 154.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.624 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.401 ' C ' HG23 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -98.01 166.16 11.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.691 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 17' ' ' MET . 58.7 t -144.08 148.75 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -152.58 19.7 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.17 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.449 ' HA3' ' OD2' ' A' ' 72' ' ' ASP . . . -148.25 80.88 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.828 ' O ' HG23 ' A' ' 18' ' ' THR . 63.4 mtm -130.68 -143.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.402 -1.058 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER 174.73 -71.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.321 -0.862 . . . . 0.0 109.735 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ASN . 33.5 m -112.76 160.66 17.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.53 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 14.5 p30 -42.73 -43.86 4.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.019 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.532 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 83.2 p -45.99 -21.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 110.694 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.745 ' O ' HD12 ' A' ' 26' ' ' ILE . 4.4 m -56.73 -86.17 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.917 -1.114 . . . . 0.0 111.375 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.831 HG22 HG11 ' A' ' 41' ' ' VAL . 12.0 p -72.34 -37.62 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.399 -0.813 . . . . 0.0 111.819 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.632 ' CZ2' ' CG2' ' A' ' 41' ' ' VAL . 9.2 m-90 -62.29 -47.43 84.35 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.517 -0.739 . . . . 0.0 110.485 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 14.7 m -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.611 -1.306 . . . . 0.0 108.16 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.029 HD11 ' CD2' ' A' ' 71' ' ' PHE . 48.0 mt -68.0 -42.66 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.517 ' CA ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -66.13 -28.23 68.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.818 . . . . 0.0 109.874 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -49.19 65.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.37 -55.5 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.776 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.922 ' O ' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -52.8 -29.43 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.586 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.614 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -86.69 -21.29 51.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -101.75 10.98 39.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -1.108 . . . . 0.0 109.76 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 30' ' ' ILE . 6.3 p -83.03 -28.88 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 110.839 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.565 ' CB ' ' HG3' ' A' ' 57' ' ' GLN . 6.0 t-20 -165.88 -135.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.941 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.13 38.67 2.73 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.22 -0.991 . . . . 0.0 110.684 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.922 HG21 ' O ' ' A' ' 30' ' ' ILE . 3.5 t -67.33 115.19 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.926 -1.337 . . . . 0.0 109.446 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.565 ' H ' HD13 ' A' ' 51' ' ' ILE . 39.6 m-70 -64.07 -85.38 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.427 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.599 ' C ' HG23 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -132.33 174.65 10.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.068 . . . . 0.0 110.907 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -157.66 173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.531 -0.731 . . . . 0.0 109.44 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 39' ' ' ILE . 12.6 mttm -166.43 148.28 6.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.055 -1.028 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.831 HG11 HG22 ' A' ' 23' ' ' VAL . 4.2 m -123.23 159.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.965 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.03 85.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -25.21 4.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -42.14 67.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.036 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.53 12.74 22.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? 49.53 69.19 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.268 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 18.3 p-10 -170.08 -177.68 2.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.43 137.85 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 110.106 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 49' ' ' THR . 15.0 t -109.98 130.33 55.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.833 HD11 HD21 ' A' ' 62' ' ' LEU . 2.0 pp -143.1 151.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.613 ' C ' HD12 ' A' ' 51' ' ' ILE . 1.1 pp -109.79 -177.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 23.5 p90 -174.33 133.26 0.39 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.122 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 0.4 OUTLIER -71.3 117.34 55.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.551 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.6 Cg_endo -72.65 -26.66 16.07 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.901 1.474 . . . . 0.0 109.5 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HD3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -70.7 -14.36 62.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.691 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.476 HD23 ' HD3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -121.99 -32.51 3.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.565 ' HG3' ' CB ' ' A' ' 34' ' ' ASN . 25.0 mm100 -134.72 -154.61 0.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.418 -0.802 . . . . 0.0 109.708 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.551 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.33 -179.17 0.64 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.013 -1.054 . . . . 0.0 110.306 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.735 ' HA ' HD13 ' A' ' 62' ' ' LEU . 42.3 Cg_endo -69.96 -17.9 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.796 1.419 . . . . 0.0 110.293 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.13 -49.04 71.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.543 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 m -50.19 -44.08 52.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.202 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.833 HD21 HD11 ' A' ' 50' ' ' ILE . 6.2 mp -57.07 -43.66 82.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 108.68 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -45.16 92.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.09 -31.6 70.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.475 -0.766 . . . . 0.0 109.543 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -57.4 -59.42 5.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.485 -0.759 . . . . 0.0 110.087 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.18 -45.35 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.86 -16.83 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.818 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 63.6 t0 -81.08 -42.64 20.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.421 ' HE2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -86.43 -66.32 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 136.83 -26.03 3.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 1.029 ' CD2' HD11 ' A' ' 26' ' ' ILE . 92.3 m-85 -42.15 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -1.101 . . . . 0.0 110.2 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.449 ' OD2' ' HA3' ' A' ' 16' ' ' GLY . 1.2 p30 -56.99 83.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.85 . . . . 0.0 110.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 12' ' ' ILE . . . -116.78 135.94 53.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 0.0 109.984 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.7 p -111.67 142.6 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 110.502 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 5.8 mt -85.21 166.9 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.407 ' N ' HG22 ' A' ' 75' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.037 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.054 HG21 ' CE1' ' A' ' 37' ' ' HIS . 27.8 m -64.42 132.47 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.235 . . . . 0.0 110.486 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 51' ' ' ILE . 4.9 m-20 -95.5 -174.42 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.42 -0.8 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 95.5 p -131.28 132.14 44.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.942 -1.099 . . . . 0.0 111.153 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.519 HG23 ' CE1' ' A' ' 52' ' ' TYR . 2.1 t -128.66 129.12 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.765 -0.584 . . . . 0.0 109.546 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.638 HG22 HG23 ' A' ' 49' ' ' THR . 82.5 p -112.01 159.32 18.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.221 -0.925 . . . . 0.0 110.646 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.845 ' O ' HD12 ' A' ' 12' ' ' ILE . 2.7 pp -139.8 157.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.359 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -88.61 168.14 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 109.694 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.917 HG11 ' SD ' ' A' ' 17' ' ' MET . 70.5 t -140.11 147.49 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.991 -1.068 . . . . 0.0 110.585 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -170.61 42.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 17' ' ' MET . . . -171.69 -34.06 0.03 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.917 ' SD ' HG11 ' A' ' 14' ' ' VAL . 19.3 ptt? -42.88 151.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -1.118 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.532 ' N ' ' HB3' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -72.01 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -0.825 . . . . 0.0 110.716 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -107.24 -31.48 8.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -125.31 -67.19 0.91 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.192 -0.943 . . . . 0.0 109.974 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.539 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 2.7 t -49.96 -19.44 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.834 -1.166 . . . . 0.0 109.971 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.893 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -46.04 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.946 HG21 HG11 ' A' ' 41' ' ' VAL . 7.3 p -85.32 -31.64 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 111.461 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.665 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 17.1 m-90 -60.84 -32.18 71.59 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.165 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 14.7 m -80.4 -44.93 18.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.939 HD11 ' CD2' ' A' ' 71' ' ' PHE . 9.0 mt -63.64 -59.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.687 ' HG3' HG21 ' A' ' 39' ' ' ILE . 42.9 tt0 -42.91 -41.93 3.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.487 -0.758 . . . . 0.0 109.292 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.27 -43.79 83.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' A' ' 32' ' ' LYS . 1.9 mt-30 -74.98 -63.0 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.08 -1.012 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.852 ' O ' HG21 ' A' ' 36' ' ' VAL . 24.3 pt -51.45 -34.57 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 109.473 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' HG13 ' A' ' 30' ' ' ILE . . . -77.19 -22.33 71.23 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.409 -1.877 . . . . 0.0 108.409 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 12.3 tttm -101.02 3.17 41.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -1.007 . . . . 0.0 110.013 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.794 HG12 ' N ' ' A' ' 34' ' ' ASN . 1.8 t -59.94 -76.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.794 ' N ' HG12 ' A' ' 33' ' ' VAL . 23.7 t-20 -177.25 -75.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.941 -1.099 . . . . 0.0 110.95 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.61 -26.73 74.26 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.852 HG21 ' O ' ' A' ' 30' ' ' ILE . 35.9 m -50.81 123.77 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -1.146 . . . . 0.0 110.54 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 1.054 ' CE1' HG21 ' A' ' 7' ' ' VAL . 5.2 p80 -129.54 10.89 5.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.832 ' N ' HD11 ' A' ' 51' ' ' ILE . 4.7 t-80 -171.85 143.66 1.66 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 109.934 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.687 HG21 ' HG3' ' A' ' 27' ' ' GLU . 3.9 mp -141.2 149.59 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.41 108.51 4.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.946 HG11 HG21 ' A' ' 23' ' ' VAL . 4.8 p -125.89 140.4 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 0.0 110.476 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 p -112.54 150.94 30.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.987 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 -2.91 22.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 110.136 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -102.51 -32.55 9.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.3 -3.08 37.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' C ' ' HB ' ' A' ' 14' ' ' VAL . 4.8 mttp 53.75 65.06 1.62 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.321 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.55 176.01 12.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 0.0 109.707 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.63 146.56 25.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 0.0 110.781 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.638 HG23 HG22 ' A' ' 11' ' ' THR . 88.3 m -132.8 100.34 4.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.742 . . . . 0.0 109.435 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -119.23 156.5 21.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 110.231 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 1.014 HD13 ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -109.86 174.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 8.1 p90 -159.28 128.71 5.44 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.583 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.631 ' CA ' HG12 ' A' ' 7' ' ' VAL . 6.6 t0 -68.52 115.13 26.91 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 110.014 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 42.9 Cg_endo -69.44 -44.89 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.906 1.477 . . . . 0.0 110.138 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' A' ' 53' ' ' ASP . 11.1 ptmt -42.56 -26.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -123.93 -22.69 4.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.372 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 49.3 mm-40 -131.01 -158.64 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.536 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -170.72 179.42 0.71 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HA ' HD12 ' A' ' 62' ' ' LEU . 43.1 Cg_endo -69.46 -12.27 33.1 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.719 1.379 . . . . 0.0 110.291 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' THR . 11.1 mttt -74.14 -51.97 13.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.649 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' LYS . 7.4 m -45.2 -48.63 12.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 109.227 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 59' ' ' PRO . 2.1 mt -57.91 -48.88 78.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 109.263 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.9 -37.99 72.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.001 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 68' ' ' ASP . 47.1 tt0 -73.53 -31.76 63.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.251 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -55.78 -58.22 8.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.485 -0.759 . . . . 0.0 109.548 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 12' ' ' ILE . 56.7 mt -61.37 -37.62 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.489 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.89 -12.24 60.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 64' ' ' GLU . 25.0 t70 -85.59 -39.82 16.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.4 mmt -87.59 -56.13 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 123.56 -10.16 8.61 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.939 ' CD2' HD11 ' A' ' 26' ' ' ILE . 8.0 m-85 -42.76 143.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -1.179 . . . . 0.0 110.347 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.14 74.09 2.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -119.81 162.15 19.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.645 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.433 ' HB ' ' OG ' ' A' ' 13' ' ' SER . 40.8 t -144.07 108.59 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.771 ' HA ' HG22 ' A' ' 12' ' ' ILE . 14.4 pt -46.26 146.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.003 HG11 ' CE1' ' A' ' 37' ' ' HIS . 6.2 m -82.14 142.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.4 m-20 -108.09 166.64 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.073 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.3 p -114.37 131.64 56.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 62' ' ' LEU . 1.3 t -117.8 137.38 51.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.642 -0.661 . . . . 0.0 110.351 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.712 ' CG2' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -114.64 152.67 31.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.573 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.006 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -145.35 139.83 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.003 -1.06 . . . . 0.0 110.764 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.7 m -90.55 122.28 33.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG12 ' C ' ' A' ' 46' ' ' LYS . 10.2 p -111.45 153.84 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 110.494 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -139.98 -59.74 0.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.48 75.77 0.52 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.459 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -98.36 -146.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.205 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 m -156.93 -67.11 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.208 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.7 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.21 -0.931 . . . . 0.0 110.12 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.595 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 3.9 t-20 -140.8 -68.92 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.841 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -45.38 -22.73 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.103 -0.998 . . . . 0.0 109.975 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 16.0 t -49.83 -83.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.796 -1.19 . . . . 0.0 110.398 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.947 HG21 HG21 ' A' ' 41' ' ' VAL . 15.0 p -81.13 -42.22 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 111.531 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.622 ' N ' HG13 ' A' ' 23' ' ' VAL . 9.8 m-90 -52.55 -33.75 47.07 Favored 'General case' 0 C--N 1.285 -2.223 0 O-C-N 121.127 -0.983 . . . . 0.0 109.725 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.513 ' CB ' ' O ' ' A' ' 21' ' ' SER . 25.7 m -77.8 -43.04 31.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.12 HD11 ' CD2' ' A' ' 71' ' ' PHE . 63.0 mt -64.22 -58.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.7 tm-20 -42.76 -39.72 2.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.529 -0.732 . . . . 0.0 109.407 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.34 -47.74 82.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.77 -56.53 5.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.212 -0.93 . . . . 0.0 110.129 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.813 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.5 tp -48.81 -30.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.49 -32.86 32.98 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -89.14 6.3 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -1.121 . . . . 0.0 110.05 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 30' ' ' ILE . 6.1 p -81.81 -18.73 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -161.35 -132.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 109.985 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 37' ' ' HIS . . . -115.05 47.99 0.98 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 51' ' ' ILE . 9.9 p -45.77 135.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -1.156 . . . . 0.0 110.415 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 1.003 ' CE1' HG11 ' A' ' 7' ' ' VAL . 13.1 m80 -105.63 -10.54 16.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.959 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.514 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 25.4 t60 -163.87 145.25 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.416 -0.802 . . . . 0.0 109.822 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.914 HD12 HG13 ' A' ' 50' ' ' ILE . 6.8 tt -162.27 124.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.049 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -145.23 140.1 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 110.399 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.947 HG21 HG21 ' A' ' 23' ' ' VAL . 4.6 p -131.9 148.03 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 m -126.88 168.47 14.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.07 -1.82 14.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 17.6 pt-20 -95.57 -34.12 12.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 9.6 mt-10 -102.04 4.97 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.559 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER 45.65 58.69 4.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.464 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.485 ' N ' HG12 ' A' ' 14' ' ' VAL . 9.3 p-10 -169.63 166.15 10.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.049 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.553 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -148.61 148.24 29.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.455 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.712 HG23 ' CG2' ' A' ' 11' ' ' THR . 3.4 m -109.89 152.82 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.791 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.914 HG13 HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.79 157.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.989 -1.069 . . . . 0.0 110.593 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.59 169.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.547 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.642 ' CE1' HG23 ' A' ' 10' ' ' VAL . 9.7 p90 -165.1 118.73 1.24 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.883 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.651 ' CG ' HG12 ' A' ' 7' ' ' VAL . 3.9 t0 -63.65 117.98 40.18 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.158 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.542 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.7 Cg_endo -70.68 -43.11 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.864 1.455 . . . . 0.0 109.841 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HD3' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.93 -26.04 0.37 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 tp -117.31 -34.89 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 110.07 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' HG23 ' A' ' 58' ' ' THR . 1.9 tp-100 -124.39 -150.95 0.46 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.955 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.56 HG22 ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.11 -179.36 0.35 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.294 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 58' ' ' THR . 41.7 Cg_endo -69.81 -30.43 22.04 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.917 1.483 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -36.2 83.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.863 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.411 HG21 ' CG ' ' A' ' 57' ' ' GLN . 97.2 m -57.75 -56.7 18.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.785 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.651 HD22 HG11 ' A' ' 10' ' ' VAL . 2.2 mp -50.16 -41.94 50.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.17 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.544 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.9 tt0 -61.49 -44.5 96.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.103 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -27.36 66.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.518 -0.739 . . . . 0.0 109.459 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -65.35 -62.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 109.942 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 73' ' ' ALA . 18.2 mm -51.63 -38.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.608 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -68.94 -26.15 64.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -70.88 -32.34 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.81 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.519 ' HE2' ' HA ' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -89.66 -50.49 6.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.266 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 121.72 -25.68 6.79 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 1.12 ' CD2' HD11 ' A' ' 26' ' ' ILE . 39.7 m-85 -43.01 116.7 0.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 110.281 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.03 83.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 110.398 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.006 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -129.26 137.04 50.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.4 p -117.93 133.93 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.226 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.544 HD11 ' HA ' ' A' ' 63' ' ' GLN . 6.1 mt -73.94 162.61 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.01 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.123 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.533 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 2.5 t -64.58 168.24 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -1.092 . . . . 0.0 110.805 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.4 m-20 -149.95 173.97 13.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.659 -0.651 . . . . 0.0 109.29 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 11.2 p -127.41 147.72 50.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.941 -1.099 . . . . 0.0 110.771 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.753 HG11 HD22 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -136.38 125.55 38.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.547 -0.72 . . . . 0.0 110.208 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.649 ' CG2' HG23 ' A' ' 49' ' ' THR . 0.9 OUTLIER -109.55 144.93 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.527 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.71 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.3 pp -144.1 169.65 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.551 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.44 ' N ' HD12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -114.34 138.24 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.393 -0.817 . . . . 0.0 109.809 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.85 146.68 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.528 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -145.94 27.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.868 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.36 80.42 0.12 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.603 ' O ' HG23 ' A' ' 18' ' ' THR . 0.0 OUTLIER -122.94 -138.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -1.141 . . . . 0.0 110.026 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 17' ' ' MET . 19.2 p -156.32 -94.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.346 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.5 p -142.51 -40.56 0.34 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.082 -1.011 . . . . 0.0 110.029 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 16.7 t-20 -145.34 -47.45 0.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.804 ' HA ' HG23 ' A' ' 25' ' ' THR . 0.8 OUTLIER -49.32 -20.47 0.66 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.925 -1.109 . . . . 0.0 110.325 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' O ' HD12 ' A' ' 26' ' ' ILE . 14.3 t -52.44 -81.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.939 -1.101 . . . . 0.0 111.381 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.768 ' CG1' HG21 ' A' ' 41' ' ' VAL . 7.5 p -81.16 -34.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.187 -0.946 . . . . 0.0 111.986 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.685 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.7 m-90 -60.2 -38.01 82.02 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 121.12 -0.988 . . . . 0.0 110.534 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.804 HG23 ' HA ' ' A' ' 21' ' ' SER . 16.4 p -80.49 -44.92 18.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.634 -1.291 . . . . 0.0 107.832 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 71' ' ' PHE . 50.4 mt -61.42 -56.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' VAL . 7.3 tt0 -43.22 -48.91 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.124 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -53.14 -41.8 65.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' HG23 ' A' ' 33' ' ' VAL . 18.6 tp60 -75.83 -51.87 11.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.799 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.832 ' O ' HG21 ' A' ' 36' ' ' VAL . 9.8 mm -51.24 -39.43 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.467 ' HA2' ' HB ' ' A' ' 36' ' ' VAL . . . -72.15 -30.95 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -82.89 -1.8 53.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -1.089 . . . . 0.0 110.126 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 29' ' ' GLN . 6.2 t -80.95 -47.31 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -155.66 -147.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.43 42.71 3.17 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.832 HG21 ' O ' ' A' ' 30' ' ' ILE . 41.4 t -46.73 100.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 110.109 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.523 ' HB2' HG12 ' A' ' 51' ' ' ILE . 59.7 m80 -57.83 -85.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.293 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.552 ' CD2' HG13 ' A' ' 51' ' ' ILE . 14.0 p80 -111.54 161.64 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.095 -1.003 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.559 HD12 HG21 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -162.01 140.45 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.412 -0.805 . . . . 0.0 109.623 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.69 155.43 35.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.768 HG21 ' CG1' ' A' ' 23' ' ' VAL . 14.0 m -133.86 151.52 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.842 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 t -114.39 162.42 16.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 43' ' ' LEU . 2.1 mp -115.45 -18.08 11.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 110.342 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.86 -44.8 12.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.94 -5.32 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.355 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 54.68 79.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -168.07 -172.45 1.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.25 134.11 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.649 HG23 ' CG2' ' A' ' 11' ' ' THR . 32.2 m -122.31 118.04 27.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 109.563 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.11 HD11 ' CD2' ' A' ' 62' ' ' LEU . 1.3 pp -143.76 167.43 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.758 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.679 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.1 pp -115.57 -173.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.484 -0.76 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 20.5 p90 -175.5 152.18 1.31 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.875 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 4.6 t0 -92.85 105.23 14.02 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 42.6 Cg_endo -69.25 -10.07 27.97 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.0 1.526 . . . . 0.0 109.479 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.782 ' HB2' HD12 ' A' ' 56' ' ' LEU . 7.2 mtpt -57.01 -32.03 65.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.44 -0.787 . . . . 0.0 109.149 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.782 HD12 ' HB2' ' A' ' 55' ' ' LYS . 5.0 mp -118.35 -44.5 2.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.656 . . . . 0.0 109.381 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' A' ' 58' ' ' THR . 3.3 pt20 -107.84 -141.59 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 109.509 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.607 HG22 ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.33 -178.35 0.31 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.008 . . . . 0.0 110.279 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.607 ' HD2' HG22 ' A' ' 58' ' ' THR . 43.9 Cg_endo -70.9 -17.68 32.23 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.905 1.476 . . . . 0.0 110.11 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HE3' ' HG2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -73.07 -36.46 66.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.768 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.5 m -53.43 -52.81 58.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.536 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.11 ' CD2' HD11 ' A' ' 50' ' ' ILE . 2.0 mp -52.27 -41.23 62.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.026 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.402 ' HG3' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -65.42 -45.31 84.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 178.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -33.69 74.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.386 -0.821 . . . . 0.0 109.181 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.78 -52.1 66.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.52 -44.65 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.636 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.15 -17.65 58.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.86 -34.49 21.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.408 -0.807 . . . . 0.0 110.101 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 mmm -85.77 -57.79 2.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 128.61 -17.98 5.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 26' ' ' ILE . 33.7 m-85 -42.73 115.62 0.75 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -1.187 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.02 82.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.281 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -132.55 144.36 50.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.02 128.78 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.655 ' HA ' HG22 ' A' ' 12' ' ' ILE . 2.6 tt -54.52 161.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.53 ' N ' HG12 ' A' ' 75' ' ' ILE . 46.1 t-80 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.494 ' HA3' ' HD2' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.527 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 3.4 m -141.9 131.64 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.279 . . . . 0.0 110.583 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -96.9 -165.37 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.519 -0.738 . . . . 0.0 109.076 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.928 ' CB ' HG22 ' A' ' 51' ' ' ILE . 49.5 p -148.43 141.95 25.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.799 -1.188 . . . . 0.0 111.129 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.623 HG11 HD11 ' A' ' 62' ' ' LEU . 2.2 t -142.89 141.31 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.708 -0.62 . . . . 0.0 109.944 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.406 HG22 HG23 ' A' ' 49' ' ' THR . 66.9 p -117.89 156.31 28.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.776 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.6 pp -133.61 -175.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.267 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.501 ' N ' HD12 ' A' ' 12' ' ' ILE . 97.5 p -117.88 131.78 56.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 14' ' ' VAL . 3.4 p -116.98 125.56 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -134.05 -40.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.29 85.66 1.2 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.468 ' O ' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -110.75 -151.02 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.512 HG23 ' N ' ' A' ' 19' ' ' CYS . 8.9 t -179.06 -138.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.85 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.512 ' N ' HG23 ' A' ' 18' ' ' THR . 8.0 p -56.67 163.22 1.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.066 -1.021 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.496 ' OD1' ' HB2' ' A' ' 24' ' ' TRP . 5.4 t-20 -37.79 -30.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 110.846 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.555 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 0.1 OUTLIER -51.24 -20.74 1.72 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.809 -1.182 . . . . 0.0 110.056 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -46.31 -74.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 111.835 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.861 ' CG2' HG21 ' A' ' 41' ' ' VAL . 2.0 m -88.42 -38.68 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.646 ' CE3' HG22 ' A' ' 23' ' ' VAL . 25.9 m-90 -59.44 -31.73 69.57 Favored 'General case' 0 C--N 1.28 -2.438 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.278 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.555 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 7.6 m -84.42 -48.23 9.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 0.0 107.911 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.051 HD11 ' CD2' ' A' ' 71' ' ' PHE . 33.9 mt -59.9 -44.31 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.884 ' HG3' HD13 ' A' ' 39' ' ' ILE . 35.2 tt0 -57.55 -45.87 84.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.602 -0.686 . . . . 0.0 109.523 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 11.8 tt0 -54.84 -42.33 71.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.429 -0.795 . . . . 0.0 109.948 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -74.98 -63.62 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.645 ' O ' HG11 ' A' ' 36' ' ' VAL . 22.7 pt -50.44 -38.86 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.025 -1.047 . . . . 0.0 108.972 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.538 ' C ' HG11 ' A' ' 36' ' ' VAL . . . -69.18 -24.71 75.87 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -102.83 9.24 39.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.655 -0.909 . . . . 0.0 109.918 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.648 HG22 ' H ' ' A' ' 34' ' ' ASN . 1.2 p -66.13 -161.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.553 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.66 ' ND2' HD21 ' A' ' 56' ' ' LEU . 2.3 m-20 -61.74 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -118.13 87.73 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.29 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 36' ' ' VAL . 7.6 p -121.31 82.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.943 ' CD2' HD13 ' A' ' 51' ' ' ILE . 8.2 p80 -73.89 7.04 2.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 111.985 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.76 ' H ' HD11 ' A' ' 51' ' ' ILE . 15.9 t60 -173.34 149.81 1.79 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.773 -1.204 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.884 HD13 ' HG3' ' A' ' 27' ' ' GLU . 2.8 pp -157.8 158.01 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.457 -0.777 . . . . 0.0 109.575 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -154.35 163.69 39.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.832 -1.168 . . . . 0.0 111.11 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.861 HG21 ' CG2' ' A' ' 23' ' ' VAL . 73.4 t -136.96 138.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.483 -0.761 . . . . 0.0 110.019 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -124.85 76.2 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.21 -33.19 69.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -53.01 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.421 -0.8 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.54 58.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.315 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 60.51 70.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.38 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 14.6 t-20 -170.26 163.39 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB3' ' CG1' ' A' ' 12' ' ' ILE . . . -129.81 137.25 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 110.318 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 1.6 m -113.17 108.25 17.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.862 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.637 HD11 HD13 ' A' ' 62' ' ' LEU . 2.5 pp -136.77 154.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.943 HD13 ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -116.98 -166.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 22.5 p90 -174.52 155.13 2.19 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.292 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 3.0 p-10 -95.06 117.96 66.69 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 110.464 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 44.7 Cg_endo -70.89 -6.2 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.684 1.36 . . . . 0.0 109.305 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HD2' ' HA3' ' A' ' 6' ' ' GLY . 0.7 OUTLIER -66.73 -43.38 84.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.652 . . . . 0.0 109.544 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.66 HD21 ' ND2' ' A' ' 34' ' ' ASN . 1.2 tt -129.16 -8.28 4.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.37 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.61 -165.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.537 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.493 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -163.86 177.81 1.68 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 110.1 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HA ' HD21 ' A' ' 62' ' ' LEU . 45.6 Cg_endo -72.11 -7.98 22.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.017 1.535 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -33.96 21.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.348 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' LEU . 3.5 m -55.61 -68.16 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.831 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -45.45 -32.96 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 109.084 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -45.71 63.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 108.814 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -68.12 -29.9 68.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.2 -68.54 0.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.727 . . . . 0.0 110.153 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 67' ' ' ASP . 27.6 pt -50.56 -34.2 12.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.102 -0.999 . . . . 0.0 109.88 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 66' ' ' ILE . 11.4 t70 -74.25 -22.26 59.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.738 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.3 t0 -76.68 -34.82 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.512 ' CE ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -75.34 -46.22 34.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.78 9.97 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 1.051 ' CD2' HD11 ' A' ' 26' ' ' ILE . 9.3 m-85 -64.15 134.23 54.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 7.4 m-20 -69.29 58.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.377 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -109.94 143.88 39.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 110.008 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 t -139.6 146.7 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 0.0 110.288 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' A' ' 12' ' ' ILE . 9.4 tt -59.89 147.18 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 83.1 t60 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.477 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 7' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.617 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 1.4 t -153.43 162.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -1.145 . . . . 0.0 110.318 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.59 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 5.9 m-20 -150.53 147.1 27.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -0.782 . . . . 0.0 109.872 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 t -106.56 138.31 42.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.325 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.726 HG21 HD23 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -124.76 131.21 72.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.571 -0.706 . . . . 0.0 110.381 -178.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.97 139.71 49.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 109.91 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.993 HD13 ' HB1' ' A' ' 73' ' ' ALA . 2.5 pp -141.07 167.2 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.674 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.562 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 4.6 m -90.08 140.85 29.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.348 -0.845 . . . . 0.0 108.803 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.692 HG12 ' SD ' ' A' ' 17' ' ' MET . 38.0 t -110.56 143.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.893 -1.13 . . . . 0.0 111.013 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -168.67 28.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 72' ' ' ASP . . . -153.08 57.64 0.42 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.692 ' SD ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.92 -153.91 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -1.206 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 19' ' ' CYS . 23.8 m -148.5 -83.59 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -0.918 . . . . 0.0 109.912 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.462 ' N ' HG22 ' A' ' 18' ' ' THR . 1.2 t -137.77 -141.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.496 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 5.1 m120 -46.41 -25.06 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.993 -1.067 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.543 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 67.9 p -57.84 -11.05 1.99 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.013 -1.055 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 93.9 m -52.9 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.846 -1.159 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.68 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 8.2 p -80.58 -30.09 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 111.252 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.68 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 18.2 m-90 -67.16 -43.34 82.55 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.671 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.651 HG22 ' SD ' ' A' ' 69' ' ' MET . 12.4 m -71.27 -45.22 63.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.496 -1.377 . . . . 0.0 107.867 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.944 ' CG2' HD11 ' A' ' 39' ' ' ILE . 1.1 mp -61.17 -58.52 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' ' 26' ' ' ILE . 82.4 tt0 -49.52 -32.89 13.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -68.95 -56.54 7.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' LYS . 5.8 tp60 -73.41 -61.62 1.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.962 HG21 HD13 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -49.13 -34.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.288 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.58 -27.45 67.41 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 29' ' ' GLN . 2.1 tttp -92.44 0.57 57.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -1.065 . . . . 0.0 110.088 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.804 HG13 ' N ' ' A' ' 34' ' ' ASN . 1.7 p -82.75 -146.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.351 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.804 ' N ' HG13 ' A' ' 33' ' ' VAL . 95.6 m-20 -49.06 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.32 61.75 0.33 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.145 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.953 HG11 HG23 ' A' ' 30' ' ' ILE . 25.8 m -59.92 135.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.128 -1.219 . . . . 0.0 109.818 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.617 ' CE1' ' CG1' ' A' ' 7' ' ' VAL . 37.5 m80 -92.88 -24.44 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.136 -0.977 . . . . 0.0 111.017 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.406 ' CG ' ' C ' ' A' ' 37' ' ' HIS . 69.3 m80 -147.04 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.952 -1.093 . . . . 0.0 110.778 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.962 HD13 HG21 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -167.07 123.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.133 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.95 140.09 24.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 23' ' ' VAL . 8.0 m -109.85 139.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.399 -0.813 . . . . 0.0 110.112 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.39 112.27 23.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.038 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 -16.46 38.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.301 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.77 -10.45 20.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.269 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -121.3 -1.53 9.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.215 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 50.75 67.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.648 ' HA ' HG23 ' A' ' 14' ' ' VAL . 1.2 t-20 -169.98 170.32 7.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 110.022 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.68 144.81 22.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.216 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.446 ' C ' ' CG2' ' A' ' 50' ' ' ILE . 88.1 m -120.31 129.76 54.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -0.821 . . . . 0.0 109.662 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.446 ' CG2' ' C ' ' A' ' 49' ' ' THR . 1.5 pp -147.33 161.27 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.07 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -114.49 170.72 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.902 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 10.6 p90 -168.45 126.52 1.11 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 20.4 p-10 -68.85 118.83 64.87 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 110.434 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 42.4 Cg_endo -69.73 -29.59 23.74 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.901 1.474 . . . . 0.0 110.058 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.37 -26.44 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.725 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.412 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.4 -57.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.871 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.68 ' C ' HG22 ' A' ' 58' ' ' THR . 2.5 tt0 -158.58 -178.64 7.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.732 HG23 ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -168.86 -60.19 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.791 -1.193 . . . . 0.0 111.603 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.732 ' CD ' HG23 ' A' ' 58' ' ' THR . 53.7 Cg_endo -75.59 -48.42 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.227 1.119 . . . . 0.0 111.745 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -76.22 -37.05 58.24 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.216 -0.927 . . . . 0.0 111.665 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 57' ' ' GLN . 12.7 m -64.19 -59.63 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 110.233 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.726 HD23 HG21 ' A' ' 10' ' ' VAL . 5.4 mp -52.28 -40.99 62.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -65.55 -46.09 80.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.272 -0.893 . . . . 0.0 109.087 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -66.96 -28.78 68.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.355 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.66 -53.2 58.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.499 -0.751 . . . . 0.0 109.666 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 71' ' ' PHE . 30.0 mt -58.37 -50.06 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.35 -22.62 32.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -79.23 -31.09 43.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 110.025 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.651 ' SD ' HG22 ' A' ' 25' ' ' THR . 26.2 mmt -106.27 12.46 29.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.0 22.15 5.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD13 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -72.52 78.43 1.06 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.723 -0.869 . . . . 0.0 110.422 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.038 . . . . 0.0 109.562 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 12' ' ' ILE . . . -125.68 167.95 14.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 111.062 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.66 120.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.753 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 12' ' ' ILE . 15.8 tt -80.95 140.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 0.0 110.764 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.7 p80 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.84 . . . . 0.0 109.98 179.636 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.487 ' CA ' ' HD2' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.582 ' CG2' ' N ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -167.61 170.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.168 -1.195 . . . . 0.0 111.056 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.582 ' N ' ' CG2' ' A' ' 7' ' ' VAL . 1.3 m-20 -155.17 163.19 40.55 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 p -104.15 161.59 13.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.82 -1.175 . . . . 0.0 110.848 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.926 HG21 ' CD2' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -151.99 126.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 110.18 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -116.19 161.63 18.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.32 -0.863 . . . . 0.0 109.574 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.801 ' CD1' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -150.35 162.59 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.479 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 3.1 m -97.7 126.37 43.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.888 HG12 ' HG2' ' A' ' 17' ' ' MET . 91.8 t -111.54 134.12 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.554 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.8 -40.61 0.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 17' ' ' MET . . . -50.73 -30.83 22.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.888 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -52.69 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -1.139 . . . . 0.0 110.102 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.461 HG22 ' SG ' ' A' ' 22' ' ' CYS . 2.4 t -164.21 -37.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.417 ' N ' HG23 ' A' ' 18' ' ' THR . 29.8 p -118.0 -138.89 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.59 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 7.1 m-20 -99.84 -57.3 2.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.523 ' O ' ' HB ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -45.72 -20.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 110.814 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' HD12 ' A' ' 26' ' ' ILE . 3.4 m -58.46 -87.25 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.816 -1.178 . . . . 0.0 111.336 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.079 HG21 HG21 ' A' ' 41' ' ' VAL . 12.1 p -70.56 -36.61 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.912 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.63 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.3 m-90 -63.69 -43.07 97.71 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.299 -0.876 . . . . 0.0 110.751 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 21' ' ' SER . 43.7 m -65.52 -38.82 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.449 -1.407 . . . . 0.0 107.914 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.959 HD11 ' CD2' ' A' ' 71' ' ' PHE . 52.1 mt -68.24 -48.66 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' OE2' ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -58.53 -27.42 64.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.596 179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -67.82 -54.16 21.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 109.936 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 33' ' ' VAL . 11.5 tt0 -64.11 -48.92 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.665 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.8 ' O ' HG21 ' A' ' 36' ' ' VAL . 56.8 mt -52.73 -38.91 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.564 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.909 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -69.97 -27.18 73.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.64 5.48 41.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.515 -0.991 . . . . 0.0 109.729 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 34' ' ' ASN . 1.3 t -51.84 -69.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.713 ' N ' HG12 ' A' ' 33' ' ' VAL . 2.5 m120 -142.76 -98.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.077 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . -106.04 62.63 0.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.909 HG11 ' HA2' ' A' ' 31' ' ' GLY . 42.1 t -89.12 118.34 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.26 . . . . 0.0 110.221 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.575 ' CD2' HG21 ' A' ' 7' ' ' VAL . 49.7 m-70 -65.91 -75.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 110.313 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.19 164.81 16.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.791 HD12 ' HB ' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -155.04 142.49 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -166.6 142.84 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.601 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.079 HG21 HG21 ' A' ' 23' ' ' VAL . 2.7 p -123.14 140.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.988 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.64 168.22 16.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mt -110.14 -28.91 8.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.226 -0.921 . . . . 0.0 109.979 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.23 -22.54 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.232 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -134.38 8.2 3.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mttt 46.92 74.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 0.0 110.507 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 12' ' ' ILE . 8.5 p-10 -170.26 -170.88 1.02 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.477 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.801 ' HB3' ' CD1' ' A' ' 12' ' ' ILE . . . -155.91 141.41 17.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.033 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 11' ' ' THR . 2.9 m -110.99 128.38 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -153.06 147.84 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -113.17 171.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.312 -0.868 . . . . 0.0 110.265 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.3 p90 -157.35 127.59 6.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.695 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.707 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 1.4 p30 -107.24 18.57 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.352 -0.842 . . . . 0.0 111.757 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 52.1 Cg_endo -79.62 65.42 8.88 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 N-CA-C 108.141 -1.523 . . . . 0.0 108.141 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HD2' ' CA ' ' A' ' 6' ' ' GLY . 0.9 OUTLIER -40.15 -27.15 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.636 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.543 ' O ' ' NE2' ' A' ' 57' ' ' GLN . 0.7 OUTLIER -54.07 -22.32 10.57 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 56' ' ' LEU . 20.3 mm-40 -154.77 178.17 10.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -175.05 -65.05 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 49.6 Cg_endo -73.09 -49.07 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.648 1.341 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -67.85 -32.6 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 110.781 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 57' ' ' GLN . 12.6 m -68.9 -58.35 4.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.926 ' CD2' HG21 ' A' ' 10' ' ' VAL . 4.0 mp -55.65 -46.79 77.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.296 -0.878 . . . . 0.0 109.117 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 1.4 tp60 -61.17 -41.21 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 108.83 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' ASP . 84.3 tt0 -68.62 -39.65 80.7 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.654 0.74 . . . . 0.0 109.093 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -47.88 -52.12 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.56 -0.713 . . . . 0.0 109.781 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 73' ' ' ALA . 34.3 mm -64.93 -55.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.581 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.53 -24.1 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 64' ' ' GLU . 2.7 t70 -75.89 -38.83 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.701 ' HG3' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -81.99 -65.95 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.19 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.12 41.38 0.76 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.959 ' CD2' HD11 ' A' ' 26' ' ' ILE . 19.9 m-85 -119.89 143.27 48.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -1.126 . . . . 0.0 110.243 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.409 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -65.62 74.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.456 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 66' ' ' ILE . . . -117.69 148.89 41.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.096 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 74' ' ' VAL . 27.1 m -132.55 120.15 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.351 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.74 152.39 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.3 -0.875 . . . . 0.0 110.021 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 t60 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.262 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.441 ' HA3' ' CE ' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.732 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -141.79 135.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -1.168 . . . . 0.0 110.599 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -110.14 -177.78 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.817 ' OG ' HG22 ' A' ' 51' ' ' ILE . 57.9 m -131.6 135.08 46.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.761 -1.212 . . . . 0.0 110.776 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.8 HG11 HD23 ' A' ' 62' ' ' LEU . 2.1 t -127.91 145.23 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.91 173.35 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.089 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.024 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.2 130.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.279 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 8.5 t -84.5 135.65 34.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.221 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.675 HG12 ' C ' ' A' ' 46' ' ' LYS . 8.1 p -123.76 166.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.655 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -161.02 -39.27 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.437 -0.789 . . . . 0.0 109.927 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.83 97.85 2.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.545 ' HE1' ' HG3' ' A' ' 46' ' ' LYS . 0.9 OUTLIER -150.33 100.22 2.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.15 . . . . 0.0 110.238 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.538 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -42.0 -68.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.845 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 20' ' ' ASN . 6.0 m -154.68 -162.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.959 -1.088 . . . . 0.0 110.841 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.621 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.4 t30 -39.36 -50.13 2.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 110.806 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.516 ' O ' ' HB ' ' A' ' 25' ' ' THR . 42.7 m -43.69 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.601 ' C ' HD12 ' A' ' 26' ' ' ILE . 97.2 m -75.31 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.597 -1.315 . . . . 0.0 111.831 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.902 HG13 ' CE3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -43.1 -38.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.382 -0.824 . . . . 0.0 110.773 -178.353 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.902 ' CE3' HG13 ' A' ' 23' ' ' VAL . 21.4 m-90 -69.8 -50.18 45.5 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.141 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 21' ' ' SER . 49.4 m -60.06 -38.19 82.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.464 -1.398 . . . . 0.0 107.827 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 71' ' ' PHE . 17.0 mt -69.29 -54.23 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 3.7 tt0 -54.89 -20.76 9.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -57.77 3.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.435 ' OE1' ' CE ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -61.12 -52.07 66.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 109.721 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.51 ' CG2' ' HA ' ' A' ' 27' ' ' GLU . 11.8 tt -51.39 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.555 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.753 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -77.92 -15.69 80.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -116.78 18.82 14.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.852 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.536 HG13 ' N ' ' A' ' 34' ' ' ASN . 5.0 p -82.51 -42.6 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.725 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' N ' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -170.69 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.065 -1.022 . . . . 0.0 110.867 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 53' ' ' ASP . . . -67.91 55.31 0.38 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.163 -0.96 . . . . 0.0 110.841 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.753 HG11 ' HA2' ' A' ' 31' ' ' GLY . 5.7 p -95.39 151.55 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.914 -1.345 . . . . 0.0 108.476 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.849 ' CE1' ' HB ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -115.32 -68.63 0.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.069 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.555 ' O ' ' CD1' ' A' ' 51' ' ' ILE . 23.0 p-80 -124.66 168.76 12.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.593 -1.317 . . . . 0.0 111.091 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.477 HG23 ' HB ' ' A' ' 50' ' ' ILE . 1.8 mp -145.75 150.01 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 110.571 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.589 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -125.87 149.96 48.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 109.814 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.891 HG21 ' CG2' ' A' ' 23' ' ' VAL . 7.7 p -164.08 137.4 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.001 -1.062 . . . . 0.0 110.49 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.18 127.8 17.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.9 -3.45 51.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 110.45 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.45 -33.01 32.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 110.087 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.74 -1.41 21.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.068 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.675 ' C ' HG12 ' A' ' 14' ' ' VAL . 3.1 mptt 58.86 58.34 3.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.663 ' N ' HG12 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -170.38 167.81 8.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 109.69 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 40' ' ' LYS . . . -150.35 142.71 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.306 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 33.1 m -110.0 105.08 14.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 109.28 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -118.69 153.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.672 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.849 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -108.99 -177.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.438 -0.788 . . . . 0.0 110.591 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.642 ' CE1' HG23 ' A' ' 10' ' ' VAL . 20.3 p90 -178.34 141.51 0.23 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.618 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 6.3 p-10 -79.68 111.91 25.04 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.677 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 52' ' ' TYR . 46.5 Cg_endo -73.5 0.76 7.65 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.724 1.381 . . . . 0.0 110.477 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HA3' ' A' ' 6' ' ' GLY . 3.4 mttm -70.34 -19.39 63.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 0.0 110.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -139.05 3.1 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.955 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.685 ' C ' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -177.71 137.01 0.19 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 110.078 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.759 HG23 ' HD3' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -169.05 -60.34 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.948 -1.095 . . . . 0.0 112.054 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.759 ' HD3' HG23 ' A' ' 58' ' ' THR . 51.8 Cg_endo -74.45 -52.1 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.159 1.084 . . . . 0.0 111.499 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -86.92 -50.57 6.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 111.396 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 57' ' ' GLN . 63.9 m -46.15 -61.8 1.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.915 -1.116 . . . . 0.0 110.336 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.8 HD23 HG11 ' A' ' 10' ' ' VAL . 2.1 mp -52.23 -44.18 64.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.339 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -44.3 93.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.216 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -69.12 -19.95 64.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.544 -0.723 . . . . 0.0 109.329 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -69.93 -65.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.787 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 73' ' ' ALA . 1.3 tp -53.75 -35.3 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -78.59 -30.18 46.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 6.7 t0 -64.71 -36.11 83.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 109.929 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.435 ' CE ' ' OE1' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -89.64 -68.6 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.017 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.44 -9.06 10.96 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.165 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.826 ' CD2' HD11 ' A' ' 26' ' ' ILE . 30.6 m-85 -49.79 124.7 10.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.942 -1.328 . . . . 0.0 110.122 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.68 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.273 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -133.11 178.39 6.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.972 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' SER . 58.5 t -135.49 95.69 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 110.166 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.538 HG23 HD13 ' A' ' 66' ' ' ILE . 50.1 pt -56.62 162.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.227 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.962 HG11 ' NE2' ' A' ' 37' ' ' HIS . 11.4 m -66.87 143.32 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -1.214 . . . . 0.0 110.669 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -118.06 167.55 11.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.805 . . . . 0.0 109.927 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.3 t -112.11 136.81 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.063 -1.023 . . . . 0.0 110.287 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.103 ' CG1' HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -120.65 126.2 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.627 -0.671 . . . . 0.0 110.438 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.495 ' C ' ' CG2' ' A' ' 12' ' ' ILE . 12.3 p -116.88 161.01 19.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 0.0 109.603 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.823 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -152.38 166.98 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.411 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -98.21 159.99 14.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.683 HG11 ' SD ' ' A' ' 17' ' ' MET . 58.4 t -145.27 147.34 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.079 . . . . 0.0 110.705 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 3.3 tp10 -146.15 -41.36 0.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 109.706 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.05 88.81 1.49 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.683 ' SD ' HG11 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -114.5 -160.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -1.163 . . . . 0.0 110.614 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' C ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -167.04 -144.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.546 -0.721 . . . . 0.0 109.711 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -58.74 153.29 17.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 109.764 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -27.88 -44.26 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.65 0.738 . . . . 0.0 111.535 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.536 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 96.0 p -50.18 -15.9 0.27 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.745 -1.222 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 1.2 p -49.56 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.838 -1.164 . . . . 0.0 111.058 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.079 HG11 HG21 ' A' ' 41' ' ' VAL . 7.9 p -82.84 -23.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 111.374 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.643 ' CH2' HD21 ' A' ' 43' ' ' LEU . 14.4 m-90 -69.34 -28.46 66.24 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.264 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 28.4 m -82.29 -41.69 19.81 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.105 HD11 ' CD2' ' A' ' 71' ' ' PHE . 83.4 mt -65.1 -45.86 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.567 ' CG ' HD13 ' A' ' 39' ' ' ILE . 19.1 tt0 -60.32 -36.45 77.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.459 -0.776 . . . . 0.0 109.659 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -45.11 80.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.149 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.0 mm100 -54.23 -42.54 69.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.859 ' O ' HG21 ' A' ' 36' ' ' VAL . 75.2 mt -61.36 -46.93 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.466 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . -62.78 -14.65 52.3 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -107.26 -9.86 15.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -1.043 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' A' ' 30' ' ' ILE . 3.2 t -49.02 -64.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.493 ' C ' HD21 ' A' ' 34' ' ' ASN . 0.5 OUTLIER -169.66 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.095 . . . . 0.0 110.812 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.13 34.84 4.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.859 HG21 ' O ' ' A' ' 30' ' ' ILE . 29.0 t -70.61 115.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.055 -1.262 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.962 ' NE2' HG11 ' A' ' 7' ' ' VAL . 52.3 m-70 -65.27 -87.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 110.691 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.58 ' CD2' HG13 ' A' ' 51' ' ' ILE . 19.5 p80 -120.52 163.07 18.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.89 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.031 ' O ' HD12 ' A' ' 39' ' ' ILE . 2.3 pp -148.42 153.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.449 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -164.83 141.54 5.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.95 -1.094 . . . . 0.0 111.096 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.079 HG21 HG11 ' A' ' 23' ' ' VAL . 1.2 p -124.32 135.34 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.813 ' C ' HD22 ' A' ' 43' ' ' LEU . 15.2 p -109.52 172.73 6.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 110.213 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.813 HD22 ' C ' ' A' ' 42' ' ' SER . 3.9 mm? -117.62 -29.06 5.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.998 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -66.04 -29.11 69.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 110.352 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 35.2 mt-10 -116.08 5.08 13.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.503 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER 43.01 65.61 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 45' ' ' GLU . 15.1 p-10 -155.59 171.89 19.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 12' ' ' ILE . . . -141.22 154.78 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 110.372 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 49' ' ' THR . 10.1 t -136.83 127.61 27.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 110.02 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.912 ' CB ' HG22 ' A' ' 39' ' ' ILE . 2.3 pp -144.62 161.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.138 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.58 HG13 ' CD2' ' A' ' 38' ' ' HIS . 0.5 OUTLIER -112.41 168.17 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 110.509 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.687 ' OH ' HG23 ' A' ' 10' ' ' VAL . 9.8 p90 -166.2 130.68 2.2 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.338 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.538 ' CB ' HG12 ' A' ' 7' ' ' VAL . 18.1 p-10 -77.34 125.85 85.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.368 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 42.2 Cg_endo -68.93 -30.16 26.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.87 1.458 . . . . 0.0 109.597 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -20.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.961 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -135.86 -40.9 0.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 5.2 mp0 -106.77 -166.1 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 0.0 110.677 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.508 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.01 179.73 0.8 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 0.0 110.169 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 45.7 Cg_endo -73.44 -11.88 24.75 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.959 1.505 . . . . 0.0 110.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -76.29 -51.34 12.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 65' ' ' ALA . 54.3 m -44.37 -47.25 9.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.455 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.103 HD22 ' CG1' ' A' ' 10' ' ' VAL . 1.3 mp -57.32 -45.95 83.73 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.317 -0.865 . . . . 0.0 108.871 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HG3' HG21 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -62.74 -51.09 68.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.489 -0.757 . . . . 0.0 109.203 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.2 -34.66 78.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.389 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' THR . . . -56.5 -55.86 28.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 109.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 mm -55.2 -42.82 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -29.46 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.32 -23.96 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.945 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.78 -47.94 5.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.04 74.07 1.0 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 1.105 ' CD2' HD11 ' A' ' 26' ' ' ILE . 8.4 m-85 -146.48 135.52 22.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -1.139 . . . . 0.0 110.213 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.26 81.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.501 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -113.0 171.24 7.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' C ' ' A' ' 73' ' ' ALA . 71.3 t -147.51 79.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.383 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.427 HG21 ' HG3' ' A' ' 63' ' ' GLN . 8.2 tt -56.93 141.77 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.876 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.113 HG11 ' CE1' ' A' ' 37' ' ' HIS . 16.1 m -53.64 131.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.326 . . . . 0.0 110.698 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 51' ' ' ILE . 3.0 t-20 -118.77 -177.81 3.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.55 -0.719 . . . . 0.0 109.759 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -117.5 140.56 49.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.084 -1.01 . . . . 0.0 110.399 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.813 HG11 HD23 ' A' ' 62' ' ' LEU . 1.4 t -139.83 141.12 35.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.613 -0.68 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.3 p -114.35 159.39 20.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.233 -0.917 . . . . 0.0 110.186 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.843 ' O ' HD12 ' A' ' 12' ' ' ILE . 2.4 pp -135.99 136.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 110.196 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.53 ' HA ' ' ND2' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -84.73 135.5 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 110.058 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.633 HG12 ' SD ' ' A' ' 17' ' ' MET . 71.1 t -117.33 142.42 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.26 52.77 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.2 51.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.633 ' SD ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -97.19 -139.79 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.392 -1.063 . . . . 0.0 110.15 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.716 HG22 ' SG ' ' A' ' 22' ' ' CYS . 1.4 t -179.43 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.203 -0.936 . . . . 0.0 110.42 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.8 OUTLIER -159.28 -139.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -89.32 -51.19 5.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 25' ' ' THR . 1.8 t -48.04 -17.75 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.667 -1.271 . . . . 0.0 110.619 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.757 ' O ' HD12 ' A' ' 26' ' ' ILE . 2.0 m -59.96 -87.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.73 -1.231 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.648 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 12.4 p -72.47 -17.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 112.044 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.648 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 8.0 m-90 -86.39 -40.87 14.96 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.02 -1.05 . . . . 0.0 110.522 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -68.41 -40.27 81.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.536 -1.353 . . . . 0.0 107.909 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.004 HD11 ' CD2' ' A' ' 71' ' ' PHE . 60.8 mt -60.7 -44.47 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.666 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -60.48 -28.8 68.64 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -42.87 88.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.527 ' HG3' ' CE ' ' A' ' 69' ' ' MET . 0.2 OUTLIER -67.09 -56.81 8.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.653 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 27' ' ' GLU . 1.5 tt -47.57 -28.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.23 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA2' ' CG2' ' A' ' 36' ' ' VAL . . . -83.6 -28.24 36.26 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -83.31 -0.26 48.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.015 . . . . 0.0 109.86 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.61 HG11 HG23 ' A' ' 61' ' ' THR . 13.2 t -102.49 -62.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -105.46 154.16 20.72 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.272 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 37' ' ' HIS . . . -66.85 62.49 0.19 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 35.6 m -52.15 125.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.186 -1.185 . . . . 0.0 110.521 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 1.113 ' CE1' HG11 ' A' ' 7' ' ' VAL . 35.7 m80 -93.24 -20.47 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.301 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.53 ' CD2' ' HA ' ' A' ' 50' ' ' ILE . 2.2 t60 -136.95 138.61 40.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.859 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.781 ' HA ' HG22 ' A' ' 50' ' ' ILE . 7.5 tt -139.27 123.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.58 148.19 35.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 110.417 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 23' ' ' VAL . 24.7 t -126.94 151.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.296 -0.877 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 47' ' ' ASN . 15.0 p -122.4 145.91 47.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -106.67 -66.09 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.372 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -15.19 4.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.649 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.61 -9.07 13.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 110.362 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.588 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 0.0 OUTLIER 48.72 73.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.168 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -163.79 178.73 7.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB3' HG13 ' A' ' 12' ' ' ILE . . . -152.71 151.96 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.416 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 49' ' ' THR . 8.9 t -140.89 122.36 15.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.781 HG22 ' HA ' ' A' ' 39' ' ' ILE . 2.3 pp -145.64 172.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.687 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.36 170.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 109.755 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.905 ' HE2' HG22 ' A' ' 58' ' ' THR . 7.4 p90 -164.0 126.22 2.41 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.63 ' CA ' HG12 ' A' ' 7' ' ' VAL . 4.5 p-10 -68.31 121.08 79.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.568 -0.707 . . . . 0.0 110.017 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.588 ' HA ' HG23 ' A' ' 58' ' ' THR . 42.4 Cg_endo -67.77 -7.01 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.731 1.385 . . . . 0.0 110.084 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.9 -48.14 11.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.838 . . . . 0.0 109.81 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 8.9 mp -82.09 -63.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.907 ' O ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -156.76 -154.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 109.25 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -175.53 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 110.627 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 47.8 Cg_endo -73.02 -28.66 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.419 1.221 . . . . 0.0 109.159 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -91.34 -29.43 17.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.514 -0.741 . . . . 0.0 110.859 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 HG11 ' A' ' 33' ' ' VAL . 27.6 m -73.42 -63.41 1.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.738 -1.226 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.813 HD23 HG11 ' A' ' 10' ' ' VAL . 5.7 mp -46.84 -39.06 11.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 108.956 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -67.11 -48.0 69.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.533 -0.73 . . . . 0.0 109.272 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 68' ' ' ASP . 35.7 tt0 -66.75 -23.45 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.376 -0.828 . . . . 0.0 109.367 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -65.67 -69.56 0.29 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.802 . . . . 0.0 109.705 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.56 -30.43 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 109.158 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 10.7 t0 -78.58 -39.88 36.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 64' ' ' GLU . 18.0 t0 -53.15 -35.92 60.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.785 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.527 ' CE ' ' HG3' ' A' ' 29' ' ' GLN . 6.1 mmt -84.89 -68.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.193 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -12.42 7.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 1.004 ' CD2' HD11 ' A' ' 26' ' ' ILE . 15.4 m-85 -51.9 142.16 16.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.278 -1.13 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -68.62 70.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.71 164.36 27.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.414 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.49 152.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.126 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.725 HD13 ' HB3' ' A' ' 62' ' ' LEU . 1.7 pp -111.58 143.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.122 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 110.083 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.348 0.594 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -150.55 60.01 3.88 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 46.1 Cg_endo -73.86 -1.34 10.68 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.121 1.59 . . . . 0.0 109.812 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 5' ' ' MET . 0.2 OUTLIER 58.01 48.22 13.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.291 -0.88 . . . . 0.0 109.839 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.536 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 6.9 ttm 65.52 34.99 7.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.163 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 53' ' ' ASP . . . 44.51 67.66 1.07 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.551 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 1.9 t -143.92 165.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.054 -1.262 . . . . 0.0 110.079 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 6.5 m-20 -138.36 161.9 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.495 -0.753 . . . . 0.0 109.437 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 t -126.01 139.11 53.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.677 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.792 HG11 ' CD2' ' A' ' 62' ' ' LEU . 1.5 t -127.99 127.58 68.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.671 -0.643 . . . . 0.0 110.061 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.66 143.05 39.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.752 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.2 pp -138.59 154.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.624 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.401 ' C ' HG23 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -98.01 166.16 11.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.691 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 17' ' ' MET . 58.7 t -144.08 148.75 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -152.58 19.7 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.17 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.449 ' HA3' ' OD2' ' A' ' 72' ' ' ASP . . . -148.25 80.88 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.828 ' O ' HG23 ' A' ' 18' ' ' THR . 63.4 mtm -130.68 -143.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.402 -1.058 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER 174.73 -71.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.321 -0.862 . . . . 0.0 109.735 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ASN . 33.5 m -112.76 160.66 17.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.53 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 14.5 p30 -42.73 -43.86 4.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.019 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.532 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 83.2 p -45.99 -21.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 110.694 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.745 ' O ' HD12 ' A' ' 26' ' ' ILE . 4.4 m -56.73 -86.17 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.917 -1.114 . . . . 0.0 111.375 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.831 HG22 HG11 ' A' ' 41' ' ' VAL . 12.0 p -72.34 -37.62 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.399 -0.813 . . . . 0.0 111.819 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.632 ' CZ2' ' CG2' ' A' ' 41' ' ' VAL . 9.2 m-90 -62.29 -47.43 84.35 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.517 -0.739 . . . . 0.0 110.485 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 14.7 m -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.611 -1.306 . . . . 0.0 108.16 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.029 HD11 ' CD2' ' A' ' 71' ' ' PHE . 48.0 mt -68.0 -42.66 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.517 ' CA ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -66.13 -28.23 68.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.818 . . . . 0.0 109.874 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -49.19 65.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.37 -55.5 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.776 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.922 ' O ' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -52.8 -29.43 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.586 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.614 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -86.69 -21.29 51.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -101.75 10.98 39.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -1.108 . . . . 0.0 109.76 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 30' ' ' ILE . 6.3 p -83.03 -28.88 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 110.839 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.565 ' CB ' ' HG3' ' A' ' 57' ' ' GLN . 6.0 t-20 -165.88 -135.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.941 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.13 38.67 2.73 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.22 -0.991 . . . . 0.0 110.684 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.922 HG21 ' O ' ' A' ' 30' ' ' ILE . 3.5 t -67.33 115.19 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.926 -1.337 . . . . 0.0 109.446 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.565 ' H ' HD13 ' A' ' 51' ' ' ILE . 39.6 m-70 -64.07 -85.38 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.427 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.599 ' C ' HG23 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -132.33 174.65 10.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.068 . . . . 0.0 110.907 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -157.66 173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.531 -0.731 . . . . 0.0 109.44 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 39' ' ' ILE . 12.6 mttm -166.43 148.28 6.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.055 -1.028 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.831 HG11 HG22 ' A' ' 23' ' ' VAL . 4.2 m -123.23 159.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.965 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.03 85.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -25.21 4.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -42.14 67.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.036 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.53 12.74 22.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? 49.53 69.19 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.268 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 18.3 p-10 -170.08 -177.68 2.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.43 137.85 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 110.106 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 49' ' ' THR . 15.0 t -109.98 130.33 55.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.833 HD11 HD21 ' A' ' 62' ' ' LEU . 2.0 pp -143.1 151.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.613 ' C ' HD12 ' A' ' 51' ' ' ILE . 1.1 pp -109.79 -177.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 23.5 p90 -174.33 133.26 0.39 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.122 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 0.4 OUTLIER -71.3 117.34 55.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.551 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.6 Cg_endo -72.65 -26.66 16.07 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.901 1.474 . . . . 0.0 109.5 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HD3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -70.7 -14.36 62.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.691 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.476 HD23 ' HD3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -121.99 -32.51 3.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.565 ' HG3' ' CB ' ' A' ' 34' ' ' ASN . 25.0 mm100 -134.72 -154.61 0.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.418 -0.802 . . . . 0.0 109.708 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.551 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.33 -179.17 0.64 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.013 -1.054 . . . . 0.0 110.306 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.735 ' HA ' HD13 ' A' ' 62' ' ' LEU . 42.3 Cg_endo -69.96 -17.9 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.796 1.419 . . . . 0.0 110.293 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.13 -49.04 71.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.543 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 m -50.19 -44.08 52.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.202 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.833 HD21 HD11 ' A' ' 50' ' ' ILE . 6.2 mp -57.07 -43.66 82.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 108.68 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -45.16 92.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.09 -31.6 70.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.475 -0.766 . . . . 0.0 109.543 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -57.4 -59.42 5.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.485 -0.759 . . . . 0.0 110.087 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.18 -45.35 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.86 -16.83 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.818 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 63.6 t0 -81.08 -42.64 20.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.421 ' HE2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -86.43 -66.32 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 136.83 -26.03 3.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 1.029 ' CD2' HD11 ' A' ' 26' ' ' ILE . 92.3 m-85 -42.15 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -1.101 . . . . 0.0 110.2 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.449 ' OD2' ' HA3' ' A' ' 16' ' ' GLY . 1.2 p30 -56.99 83.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.85 . . . . 0.0 110.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 12' ' ' ILE . . . -116.78 135.94 53.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 0.0 109.984 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.7 p -111.67 142.6 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 110.502 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.616 HG22 ' H ' ' A' ' 77' ' ' ASN . 5.8 mt -85.21 166.9 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.407 ' N ' HG22 ' A' ' 75' ' ' ILE . 0.4 OUTLIER -133.79 9.45 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.037 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.616 ' H ' HG22 ' A' ' 75' ' ' ILE . 1.6 m-20 -115.55 128.84 25.62 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 0.0 109.979 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.58 -38.23 4.64 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.811 1.427 . . . . 0.0 110.559 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.276 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 3' ' ' PRO . 6.9 mmm . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' A' ' 1' ' ' MET . 29.2 m-20 -33.08 94.49 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.827 -0.546 . . . . 0.0 111.37 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.481 ' N ' ' O ' ' A' ' 1' ' ' MET . 47.7 Cg_endo -75.52 -4.7 15.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.302 1.685 . . . . 0.0 108.606 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.575 ' HB2' HG22 ' A' ' 7' ' ' VAL . 2.2 p -80.82 -72.65 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 44.62 47.14 8.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 110.232 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.6 -41.23 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.054 HG21 ' CE1' ' A' ' 37' ' ' HIS . 27.8 m -64.42 132.47 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.235 . . . . 0.0 110.486 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 51' ' ' ILE . 4.9 m-20 -95.5 -174.42 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.42 -0.8 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 95.5 p -131.28 132.14 44.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.942 -1.099 . . . . 0.0 111.153 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.519 HG23 ' CE1' ' A' ' 52' ' ' TYR . 2.1 t -128.66 129.12 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.765 -0.584 . . . . 0.0 109.546 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.638 HG22 HG23 ' A' ' 49' ' ' THR . 82.5 p -112.01 159.32 18.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.221 -0.925 . . . . 0.0 110.646 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.845 ' O ' HD12 ' A' ' 12' ' ' ILE . 2.7 pp -139.8 157.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.359 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -88.61 168.14 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 109.694 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.917 HG11 ' SD ' ' A' ' 17' ' ' MET . 70.5 t -140.11 147.49 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.991 -1.068 . . . . 0.0 110.585 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -170.61 42.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 17' ' ' MET . . . -171.69 -34.06 0.03 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.917 ' SD ' HG11 ' A' ' 14' ' ' VAL . 19.3 ptt? -42.88 151.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -1.118 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.532 ' N ' ' HB3' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -72.01 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -0.825 . . . . 0.0 110.716 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -107.24 -31.48 8.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -125.31 -67.19 0.91 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.192 -0.943 . . . . 0.0 109.974 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.539 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 2.7 t -49.96 -19.44 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.834 -1.166 . . . . 0.0 109.971 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.893 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -46.04 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.946 HG21 HG11 ' A' ' 41' ' ' VAL . 7.3 p -85.32 -31.64 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 111.461 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.665 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 17.1 m-90 -60.84 -32.18 71.59 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.165 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 14.7 m -80.4 -44.93 18.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.939 HD11 ' CD2' ' A' ' 71' ' ' PHE . 9.0 mt -63.64 -59.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.687 ' HG3' HG21 ' A' ' 39' ' ' ILE . 42.9 tt0 -42.91 -41.93 3.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.487 -0.758 . . . . 0.0 109.292 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.27 -43.79 83.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' A' ' 32' ' ' LYS . 1.9 mt-30 -74.98 -63.0 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.08 -1.012 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.852 ' O ' HG21 ' A' ' 36' ' ' VAL . 24.3 pt -51.45 -34.57 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 109.473 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' HG13 ' A' ' 30' ' ' ILE . . . -77.19 -22.33 71.23 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.409 -1.877 . . . . 0.0 108.409 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 12.3 tttm -101.02 3.17 41.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -1.007 . . . . 0.0 110.013 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.794 HG12 ' N ' ' A' ' 34' ' ' ASN . 1.8 t -59.94 -76.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.794 ' N ' HG12 ' A' ' 33' ' ' VAL . 23.7 t-20 -177.25 -75.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.941 -1.099 . . . . 0.0 110.95 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.61 -26.73 74.26 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.852 HG21 ' O ' ' A' ' 30' ' ' ILE . 35.9 m -50.81 123.77 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -1.146 . . . . 0.0 110.54 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 1.054 ' CE1' HG21 ' A' ' 7' ' ' VAL . 5.2 p80 -129.54 10.89 5.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.832 ' N ' HD11 ' A' ' 51' ' ' ILE . 4.7 t-80 -171.85 143.66 1.66 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 109.934 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.687 HG21 ' HG3' ' A' ' 27' ' ' GLU . 3.9 mp -141.2 149.59 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.41 108.51 4.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.946 HG11 HG21 ' A' ' 23' ' ' VAL . 4.8 p -125.89 140.4 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 0.0 110.476 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 p -112.54 150.94 30.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.987 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 -2.91 22.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 110.136 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -102.51 -32.55 9.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.3 -3.08 37.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' C ' ' HB ' ' A' ' 14' ' ' VAL . 4.8 mttp 53.75 65.06 1.62 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.321 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.55 176.01 12.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 0.0 109.707 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.63 146.56 25.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 0.0 110.781 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.638 HG23 HG22 ' A' ' 11' ' ' THR . 88.3 m -132.8 100.34 4.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.742 . . . . 0.0 109.435 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -119.23 156.5 21.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 110.231 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 1.014 HD13 ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -109.86 174.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 8.1 p90 -159.28 128.71 5.44 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.583 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.631 ' CA ' HG12 ' A' ' 7' ' ' VAL . 6.6 t0 -68.52 115.13 26.91 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 110.014 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 42.9 Cg_endo -69.44 -44.89 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.906 1.477 . . . . 0.0 110.138 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' A' ' 53' ' ' ASP . 11.1 ptmt -42.56 -26.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -123.93 -22.69 4.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.372 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 49.3 mm-40 -131.01 -158.64 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.536 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -170.72 179.42 0.71 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HA ' HD12 ' A' ' 62' ' ' LEU . 43.1 Cg_endo -69.46 -12.27 33.1 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.719 1.379 . . . . 0.0 110.291 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' THR . 11.1 mttt -74.14 -51.97 13.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.649 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' LYS . 7.4 m -45.2 -48.63 12.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 109.227 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 59' ' ' PRO . 2.1 mt -57.91 -48.88 78.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 109.263 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.9 -37.99 72.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.001 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 68' ' ' ASP . 47.1 tt0 -73.53 -31.76 63.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.251 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -55.78 -58.22 8.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.485 -0.759 . . . . 0.0 109.548 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 12' ' ' ILE . 56.7 mt -61.37 -37.62 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.489 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.89 -12.24 60.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 64' ' ' GLU . 25.0 t70 -85.59 -39.82 16.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.4 mmt -87.59 -56.13 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 123.56 -10.16 8.61 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.939 ' CD2' HD11 ' A' ' 26' ' ' ILE . 8.0 m-85 -42.76 143.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -1.179 . . . . 0.0 110.347 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.14 74.09 2.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -119.81 162.15 19.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.645 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.433 ' HB ' ' OG ' ' A' ' 13' ' ' SER . 40.8 t -144.07 108.59 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.771 ' HA ' HG22 ' A' ' 12' ' ' ILE . 14.4 pt -46.26 146.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -122.34 45.99 2.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 10' ' ' VAL . 32.7 m-80 -109.88 108.85 59.39 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.251 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.25 -44.67 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.012 1.533 . . . . 0.0 110.437 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.231 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.249 0.547 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.56 61.22 36.05 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' O ' ' CB ' ' A' ' 4' ' ' SER . 49.4 Cg_endo -75.92 2.81 6.66 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.17 1.616 . . . . 0.0 109.822 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.537 ' O ' HG22 ' A' ' 7' ' ' VAL . 1.1 m 71.29 30.61 2.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 110.172 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.468 ' O ' ' HG3' ' A' ' 5' ' ' MET . 6.5 ptm -68.7 100.36 1.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 110.276 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 137.96 -19.43 3.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.003 HG11 ' CE1' ' A' ' 37' ' ' HIS . 6.2 m -82.14 142.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.4 m-20 -108.09 166.64 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.073 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.3 p -114.37 131.64 56.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 62' ' ' LEU . 1.3 t -117.8 137.38 51.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.642 -0.661 . . . . 0.0 110.351 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.712 ' CG2' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -114.64 152.67 31.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.573 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.006 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -145.35 139.83 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.003 -1.06 . . . . 0.0 110.764 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.7 m -90.55 122.28 33.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG12 ' C ' ' A' ' 46' ' ' LYS . 10.2 p -111.45 153.84 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 110.494 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -139.98 -59.74 0.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.48 75.77 0.52 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.459 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -98.36 -146.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.205 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 m -156.93 -67.11 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.208 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.7 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.21 -0.931 . . . . 0.0 110.12 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.595 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 3.9 t-20 -140.8 -68.92 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.841 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -45.38 -22.73 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.103 -0.998 . . . . 0.0 109.975 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 16.0 t -49.83 -83.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.796 -1.19 . . . . 0.0 110.398 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.947 HG21 HG21 ' A' ' 41' ' ' VAL . 15.0 p -81.13 -42.22 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 111.531 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.622 ' N ' HG13 ' A' ' 23' ' ' VAL . 9.8 m-90 -52.55 -33.75 47.07 Favored 'General case' 0 C--N 1.285 -2.223 0 O-C-N 121.127 -0.983 . . . . 0.0 109.725 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.513 ' CB ' ' O ' ' A' ' 21' ' ' SER . 25.7 m -77.8 -43.04 31.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.12 HD11 ' CD2' ' A' ' 71' ' ' PHE . 63.0 mt -64.22 -58.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.7 tm-20 -42.76 -39.72 2.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.529 -0.732 . . . . 0.0 109.407 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.34 -47.74 82.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.77 -56.53 5.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.212 -0.93 . . . . 0.0 110.129 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.813 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.5 tp -48.81 -30.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.49 -32.86 32.98 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -89.14 6.3 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -1.121 . . . . 0.0 110.05 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 30' ' ' ILE . 6.1 p -81.81 -18.73 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -161.35 -132.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 109.985 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 37' ' ' HIS . . . -115.05 47.99 0.98 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 51' ' ' ILE . 9.9 p -45.77 135.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -1.156 . . . . 0.0 110.415 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 1.003 ' CE1' HG11 ' A' ' 7' ' ' VAL . 13.1 m80 -105.63 -10.54 16.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.959 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.514 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 25.4 t60 -163.87 145.25 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.416 -0.802 . . . . 0.0 109.822 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.914 HD12 HG13 ' A' ' 50' ' ' ILE . 6.8 tt -162.27 124.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.049 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -145.23 140.1 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 110.399 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.947 HG21 HG21 ' A' ' 23' ' ' VAL . 4.6 p -131.9 148.03 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 m -126.88 168.47 14.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.07 -1.82 14.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 17.6 pt-20 -95.57 -34.12 12.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 9.6 mt-10 -102.04 4.97 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.559 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER 45.65 58.69 4.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.464 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.485 ' N ' HG12 ' A' ' 14' ' ' VAL . 9.3 p-10 -169.63 166.15 10.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.049 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.553 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -148.61 148.24 29.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.455 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.712 HG23 ' CG2' ' A' ' 11' ' ' THR . 3.4 m -109.89 152.82 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.791 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.914 HG13 HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.79 157.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.989 -1.069 . . . . 0.0 110.593 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.59 169.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.547 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.642 ' CE1' HG23 ' A' ' 10' ' ' VAL . 9.7 p90 -165.1 118.73 1.24 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.883 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.651 ' CG ' HG12 ' A' ' 7' ' ' VAL . 3.9 t0 -63.65 117.98 40.18 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.158 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.542 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.7 Cg_endo -70.68 -43.11 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.864 1.455 . . . . 0.0 109.841 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HD3' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.93 -26.04 0.37 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 tp -117.31 -34.89 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 110.07 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' HG23 ' A' ' 58' ' ' THR . 1.9 tp-100 -124.39 -150.95 0.46 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.955 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.56 HG22 ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.11 -179.36 0.35 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.294 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 58' ' ' THR . 41.7 Cg_endo -69.81 -30.43 22.04 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.917 1.483 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -36.2 83.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.863 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.411 HG21 ' CG ' ' A' ' 57' ' ' GLN . 97.2 m -57.75 -56.7 18.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.785 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.651 HD22 HG11 ' A' ' 10' ' ' VAL . 2.2 mp -50.16 -41.94 50.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.17 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.544 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.9 tt0 -61.49 -44.5 96.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.103 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -27.36 66.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.518 -0.739 . . . . 0.0 109.459 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -65.35 -62.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 109.942 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 73' ' ' ALA . 18.2 mm -51.63 -38.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.608 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -68.94 -26.15 64.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -70.88 -32.34 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.81 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.519 ' HE2' ' HA ' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -89.66 -50.49 6.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.266 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 121.72 -25.68 6.79 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 1.12 ' CD2' HD11 ' A' ' 26' ' ' ILE . 39.7 m-85 -43.01 116.7 0.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 110.281 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.03 83.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 110.398 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.006 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -129.26 137.04 50.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.4 p -117.93 133.93 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.226 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 77' ' ' ASN . 6.1 mt -73.94 162.61 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.01 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.22 23.75 5.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.123 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.552 ' H ' HG22 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -166.93 85.7 0.84 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.65 -90.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.084 1.571 . . . . 0.0 110.347 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t0 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.085 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.5 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.241 0.543 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -158.37 60.35 1.77 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 110.491 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.92 -3.3 13.36 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.114 1.586 . . . . 0.0 109.526 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m -159.61 79.38 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.49 -0.756 . . . . 0.0 109.842 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.06 62.59 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.321 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' PRO . . . 172.45 -64.8 0.13 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.533 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 2.5 t -64.58 168.24 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -1.092 . . . . 0.0 110.805 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.4 m-20 -149.95 173.97 13.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.659 -0.651 . . . . 0.0 109.29 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 11.2 p -127.41 147.72 50.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.941 -1.099 . . . . 0.0 110.771 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.753 HG11 HD22 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -136.38 125.55 38.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.547 -0.72 . . . . 0.0 110.208 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.649 ' CG2' HG23 ' A' ' 49' ' ' THR . 0.9 OUTLIER -109.55 144.93 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.527 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.71 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.3 pp -144.1 169.65 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.551 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.44 ' N ' HD12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -114.34 138.24 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.393 -0.817 . . . . 0.0 109.809 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.85 146.68 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.528 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -145.94 27.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.868 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.36 80.42 0.12 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.603 ' O ' HG23 ' A' ' 18' ' ' THR . 0.0 OUTLIER -122.94 -138.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -1.141 . . . . 0.0 110.026 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 17' ' ' MET . 19.2 p -156.32 -94.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.346 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.5 p -142.51 -40.56 0.34 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.082 -1.011 . . . . 0.0 110.029 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 16.7 t-20 -145.34 -47.45 0.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.804 ' HA ' HG23 ' A' ' 25' ' ' THR . 0.8 OUTLIER -49.32 -20.47 0.66 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.925 -1.109 . . . . 0.0 110.325 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' O ' HD12 ' A' ' 26' ' ' ILE . 14.3 t -52.44 -81.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.939 -1.101 . . . . 0.0 111.381 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.768 ' CG1' HG21 ' A' ' 41' ' ' VAL . 7.5 p -81.16 -34.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.187 -0.946 . . . . 0.0 111.986 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.685 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.7 m-90 -60.2 -38.01 82.02 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 121.12 -0.988 . . . . 0.0 110.534 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.804 HG23 ' HA ' ' A' ' 21' ' ' SER . 16.4 p -80.49 -44.92 18.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.634 -1.291 . . . . 0.0 107.832 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 71' ' ' PHE . 50.4 mt -61.42 -56.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' VAL . 7.3 tt0 -43.22 -48.91 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.124 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -53.14 -41.8 65.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' HG23 ' A' ' 33' ' ' VAL . 18.6 tp60 -75.83 -51.87 11.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.799 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.832 ' O ' HG21 ' A' ' 36' ' ' VAL . 9.8 mm -51.24 -39.43 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.467 ' HA2' ' HB ' ' A' ' 36' ' ' VAL . . . -72.15 -30.95 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -82.89 -1.8 53.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -1.089 . . . . 0.0 110.126 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 29' ' ' GLN . 6.2 t -80.95 -47.31 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -155.66 -147.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.43 42.71 3.17 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.832 HG21 ' O ' ' A' ' 30' ' ' ILE . 41.4 t -46.73 100.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 110.109 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.523 ' HB2' HG12 ' A' ' 51' ' ' ILE . 59.7 m80 -57.83 -85.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.293 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.552 ' CD2' HG13 ' A' ' 51' ' ' ILE . 14.0 p80 -111.54 161.64 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.095 -1.003 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.559 HD12 HG21 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -162.01 140.45 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.412 -0.805 . . . . 0.0 109.623 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.69 155.43 35.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.768 HG21 ' CG1' ' A' ' 23' ' ' VAL . 14.0 m -133.86 151.52 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.842 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 t -114.39 162.42 16.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 43' ' ' LEU . 2.1 mp -115.45 -18.08 11.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 110.342 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.86 -44.8 12.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.94 -5.32 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.355 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 54.68 79.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -168.07 -172.45 1.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.25 134.11 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.649 HG23 ' CG2' ' A' ' 11' ' ' THR . 32.2 m -122.31 118.04 27.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 109.563 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.11 HD11 ' CD2' ' A' ' 62' ' ' LEU . 1.3 pp -143.76 167.43 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.758 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.679 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.1 pp -115.57 -173.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.484 -0.76 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 20.5 p90 -175.5 152.18 1.31 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.875 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 4.6 t0 -92.85 105.23 14.02 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 42.6 Cg_endo -69.25 -10.07 27.97 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.0 1.526 . . . . 0.0 109.479 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.782 ' HB2' HD12 ' A' ' 56' ' ' LEU . 7.2 mtpt -57.01 -32.03 65.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.44 -0.787 . . . . 0.0 109.149 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.782 HD12 ' HB2' ' A' ' 55' ' ' LYS . 5.0 mp -118.35 -44.5 2.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.656 . . . . 0.0 109.381 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' A' ' 58' ' ' THR . 3.3 pt20 -107.84 -141.59 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 109.509 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.607 HG22 ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.33 -178.35 0.31 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.008 . . . . 0.0 110.279 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.607 ' HD2' HG22 ' A' ' 58' ' ' THR . 43.9 Cg_endo -70.9 -17.68 32.23 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.905 1.476 . . . . 0.0 110.11 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HE3' ' HG2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -73.07 -36.46 66.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.768 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.5 m -53.43 -52.81 58.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.536 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.11 ' CD2' HD11 ' A' ' 50' ' ' ILE . 2.0 mp -52.27 -41.23 62.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.026 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.402 ' HG3' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -65.42 -45.31 84.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 178.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -33.69 74.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.386 -0.821 . . . . 0.0 109.181 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.78 -52.1 66.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.52 -44.65 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.636 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.15 -17.65 58.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.86 -34.49 21.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.408 -0.807 . . . . 0.0 110.101 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 mmm -85.77 -57.79 2.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 128.61 -17.98 5.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 26' ' ' ILE . 33.7 m-85 -42.73 115.62 0.75 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -1.187 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.02 82.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.281 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -132.55 144.36 50.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.02 128.78 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.655 ' HA ' HG22 ' A' ' 12' ' ' ILE . 2.6 tt -54.52 161.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.53 ' N ' HG12 ' A' ' 75' ' ' ILE . 46.1 t-80 -158.96 59.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.414 ' CG ' ' O ' ' A' ' 77' ' ' ASN . 25.1 p-10 -117.66 109.41 41.69 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.305 -0.872 . . . . 0.0 110.24 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -75.15 -81.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.987 1.52 . . . . 0.0 110.528 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.216 179.888 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.247 0.546 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.453 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.7 p30 -161.45 54.9 0.56 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.278 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 44.9 Cg_endo -73.42 -2.69 12.49 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.039 1.547 . . . . 0.0 109.557 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.41 ' OG ' ' C ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER 174.04 63.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.453 -0.779 . . . . 0.0 109.724 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.49 65.85 9.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 110.62 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.494 ' HA3' ' HD2' ' A' ' 55' ' ' LYS . . . 120.96 47.17 0.31 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.527 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 3.4 m -141.9 131.64 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.279 . . . . 0.0 110.583 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -96.9 -165.37 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.519 -0.738 . . . . 0.0 109.076 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.928 ' CB ' HG22 ' A' ' 51' ' ' ILE . 49.5 p -148.43 141.95 25.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.799 -1.188 . . . . 0.0 111.129 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.623 HG11 HD11 ' A' ' 62' ' ' LEU . 2.2 t -142.89 141.31 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.708 -0.62 . . . . 0.0 109.944 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.406 HG22 HG23 ' A' ' 49' ' ' THR . 66.9 p -117.89 156.31 28.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.776 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.6 pp -133.61 -175.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.267 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.501 ' N ' HD12 ' A' ' 12' ' ' ILE . 97.5 p -117.88 131.78 56.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 14' ' ' VAL . 3.4 p -116.98 125.56 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -134.05 -40.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.29 85.66 1.2 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.468 ' O ' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -110.75 -151.02 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.512 HG23 ' N ' ' A' ' 19' ' ' CYS . 8.9 t -179.06 -138.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.85 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.512 ' N ' HG23 ' A' ' 18' ' ' THR . 8.0 p -56.67 163.22 1.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.066 -1.021 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.496 ' OD1' ' HB2' ' A' ' 24' ' ' TRP . 5.4 t-20 -37.79 -30.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 110.846 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.555 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 0.1 OUTLIER -51.24 -20.74 1.72 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.809 -1.182 . . . . 0.0 110.056 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -46.31 -74.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 111.835 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.861 ' CG2' HG21 ' A' ' 41' ' ' VAL . 2.0 m -88.42 -38.68 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.646 ' CE3' HG22 ' A' ' 23' ' ' VAL . 25.9 m-90 -59.44 -31.73 69.57 Favored 'General case' 0 C--N 1.28 -2.438 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.278 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.555 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 7.6 m -84.42 -48.23 9.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 0.0 107.911 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.051 HD11 ' CD2' ' A' ' 71' ' ' PHE . 33.9 mt -59.9 -44.31 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.884 ' HG3' HD13 ' A' ' 39' ' ' ILE . 35.2 tt0 -57.55 -45.87 84.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.602 -0.686 . . . . 0.0 109.523 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 11.8 tt0 -54.84 -42.33 71.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.429 -0.795 . . . . 0.0 109.948 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -74.98 -63.62 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.645 ' O ' HG11 ' A' ' 36' ' ' VAL . 22.7 pt -50.44 -38.86 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.025 -1.047 . . . . 0.0 108.972 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.538 ' C ' HG11 ' A' ' 36' ' ' VAL . . . -69.18 -24.71 75.87 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -102.83 9.24 39.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.655 -0.909 . . . . 0.0 109.918 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.648 HG22 ' H ' ' A' ' 34' ' ' ASN . 1.2 p -66.13 -161.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.553 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.66 ' ND2' HD21 ' A' ' 56' ' ' LEU . 2.3 m-20 -61.74 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -118.13 87.73 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.29 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 36' ' ' VAL . 7.6 p -121.31 82.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.943 ' CD2' HD13 ' A' ' 51' ' ' ILE . 8.2 p80 -73.89 7.04 2.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 111.985 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.76 ' H ' HD11 ' A' ' 51' ' ' ILE . 15.9 t60 -173.34 149.81 1.79 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.773 -1.204 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.884 HD13 ' HG3' ' A' ' 27' ' ' GLU . 2.8 pp -157.8 158.01 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.457 -0.777 . . . . 0.0 109.575 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -154.35 163.69 39.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.832 -1.168 . . . . 0.0 111.11 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.861 HG21 ' CG2' ' A' ' 23' ' ' VAL . 73.4 t -136.96 138.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.483 -0.761 . . . . 0.0 110.019 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -124.85 76.2 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.21 -33.19 69.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -53.01 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.421 -0.8 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.54 58.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.315 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 60.51 70.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.38 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 14.6 t-20 -170.26 163.39 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB3' ' CG1' ' A' ' 12' ' ' ILE . . . -129.81 137.25 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 110.318 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 1.6 m -113.17 108.25 17.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.862 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.637 HD11 HD13 ' A' ' 62' ' ' LEU . 2.5 pp -136.77 154.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.943 HD13 ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -116.98 -166.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 22.5 p90 -174.52 155.13 2.19 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.292 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 3.0 p-10 -95.06 117.96 66.69 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 110.464 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 44.7 Cg_endo -70.89 -6.2 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.684 1.36 . . . . 0.0 109.305 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HD2' ' HA3' ' A' ' 6' ' ' GLY . 0.7 OUTLIER -66.73 -43.38 84.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.652 . . . . 0.0 109.544 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.66 HD21 ' ND2' ' A' ' 34' ' ' ASN . 1.2 tt -129.16 -8.28 4.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.37 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.61 -165.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.537 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.493 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -163.86 177.81 1.68 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 110.1 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HA ' HD21 ' A' ' 62' ' ' LEU . 45.6 Cg_endo -72.11 -7.98 22.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.017 1.535 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -33.96 21.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.348 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' LEU . 3.5 m -55.61 -68.16 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.831 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -45.45 -32.96 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 109.084 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -45.71 63.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 108.814 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -68.12 -29.9 68.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.2 -68.54 0.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.727 . . . . 0.0 110.153 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 67' ' ' ASP . 27.6 pt -50.56 -34.2 12.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.102 -0.999 . . . . 0.0 109.88 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 66' ' ' ILE . 11.4 t70 -74.25 -22.26 59.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.738 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.3 t0 -76.68 -34.82 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.512 ' CE ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -75.34 -46.22 34.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.78 9.97 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 1.051 ' CD2' HD11 ' A' ' 26' ' ' ILE . 9.3 m-85 -64.15 134.23 54.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 7.4 m-20 -69.29 58.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.377 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -109.94 143.88 39.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 110.008 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 t -139.6 146.7 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 0.0 110.288 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' A' ' 12' ' ' ILE . 9.4 tt -59.89 147.18 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -122.03 -43.27 2.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.477 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -129.11 95.6 30.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 110.325 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.36 -159.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.017 1.536 . . . . 0.0 110.258 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.258 0.551 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -132.3 54.34 13.67 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.288 -0.882 . . . . 0.0 110.16 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 46.8 Cg_endo -73.45 -1.61 10.92 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.1 1.579 . . . . 0.0 109.818 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -165.87 -62.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.383 -0.823 . . . . 0.0 109.961 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.65 72.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -0.865 . . . . 0.0 110.591 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 7' ' ' VAL . . . 124.43 5.32 7.24 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.617 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 1.4 t -153.43 162.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -1.145 . . . . 0.0 110.318 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.59 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 5.9 m-20 -150.53 147.1 27.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -0.782 . . . . 0.0 109.872 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 t -106.56 138.31 42.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.325 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.726 HG21 HD23 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -124.76 131.21 72.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.571 -0.706 . . . . 0.0 110.381 -178.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.97 139.71 49.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 109.91 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.993 HD13 ' HB1' ' A' ' 73' ' ' ALA . 2.5 pp -141.07 167.2 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.674 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.562 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 4.6 m -90.08 140.85 29.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.348 -0.845 . . . . 0.0 108.803 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.692 HG12 ' SD ' ' A' ' 17' ' ' MET . 38.0 t -110.56 143.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.893 -1.13 . . . . 0.0 111.013 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -168.67 28.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 72' ' ' ASP . . . -153.08 57.64 0.42 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.692 ' SD ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.92 -153.91 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -1.206 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 19' ' ' CYS . 23.8 m -148.5 -83.59 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -0.918 . . . . 0.0 109.912 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.462 ' N ' HG22 ' A' ' 18' ' ' THR . 1.2 t -137.77 -141.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.496 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 5.1 m120 -46.41 -25.06 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.993 -1.067 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.543 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 67.9 p -57.84 -11.05 1.99 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.013 -1.055 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 93.9 m -52.9 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.846 -1.159 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.68 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 8.2 p -80.58 -30.09 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 111.252 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.68 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 18.2 m-90 -67.16 -43.34 82.55 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.671 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.651 HG22 ' SD ' ' A' ' 69' ' ' MET . 12.4 m -71.27 -45.22 63.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.496 -1.377 . . . . 0.0 107.867 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.944 ' CG2' HD11 ' A' ' 39' ' ' ILE . 1.1 mp -61.17 -58.52 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' ' 26' ' ' ILE . 82.4 tt0 -49.52 -32.89 13.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -68.95 -56.54 7.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' LYS . 5.8 tp60 -73.41 -61.62 1.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.962 HG21 HD13 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -49.13 -34.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.288 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.58 -27.45 67.41 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 29' ' ' GLN . 2.1 tttp -92.44 0.57 57.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -1.065 . . . . 0.0 110.088 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.804 HG13 ' N ' ' A' ' 34' ' ' ASN . 1.7 p -82.75 -146.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.351 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.804 ' N ' HG13 ' A' ' 33' ' ' VAL . 95.6 m-20 -49.06 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.32 61.75 0.33 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.145 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.953 HG11 HG23 ' A' ' 30' ' ' ILE . 25.8 m -59.92 135.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.128 -1.219 . . . . 0.0 109.818 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.617 ' CE1' ' CG1' ' A' ' 7' ' ' VAL . 37.5 m80 -92.88 -24.44 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.136 -0.977 . . . . 0.0 111.017 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.406 ' CG ' ' C ' ' A' ' 37' ' ' HIS . 69.3 m80 -147.04 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.952 -1.093 . . . . 0.0 110.778 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.962 HD13 HG21 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -167.07 123.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.133 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.95 140.09 24.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 23' ' ' VAL . 8.0 m -109.85 139.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.399 -0.813 . . . . 0.0 110.112 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.39 112.27 23.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.038 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 -16.46 38.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.301 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.77 -10.45 20.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.269 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -121.3 -1.53 9.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.215 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 50.75 67.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.648 ' HA ' HG23 ' A' ' 14' ' ' VAL . 1.2 t-20 -169.98 170.32 7.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 110.022 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.68 144.81 22.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.216 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.446 ' C ' ' CG2' ' A' ' 50' ' ' ILE . 88.1 m -120.31 129.76 54.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -0.821 . . . . 0.0 109.662 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.446 ' CG2' ' C ' ' A' ' 49' ' ' THR . 1.5 pp -147.33 161.27 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.07 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -114.49 170.72 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.902 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 10.6 p90 -168.45 126.52 1.11 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 20.4 p-10 -68.85 118.83 64.87 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 110.434 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 42.4 Cg_endo -69.73 -29.59 23.74 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.901 1.474 . . . . 0.0 110.058 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.37 -26.44 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.725 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.4 -57.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.871 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.68 ' C ' HG22 ' A' ' 58' ' ' THR . 2.5 tt0 -158.58 -178.64 7.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.732 HG23 ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -168.86 -60.19 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.791 -1.193 . . . . 0.0 111.603 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.732 ' CD ' HG23 ' A' ' 58' ' ' THR . 53.7 Cg_endo -75.59 -48.42 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.227 1.119 . . . . 0.0 111.745 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -76.22 -37.05 58.24 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.216 -0.927 . . . . 0.0 111.665 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 57' ' ' GLN . 12.7 m -64.19 -59.63 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 110.233 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.726 HD23 HG21 ' A' ' 10' ' ' VAL . 5.4 mp -52.28 -40.99 62.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -65.55 -46.09 80.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.272 -0.893 . . . . 0.0 109.087 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -66.96 -28.78 68.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.355 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.66 -53.2 58.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.499 -0.751 . . . . 0.0 109.666 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 71' ' ' PHE . 30.0 mt -58.37 -50.06 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.35 -22.62 32.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -79.23 -31.09 43.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 110.025 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.651 ' SD ' HG22 ' A' ' 25' ' ' THR . 26.2 mmt -106.27 12.46 29.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.0 22.15 5.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD13 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -72.52 78.43 1.06 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.723 -0.869 . . . . 0.0 110.422 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.038 . . . . 0.0 109.562 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 12' ' ' ILE . . . -125.68 167.95 14.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 111.062 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.66 120.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.753 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 12' ' ' ILE . 15.8 tt -80.95 140.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 0.0 110.764 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -127.53 20.04 6.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.84 . . . . 0.0 109.98 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.98 102.42 34.58 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.291 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.13 -89.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.013 1.533 . . . . 0.0 110.309 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 p30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.189 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 tpt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.347 0.594 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 20.5 p30 -147.46 54.18 1.84 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 45.3 Cg_endo -73.15 -2.74 12.5 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.078 1.567 . . . . 0.0 109.684 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 6' ' ' GLY . 50.6 m -148.4 70.43 1.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.136 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.2 59.22 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 4' ' ' SER . . . 83.72 71.13 1.32 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.582 ' CG2' ' N ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -167.61 170.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.168 -1.195 . . . . 0.0 111.056 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.582 ' N ' ' CG2' ' A' ' 7' ' ' VAL . 1.3 m-20 -155.17 163.19 40.55 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 p -104.15 161.59 13.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.82 -1.175 . . . . 0.0 110.848 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.926 HG21 ' CD2' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -151.99 126.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 110.18 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -116.19 161.63 18.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.32 -0.863 . . . . 0.0 109.574 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.801 ' CD1' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -150.35 162.59 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.479 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 3.1 m -97.7 126.37 43.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.888 HG12 ' HG2' ' A' ' 17' ' ' MET . 91.8 t -111.54 134.12 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.554 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.8 -40.61 0.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 17' ' ' MET . . . -50.73 -30.83 22.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.888 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -52.69 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -1.139 . . . . 0.0 110.102 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.461 HG22 ' SG ' ' A' ' 22' ' ' CYS . 2.4 t -164.21 -37.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' N ' HG23 ' A' ' 18' ' ' THR . 29.8 p -118.0 -138.89 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.59 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 7.1 m-20 -99.84 -57.3 2.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.523 ' O ' ' HB ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -45.72 -20.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 110.814 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' HD12 ' A' ' 26' ' ' ILE . 3.4 m -58.46 -87.25 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.816 -1.178 . . . . 0.0 111.336 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.079 HG21 HG21 ' A' ' 41' ' ' VAL . 12.1 p -70.56 -36.61 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.912 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.63 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.3 m-90 -63.69 -43.07 97.71 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.299 -0.876 . . . . 0.0 110.751 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 21' ' ' SER . 43.7 m -65.52 -38.82 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.449 -1.407 . . . . 0.0 107.914 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.959 HD11 ' CD2' ' A' ' 71' ' ' PHE . 52.1 mt -68.24 -48.66 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' OE2' ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -58.53 -27.42 64.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.596 179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -67.82 -54.16 21.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 109.936 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 33' ' ' VAL . 11.5 tt0 -64.11 -48.92 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.665 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.8 ' O ' HG21 ' A' ' 36' ' ' VAL . 56.8 mt -52.73 -38.91 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.564 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.909 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -69.97 -27.18 73.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.64 5.48 41.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.515 -0.991 . . . . 0.0 109.729 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 34' ' ' ASN . 1.3 t -51.84 -69.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.713 ' N ' HG12 ' A' ' 33' ' ' VAL . 2.5 m120 -142.76 -98.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.077 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . -106.04 62.63 0.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.909 HG11 ' HA2' ' A' ' 31' ' ' GLY . 42.1 t -89.12 118.34 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.26 . . . . 0.0 110.221 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.575 ' CD2' HG21 ' A' ' 7' ' ' VAL . 49.7 m-70 -65.91 -75.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 110.313 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.19 164.81 16.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.791 HD12 ' HB ' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -155.04 142.49 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -166.6 142.84 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.601 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.079 HG21 HG21 ' A' ' 23' ' ' VAL . 2.7 p -123.14 140.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.988 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.64 168.22 16.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mt -110.14 -28.91 8.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.226 -0.921 . . . . 0.0 109.979 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.23 -22.54 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.232 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -134.38 8.2 3.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.402 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mttt 46.92 74.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 0.0 110.507 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 12' ' ' ILE . 8.5 p-10 -170.26 -170.88 1.02 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.477 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.801 ' HB3' ' CD1' ' A' ' 12' ' ' ILE . . . -155.91 141.41 17.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.033 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 11' ' ' THR . 2.9 m -110.99 128.38 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -153.06 147.84 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -113.17 171.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.312 -0.868 . . . . 0.0 110.265 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.3 p90 -157.35 127.59 6.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.695 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.707 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 1.4 p30 -107.24 18.57 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.352 -0.842 . . . . 0.0 111.757 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 52.1 Cg_endo -79.62 65.42 8.88 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 N-CA-C 108.141 -1.523 . . . . 0.0 108.141 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HD2' ' CA ' ' A' ' 6' ' ' GLY . 0.9 OUTLIER -40.15 -27.15 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.636 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.543 ' O ' ' NE2' ' A' ' 57' ' ' GLN . 0.7 OUTLIER -54.07 -22.32 10.57 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 56' ' ' LEU . 20.3 mm-40 -154.77 178.17 10.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -175.05 -65.05 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 49.6 Cg_endo -73.09 -49.07 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.648 1.341 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -67.85 -32.6 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 110.781 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 57' ' ' GLN . 12.6 m -68.9 -58.35 4.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.926 ' CD2' HG21 ' A' ' 10' ' ' VAL . 4.0 mp -55.65 -46.79 77.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.296 -0.878 . . . . 0.0 109.117 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 1.4 tp60 -61.17 -41.21 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 108.83 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' ASP . 84.3 tt0 -68.62 -39.65 80.7 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.654 0.74 . . . . 0.0 109.093 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -47.88 -52.12 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.56 -0.713 . . . . 0.0 109.781 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 73' ' ' ALA . 34.3 mm -64.93 -55.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.581 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.53 -24.1 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 64' ' ' GLU . 2.7 t70 -75.89 -38.83 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.701 ' HG3' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -81.99 -65.95 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.19 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.12 41.38 0.76 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.959 ' CD2' HD11 ' A' ' 26' ' ' ILE . 19.9 m-85 -119.89 143.27 48.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -1.126 . . . . 0.0 110.243 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.409 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -65.62 74.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.456 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 66' ' ' ILE . . . -117.69 148.89 41.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.096 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 74' ' ' VAL . 27.1 m -132.55 120.15 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.351 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.438 HG12 ' OD1' ' A' ' 77' ' ' ASN . 18.5 tt -63.74 152.39 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.3 -0.875 . . . . 0.0 110.021 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -148.99 61.32 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.262 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.438 ' OD1' HG12 ' A' ' 75' ' ' ILE . 15.7 p-10 -112.13 110.67 53.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.999 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -5.24 16.85 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.018 1.536 . . . . 0.0 110.513 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 27.4 p-10 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.251 0.548 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 47.45 61.17 14.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 110.287 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.5 -3.22 13.34 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.129 1.594 . . . . 0.0 109.534 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' GLY . 60.0 p -166.34 74.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.094 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.439 ' C ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -59.96 83.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.434 -0.791 . . . . 0.0 110.21 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 4' ' ' SER . . . 54.19 51.4 50.88 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.732 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -141.79 135.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -1.168 . . . . 0.0 110.599 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -110.14 -177.78 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.817 ' OG ' HG22 ' A' ' 51' ' ' ILE . 57.9 m -131.6 135.08 46.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.761 -1.212 . . . . 0.0 110.776 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.8 HG11 HD23 ' A' ' 62' ' ' LEU . 2.1 t -127.91 145.23 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.91 173.35 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.089 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.024 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.2 130.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.279 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 8.5 t -84.5 135.65 34.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.221 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.675 HG12 ' C ' ' A' ' 46' ' ' LYS . 8.1 p -123.76 166.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.655 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -161.02 -39.27 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.437 -0.789 . . . . 0.0 109.927 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.83 97.85 2.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.545 ' HE1' ' HG3' ' A' ' 46' ' ' LYS . 0.9 OUTLIER -150.33 100.22 2.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.15 . . . . 0.0 110.238 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.538 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -42.0 -68.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.845 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 20' ' ' ASN . 6.0 m -154.68 -162.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.959 -1.088 . . . . 0.0 110.841 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.621 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.4 t30 -39.36 -50.13 2.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 110.806 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.516 ' O ' ' HB ' ' A' ' 25' ' ' THR . 42.7 m -43.69 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.601 ' C ' HD12 ' A' ' 26' ' ' ILE . 97.2 m -75.31 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.597 -1.315 . . . . 0.0 111.831 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.902 HG13 ' CE3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -43.1 -38.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.382 -0.824 . . . . 0.0 110.773 -178.353 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.902 ' CE3' HG13 ' A' ' 23' ' ' VAL . 21.4 m-90 -69.8 -50.18 45.5 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.141 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 21' ' ' SER . 49.4 m -60.06 -38.19 82.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.464 -1.398 . . . . 0.0 107.827 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 71' ' ' PHE . 17.0 mt -69.29 -54.23 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 3.7 tt0 -54.89 -20.76 9.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -57.77 3.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.435 ' OE1' ' CE ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -61.12 -52.07 66.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 109.721 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.51 ' CG2' ' HA ' ' A' ' 27' ' ' GLU . 11.8 tt -51.39 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.555 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.753 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -77.92 -15.69 80.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -116.78 18.82 14.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.852 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.536 HG13 ' N ' ' A' ' 34' ' ' ASN . 5.0 p -82.51 -42.6 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.725 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' N ' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -170.69 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.065 -1.022 . . . . 0.0 110.867 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 53' ' ' ASP . . . -67.91 55.31 0.38 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.163 -0.96 . . . . 0.0 110.841 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.753 HG11 ' HA2' ' A' ' 31' ' ' GLY . 5.7 p -95.39 151.55 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.914 -1.345 . . . . 0.0 108.476 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.849 ' CE1' ' HB ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -115.32 -68.63 0.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.069 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.555 ' O ' ' CD1' ' A' ' 51' ' ' ILE . 23.0 p-80 -124.66 168.76 12.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.593 -1.317 . . . . 0.0 111.091 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.477 HG23 ' HB ' ' A' ' 50' ' ' ILE . 1.8 mp -145.75 150.01 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 110.571 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.589 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -125.87 149.96 48.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 109.814 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.891 HG21 ' CG2' ' A' ' 23' ' ' VAL . 7.7 p -164.08 137.4 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.001 -1.062 . . . . 0.0 110.49 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.18 127.8 17.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.9 -3.45 51.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 110.45 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.45 -33.01 32.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 110.087 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.74 -1.41 21.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.068 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.675 ' C ' HG12 ' A' ' 14' ' ' VAL . 3.1 mptt 58.86 58.34 3.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.663 ' N ' HG12 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -170.38 167.81 8.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 109.69 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 40' ' ' LYS . . . -150.35 142.71 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.306 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 33.1 m -110.0 105.08 14.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 109.28 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -118.69 153.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.672 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.849 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -108.99 -177.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.438 -0.788 . . . . 0.0 110.591 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.642 ' CE1' HG23 ' A' ' 10' ' ' VAL . 20.3 p90 -178.34 141.51 0.23 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.618 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 6.3 p-10 -79.68 111.91 25.04 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.677 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 52' ' ' TYR . 46.5 Cg_endo -73.5 0.76 7.65 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.724 1.381 . . . . 0.0 110.477 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HA3' ' A' ' 6' ' ' GLY . 3.4 mttm -70.34 -19.39 63.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 0.0 110.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -139.05 3.1 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.955 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.685 ' C ' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -177.71 137.01 0.19 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 110.078 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.759 HG23 ' HD3' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -169.05 -60.34 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.948 -1.095 . . . . 0.0 112.054 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.759 ' HD3' HG23 ' A' ' 58' ' ' THR . 51.8 Cg_endo -74.45 -52.1 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.159 1.084 . . . . 0.0 111.499 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -86.92 -50.57 6.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 111.396 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 57' ' ' GLN . 63.9 m -46.15 -61.8 1.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.915 -1.116 . . . . 0.0 110.336 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.8 HD23 HG11 ' A' ' 10' ' ' VAL . 2.1 mp -52.23 -44.18 64.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.339 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -44.3 93.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.216 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -69.12 -19.95 64.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.544 -0.723 . . . . 0.0 109.329 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -69.93 -65.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.787 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 73' ' ' ALA . 1.3 tp -53.75 -35.3 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -78.59 -30.18 46.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 6.7 t0 -64.71 -36.11 83.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 109.929 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.435 ' CE ' ' OE1' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -89.64 -68.6 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.017 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.44 -9.06 10.96 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.165 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.826 ' CD2' HD11 ' A' ' 26' ' ' ILE . 30.6 m-85 -49.79 124.7 10.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.942 -1.328 . . . . 0.0 110.122 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.68 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.273 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -133.11 178.39 6.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.972 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' SER . 58.5 t -135.49 95.69 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 110.166 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.538 HG23 HD13 ' A' ' 66' ' ' ILE . 50.1 pt -56.62 162.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.227 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -145.17 87.75 1.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -117.93 137.46 24.43 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.047 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.57 -9.38 23.95 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.945 1.497 . . . . 0.0 110.84 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.201 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.278 0.561 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.9 65.86 6.11 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.508 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 4' ' ' SER . 47.0 Cg_endo -74.38 -0.5 9.76 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.036 1.545 . . . . 0.0 109.581 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 0.7 OUTLIER 65.37 58.07 0.87 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.333 -0.854 . . . . 0.0 110.278 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.18 85.31 3.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.72 -33.81 0.05 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.962 HG11 ' NE2' ' A' ' 37' ' ' HIS . 11.4 m -66.87 143.32 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -1.214 . . . . 0.0 110.669 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -118.06 167.55 11.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.805 . . . . 0.0 109.927 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.3 t -112.11 136.81 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.063 -1.023 . . . . 0.0 110.287 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.103 ' CG1' HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -120.65 126.2 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.627 -0.671 . . . . 0.0 110.438 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.495 ' C ' ' CG2' ' A' ' 12' ' ' ILE . 12.3 p -116.88 161.01 19.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 0.0 109.603 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.823 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -152.38 166.98 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.411 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -98.21 159.99 14.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.683 HG11 ' SD ' ' A' ' 17' ' ' MET . 58.4 t -145.27 147.34 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.079 . . . . 0.0 110.705 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 3.3 tp10 -146.15 -41.36 0.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 109.706 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.05 88.81 1.49 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.683 ' SD ' HG11 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -114.5 -160.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -1.163 . . . . 0.0 110.614 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' C ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -167.04 -144.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.546 -0.721 . . . . 0.0 109.711 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -58.74 153.29 17.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 109.764 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -27.88 -44.26 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.65 0.738 . . . . 0.0 111.535 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.536 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 96.0 p -50.18 -15.9 0.27 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.745 -1.222 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 1.2 p -49.56 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.838 -1.164 . . . . 0.0 111.058 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.079 HG11 HG21 ' A' ' 41' ' ' VAL . 7.9 p -82.84 -23.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 111.374 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.643 ' CH2' HD21 ' A' ' 43' ' ' LEU . 14.4 m-90 -69.34 -28.46 66.24 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.264 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 28.4 m -82.29 -41.69 19.81 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.105 HD11 ' CD2' ' A' ' 71' ' ' PHE . 83.4 mt -65.1 -45.86 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.567 ' CG ' HD13 ' A' ' 39' ' ' ILE . 19.1 tt0 -60.32 -36.45 77.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.459 -0.776 . . . . 0.0 109.659 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -45.11 80.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.149 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.0 mm100 -54.23 -42.54 69.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.859 ' O ' HG21 ' A' ' 36' ' ' VAL . 75.2 mt -61.36 -46.93 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.466 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . -62.78 -14.65 52.3 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -107.26 -9.86 15.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -1.043 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' A' ' 30' ' ' ILE . 3.2 t -49.02 -64.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.493 ' C ' HD21 ' A' ' 34' ' ' ASN . 0.5 OUTLIER -169.66 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.095 . . . . 0.0 110.812 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.13 34.84 4.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.859 HG21 ' O ' ' A' ' 30' ' ' ILE . 29.0 t -70.61 115.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.055 -1.262 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.962 ' NE2' HG11 ' A' ' 7' ' ' VAL . 52.3 m-70 -65.27 -87.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 110.691 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.58 ' CD2' HG13 ' A' ' 51' ' ' ILE . 19.5 p80 -120.52 163.07 18.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.89 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.031 ' O ' HD12 ' A' ' 39' ' ' ILE . 2.3 pp -148.42 153.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.449 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -164.83 141.54 5.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.95 -1.094 . . . . 0.0 111.096 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.079 HG21 HG11 ' A' ' 23' ' ' VAL . 1.2 p -124.32 135.34 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.813 ' C ' HD22 ' A' ' 43' ' ' LEU . 15.2 p -109.52 172.73 6.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 110.213 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.813 HD22 ' C ' ' A' ' 42' ' ' SER . 3.9 mm? -117.62 -29.06 5.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.998 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -66.04 -29.11 69.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 110.352 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 35.2 mt-10 -116.08 5.08 13.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.503 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER 43.01 65.61 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 45' ' ' GLU . 15.1 p-10 -155.59 171.89 19.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 12' ' ' ILE . . . -141.22 154.78 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 110.372 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 49' ' ' THR . 10.1 t -136.83 127.61 27.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 110.02 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.912 ' CB ' HG22 ' A' ' 39' ' ' ILE . 2.3 pp -144.62 161.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.138 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.58 HG13 ' CD2' ' A' ' 38' ' ' HIS . 0.5 OUTLIER -112.41 168.17 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 110.509 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.687 ' OH ' HG23 ' A' ' 10' ' ' VAL . 9.8 p90 -166.2 130.68 2.2 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.338 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.538 ' CB ' HG12 ' A' ' 7' ' ' VAL . 18.1 p-10 -77.34 125.85 85.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.368 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 42.2 Cg_endo -68.93 -30.16 26.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.87 1.458 . . . . 0.0 109.597 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -20.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.961 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -135.86 -40.9 0.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 5.2 mp0 -106.77 -166.1 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 0.0 110.677 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.508 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.01 179.73 0.8 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 0.0 110.169 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 45.7 Cg_endo -73.44 -11.88 24.75 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.959 1.505 . . . . 0.0 110.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -76.29 -51.34 12.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 65' ' ' ALA . 54.3 m -44.37 -47.25 9.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.455 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.103 HD22 ' CG1' ' A' ' 10' ' ' VAL . 1.3 mp -57.32 -45.95 83.73 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.317 -0.865 . . . . 0.0 108.871 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HG3' HG21 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -62.74 -51.09 68.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.489 -0.757 . . . . 0.0 109.203 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.2 -34.66 78.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.389 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' THR . . . -56.5 -55.86 28.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 109.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 mm -55.2 -42.82 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -29.46 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.32 -23.96 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.945 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.78 -47.94 5.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.04 74.07 1.0 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 1.105 ' CD2' HD11 ' A' ' 26' ' ' ILE . 8.4 m-85 -146.48 135.52 22.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -1.139 . . . . 0.0 110.213 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.26 81.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.501 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -113.0 171.24 7.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' C ' ' A' ' 73' ' ' ALA . 71.3 t -147.51 79.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.383 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.427 HG21 ' HG3' ' A' ' 63' ' ' GLN . 8.2 tt -56.93 141.77 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -159.72 92.89 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.536 ' CG ' HG22 ' A' ' 10' ' ' VAL . 1.1 p30 -157.25 57.01 1.22 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 45.8 Cg_endo -73.43 162.15 40.84 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.998 1.525 . . . . 0.0 110.37 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.265 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.207 0.527 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.436 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 58.1 t0 -165.81 56.35 0.42 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.955 . . . . 0.0 110.415 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 46.3 Cg_endo -73.97 -1.58 11.06 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.069 1.562 . . . . 0.0 109.742 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.917 ' O ' HG22 ' A' ' 7' ' ' VAL . 5.8 m -67.17 -8.85 34.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.957 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 70.12 41.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.486 -0.758 . . . . 0.0 110.612 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.46 -46.56 3.0 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.605 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.113 HG11 ' CE1' ' A' ' 37' ' ' HIS . 16.1 m -53.64 131.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.326 . . . . 0.0 110.698 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 51' ' ' ILE . 3.0 t-20 -118.77 -177.81 3.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.55 -0.719 . . . . 0.0 109.759 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -117.5 140.56 49.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.084 -1.01 . . . . 0.0 110.399 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.813 HG11 HD23 ' A' ' 62' ' ' LEU . 1.4 t -139.83 141.12 35.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.613 -0.68 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.3 p -114.35 159.39 20.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.233 -0.917 . . . . 0.0 110.186 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.843 ' O ' HD12 ' A' ' 12' ' ' ILE . 2.4 pp -135.99 136.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 110.196 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.53 ' HA ' ' ND2' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -84.73 135.5 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 110.058 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.633 HG12 ' SD ' ' A' ' 17' ' ' MET . 71.1 t -117.33 142.42 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.26 52.77 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.2 51.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.633 ' SD ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -97.19 -139.79 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.392 -1.063 . . . . 0.0 110.15 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.716 HG22 ' SG ' ' A' ' 22' ' ' CYS . 1.4 t -179.43 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.203 -0.936 . . . . 0.0 110.42 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.8 OUTLIER -159.28 -139.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -89.32 -51.19 5.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 25' ' ' THR . 1.8 t -48.04 -17.75 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.667 -1.271 . . . . 0.0 110.619 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.757 ' O ' HD12 ' A' ' 26' ' ' ILE . 2.0 m -59.96 -87.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.73 -1.231 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.648 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 12.4 p -72.47 -17.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 112.044 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.648 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 8.0 m-90 -86.39 -40.87 14.96 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.02 -1.05 . . . . 0.0 110.522 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -68.41 -40.27 81.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.536 -1.353 . . . . 0.0 107.909 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.004 HD11 ' CD2' ' A' ' 71' ' ' PHE . 60.8 mt -60.7 -44.47 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.666 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -60.48 -28.8 68.64 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -42.87 88.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.527 ' HG3' ' CE ' ' A' ' 69' ' ' MET . 0.2 OUTLIER -67.09 -56.81 8.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.653 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 27' ' ' GLU . 1.5 tt -47.57 -28.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.23 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA2' ' CG2' ' A' ' 36' ' ' VAL . . . -83.6 -28.24 36.26 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -83.31 -0.26 48.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.015 . . . . 0.0 109.86 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.61 HG11 HG23 ' A' ' 61' ' ' THR . 13.2 t -102.49 -62.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -105.46 154.16 20.72 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.272 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 37' ' ' HIS . . . -66.85 62.49 0.19 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 35.6 m -52.15 125.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.186 -1.185 . . . . 0.0 110.521 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 1.113 ' CE1' HG11 ' A' ' 7' ' ' VAL . 35.7 m80 -93.24 -20.47 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.301 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.53 ' CD2' ' HA ' ' A' ' 50' ' ' ILE . 2.2 t60 -136.95 138.61 40.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.859 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.781 ' HA ' HG22 ' A' ' 50' ' ' ILE . 7.5 tt -139.27 123.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.58 148.19 35.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 110.417 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 23' ' ' VAL . 24.7 t -126.94 151.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.296 -0.877 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 47' ' ' ASN . 15.0 p -122.4 145.91 47.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -106.67 -66.09 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.372 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -15.19 4.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.649 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.61 -9.07 13.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 110.362 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.588 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 0.0 OUTLIER 48.72 73.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.168 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -163.79 178.73 7.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB3' HG13 ' A' ' 12' ' ' ILE . . . -152.71 151.96 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.416 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 49' ' ' THR . 8.9 t -140.89 122.36 15.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.781 HG22 ' HA ' ' A' ' 39' ' ' ILE . 2.3 pp -145.64 172.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.687 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.36 170.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 109.755 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.905 ' HE2' HG22 ' A' ' 58' ' ' THR . 7.4 p90 -164.0 126.22 2.41 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.63 ' CA ' HG12 ' A' ' 7' ' ' VAL . 4.5 p-10 -68.31 121.08 79.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.568 -0.707 . . . . 0.0 110.017 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.588 ' HA ' HG23 ' A' ' 58' ' ' THR . 42.4 Cg_endo -67.77 -7.01 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.731 1.385 . . . . 0.0 110.084 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.9 -48.14 11.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.838 . . . . 0.0 109.81 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 8.9 mp -82.09 -63.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.907 ' O ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -156.76 -154.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 109.25 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -175.53 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 110.627 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 47.8 Cg_endo -73.02 -28.66 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.419 1.221 . . . . 0.0 109.159 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -91.34 -29.43 17.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.514 -0.741 . . . . 0.0 110.859 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 HG11 ' A' ' 33' ' ' VAL . 27.6 m -73.42 -63.41 1.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.738 -1.226 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.813 HD23 HG11 ' A' ' 10' ' ' VAL . 5.7 mp -46.84 -39.06 11.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 108.956 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -67.11 -48.0 69.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.533 -0.73 . . . . 0.0 109.272 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 68' ' ' ASP . 35.7 tt0 -66.75 -23.45 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.376 -0.828 . . . . 0.0 109.367 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -65.67 -69.56 0.29 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.802 . . . . 0.0 109.705 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.56 -30.43 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 109.158 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 10.7 t0 -78.58 -39.88 36.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 64' ' ' GLU . 18.0 t0 -53.15 -35.92 60.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.785 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.527 ' CE ' ' HG3' ' A' ' 29' ' ' GLN . 6.1 mmt -84.89 -68.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.193 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -12.42 7.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 1.004 ' CD2' HD11 ' A' ' 26' ' ' ILE . 15.4 m-85 -51.9 142.16 16.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.278 -1.13 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -68.62 70.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.71 164.36 27.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.414 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.49 152.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.126 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.725 HD13 ' HB3' ' A' ' 62' ' ' LEU . 1.7 pp -111.58 143.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.122 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.407 ' C ' ' CG ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -129.24 -171.82 2.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 110.083 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.536 ' OD1' ' CD ' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -164.27 -61.2 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.199 -0.938 . . . . 0.0 110.275 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.536 ' CD ' ' OD1' ' A' ' 77' ' ' ASN . 46.6 Cg_endo -72.98 57.64 3.26 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.449 1.237 . . . . 0.0 110.151 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.235 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 53' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.551 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 1.9 t -143.92 165.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.054 -1.262 . . . . 0.0 110.079 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 6.5 m-20 -138.36 161.9 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.495 -0.753 . . . . 0.0 109.437 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 t -126.01 139.11 53.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.677 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.792 HG11 ' CD2' ' A' ' 62' ' ' LEU . 1.5 t -127.99 127.58 68.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.671 -0.643 . . . . 0.0 110.061 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.66 143.05 39.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.752 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.2 pp -138.59 154.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.624 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.401 ' C ' HG23 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -98.01 166.16 11.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.691 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 17' ' ' MET . 58.7 t -144.08 148.75 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -152.58 19.7 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.17 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.449 ' HA3' ' OD2' ' A' ' 72' ' ' ASP . . . -148.25 80.88 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.828 ' O ' HG23 ' A' ' 18' ' ' THR . 63.4 mtm -130.68 -143.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.402 -1.058 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER 174.73 -71.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.321 -0.862 . . . . 0.0 109.735 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ASN . 33.5 m -112.76 160.66 17.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.53 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 14.5 p30 -42.73 -43.86 4.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.019 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.532 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 83.2 p -45.99 -21.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 110.694 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.745 ' O ' HD12 ' A' ' 26' ' ' ILE . 4.4 m -56.73 -86.17 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.917 -1.114 . . . . 0.0 111.375 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.831 HG22 HG11 ' A' ' 41' ' ' VAL . 12.0 p -72.34 -37.62 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.399 -0.813 . . . . 0.0 111.819 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.632 ' CZ2' ' CG2' ' A' ' 41' ' ' VAL . 9.2 m-90 -62.29 -47.43 84.35 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.517 -0.739 . . . . 0.0 110.485 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 14.7 m -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.611 -1.306 . . . . 0.0 108.16 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.029 HD11 ' CD2' ' A' ' 71' ' ' PHE . 48.0 mt -68.0 -42.66 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.517 ' CA ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -66.13 -28.23 68.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.818 . . . . 0.0 109.874 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -49.19 65.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.37 -55.5 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.776 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.922 ' O ' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -52.8 -29.43 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.586 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.614 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -86.69 -21.29 51.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -101.75 10.98 39.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -1.108 . . . . 0.0 109.76 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 30' ' ' ILE . 6.3 p -83.03 -28.88 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 110.839 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.565 ' CB ' ' HG3' ' A' ' 57' ' ' GLN . 6.0 t-20 -165.88 -135.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.941 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.13 38.67 2.73 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.22 -0.991 . . . . 0.0 110.684 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.922 HG21 ' O ' ' A' ' 30' ' ' ILE . 3.5 t -67.33 115.19 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.926 -1.337 . . . . 0.0 109.446 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.565 ' H ' HD13 ' A' ' 51' ' ' ILE . 39.6 m-70 -64.07 -85.38 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.427 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.599 ' C ' HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -132.33 174.65 10.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.068 . . . . 0.0 110.907 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -157.66 173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.531 -0.731 . . . . 0.0 109.44 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 39' ' ' ILE . 12.6 mttm -166.43 148.28 6.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.055 -1.028 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.831 HG11 HG22 ' A' ' 23' ' ' VAL . 4.2 m -123.23 159.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.965 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.03 85.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -25.21 4.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -42.14 67.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.036 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.53 12.74 22.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? 49.53 69.19 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.268 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 18.3 p-10 -170.08 -177.68 2.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.43 137.85 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 110.106 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 49' ' ' THR . 15.0 t -109.98 130.33 55.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.833 HD11 HD21 ' A' ' 62' ' ' LEU . 2.0 pp -143.1 151.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.613 ' C ' HD12 ' A' ' 51' ' ' ILE . 1.1 pp -109.79 -177.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 23.5 p90 -174.33 133.26 0.39 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.122 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 0.4 OUTLIER -71.3 117.34 55.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.551 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.6 Cg_endo -72.65 -26.66 16.07 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.901 1.474 . . . . 0.0 109.5 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HD3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -70.7 -14.36 62.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.691 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.476 HD23 ' HD3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -121.99 -32.51 3.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.565 ' HG3' ' CB ' ' A' ' 34' ' ' ASN . 25.0 mm100 -134.72 -154.61 0.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.418 -0.802 . . . . 0.0 109.708 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.551 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.33 -179.17 0.64 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.013 -1.054 . . . . 0.0 110.306 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.735 ' HA ' HD13 ' A' ' 62' ' ' LEU . 42.3 Cg_endo -69.96 -17.9 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.796 1.419 . . . . 0.0 110.293 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.13 -49.04 71.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.543 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 m -50.19 -44.08 52.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.202 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.833 HD21 HD11 ' A' ' 50' ' ' ILE . 6.2 mp -57.07 -43.66 82.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 108.68 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -45.16 92.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.09 -31.6 70.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.475 -0.766 . . . . 0.0 109.543 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -57.4 -59.42 5.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.485 -0.759 . . . . 0.0 110.087 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.18 -45.35 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.86 -16.83 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.818 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 63.6 t0 -81.08 -42.64 20.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.421 ' HE2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -86.43 -66.32 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 136.83 -26.03 3.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 1.029 ' CD2' HD11 ' A' ' 26' ' ' ILE . 92.3 m-85 -42.15 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -1.101 . . . . 0.0 110.2 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.449 ' OD2' ' HA3' ' A' ' 16' ' ' GLY . 1.2 p30 -56.99 83.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.85 . . . . 0.0 110.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 12' ' ' ILE . . . -116.78 135.94 53.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 0.0 109.984 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.7 p -111.67 142.6 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 110.502 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 5.8 mt -85.21 166.9 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.407 ' N ' HG22 ' A' ' 75' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.037 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.054 HG21 ' CE1' ' A' ' 37' ' ' HIS . 27.8 m -64.42 132.47 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.235 . . . . 0.0 110.486 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 51' ' ' ILE . 4.9 m-20 -95.5 -174.42 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.42 -0.8 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 95.5 p -131.28 132.14 44.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.942 -1.099 . . . . 0.0 111.153 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.519 HG23 ' CE1' ' A' ' 52' ' ' TYR . 2.1 t -128.66 129.12 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.765 -0.584 . . . . 0.0 109.546 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.638 HG22 HG23 ' A' ' 49' ' ' THR . 82.5 p -112.01 159.32 18.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.221 -0.925 . . . . 0.0 110.646 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.845 ' O ' HD12 ' A' ' 12' ' ' ILE . 2.7 pp -139.8 157.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.359 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -88.61 168.14 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 109.694 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.917 HG11 ' SD ' ' A' ' 17' ' ' MET . 70.5 t -140.11 147.49 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.991 -1.068 . . . . 0.0 110.585 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -170.61 42.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 17' ' ' MET . . . -171.69 -34.06 0.03 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.917 ' SD ' HG11 ' A' ' 14' ' ' VAL . 19.3 ptt? -42.88 151.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -1.118 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.532 ' N ' ' HB3' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -72.01 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -0.825 . . . . 0.0 110.716 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -107.24 -31.48 8.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -125.31 -67.19 0.91 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.192 -0.943 . . . . 0.0 109.974 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.539 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 2.7 t -49.96 -19.44 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.834 -1.166 . . . . 0.0 109.971 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.893 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -46.04 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.946 HG21 HG11 ' A' ' 41' ' ' VAL . 7.3 p -85.32 -31.64 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 111.461 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.665 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 17.1 m-90 -60.84 -32.18 71.59 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.165 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 14.7 m -80.4 -44.93 18.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.939 HD11 ' CD2' ' A' ' 71' ' ' PHE . 9.0 mt -63.64 -59.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.687 ' HG3' HG21 ' A' ' 39' ' ' ILE . 42.9 tt0 -42.91 -41.93 3.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.487 -0.758 . . . . 0.0 109.292 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.27 -43.79 83.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' A' ' 32' ' ' LYS . 1.9 mt-30 -74.98 -63.0 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.08 -1.012 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.852 ' O ' HG21 ' A' ' 36' ' ' VAL . 24.3 pt -51.45 -34.57 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 109.473 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' HG13 ' A' ' 30' ' ' ILE . . . -77.19 -22.33 71.23 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.409 -1.877 . . . . 0.0 108.409 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 12.3 tttm -101.02 3.17 41.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -1.007 . . . . 0.0 110.013 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.794 HG12 ' N ' ' A' ' 34' ' ' ASN . 1.8 t -59.94 -76.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.794 ' N ' HG12 ' A' ' 33' ' ' VAL . 2.3 t30 -177.25 -75.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.941 -1.099 . . . . 0.0 110.95 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.61 -26.73 74.26 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.852 HG21 ' O ' ' A' ' 30' ' ' ILE . 35.9 m -50.81 123.77 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -1.146 . . . . 0.0 110.54 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 1.054 ' CE1' HG21 ' A' ' 7' ' ' VAL . 5.2 p80 -129.54 10.89 5.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.832 ' N ' HD11 ' A' ' 51' ' ' ILE . 14.9 t60 -171.85 143.66 1.66 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 109.934 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.687 HG21 ' HG3' ' A' ' 27' ' ' GLU . 3.9 mp -141.2 149.59 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.41 108.51 4.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.946 HG11 HG21 ' A' ' 23' ' ' VAL . 4.8 p -125.89 140.4 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 0.0 110.476 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 p -112.54 150.94 30.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.987 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 -2.91 22.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 110.136 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -102.51 -32.55 9.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.3 -3.08 37.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' C ' ' HB ' ' A' ' 14' ' ' VAL . 4.8 mttp 53.75 65.06 1.62 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.321 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.55 176.01 12.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 0.0 109.707 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.63 146.56 25.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 0.0 110.781 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.638 HG23 HG22 ' A' ' 11' ' ' THR . 88.3 m -132.8 100.34 4.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.742 . . . . 0.0 109.435 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -119.23 156.5 21.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 110.231 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 1.014 HD13 ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -109.86 174.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 8.1 p90 -159.28 128.71 5.44 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.583 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.631 ' CA ' HG12 ' A' ' 7' ' ' VAL . 6.6 t0 -68.52 115.13 26.91 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 110.014 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 42.9 Cg_endo -69.44 -44.89 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.906 1.477 . . . . 0.0 110.138 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' A' ' 53' ' ' ASP . 11.1 ptmt -42.56 -26.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 34' ' ' ASN . 0.2 OUTLIER -123.93 -22.69 4.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.372 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 49.3 mm-40 -131.01 -158.64 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.536 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -170.72 179.42 0.71 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HA ' HD12 ' A' ' 62' ' ' LEU . 43.1 Cg_endo -69.46 -12.27 33.1 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.719 1.379 . . . . 0.0 110.291 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' THR . 11.1 mttt -74.14 -51.97 13.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.649 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' LYS . 7.4 m -45.2 -48.63 12.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 109.227 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 59' ' ' PRO . 2.1 mt -57.91 -48.88 78.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 109.263 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.9 -37.99 72.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.001 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 68' ' ' ASP . 47.1 tt0 -73.53 -31.76 63.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.251 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -55.78 -58.22 8.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.485 -0.759 . . . . 0.0 109.548 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 12' ' ' ILE . 56.7 mt -61.37 -37.62 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.489 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.89 -12.24 60.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 64' ' ' GLU . 25.0 t70 -85.59 -39.82 16.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.4 mmt -87.59 -56.13 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 123.56 -10.16 8.61 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.939 ' CD2' HD11 ' A' ' 26' ' ' ILE . 8.0 m-85 -42.76 143.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -1.179 . . . . 0.0 110.347 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.14 74.09 2.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -119.81 162.15 19.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.645 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.433 ' HB ' ' OG ' ' A' ' 13' ' ' SER . 40.8 t -144.07 108.59 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.771 ' HA ' HG22 ' A' ' 12' ' ' ILE . 14.4 pt -46.26 146.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.94 HG11 ' CE1' ' A' ' 37' ' ' HIS . 6.2 m -82.14 142.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.4 m-20 -108.09 166.64 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.073 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.3 p -114.37 131.64 56.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 62' ' ' LEU . 1.3 t -117.8 137.38 51.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.642 -0.661 . . . . 0.0 110.351 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.712 ' CG2' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -114.64 152.67 31.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.573 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.006 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -145.35 139.83 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.003 -1.06 . . . . 0.0 110.764 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.7 m -90.55 122.28 33.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG12 ' C ' ' A' ' 46' ' ' LYS . 10.2 p -111.45 153.84 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 110.494 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -139.98 -59.74 0.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.48 75.77 0.52 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.459 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -98.36 -146.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.205 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 m -156.93 -67.11 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.208 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.7 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.21 -0.931 . . . . 0.0 110.12 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.595 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -140.8 -68.92 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.841 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -45.38 -22.73 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.103 -0.998 . . . . 0.0 109.975 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 16.0 t -49.83 -83.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.796 -1.19 . . . . 0.0 110.398 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.947 HG21 HG21 ' A' ' 41' ' ' VAL . 15.0 p -81.13 -42.22 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 111.531 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.622 ' N ' HG13 ' A' ' 23' ' ' VAL . 9.8 m-90 -52.55 -33.75 47.07 Favored 'General case' 0 C--N 1.285 -2.223 0 O-C-N 121.127 -0.983 . . . . 0.0 109.725 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.513 ' CB ' ' O ' ' A' ' 21' ' ' SER . 25.7 m -77.8 -43.04 31.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.12 HD11 ' CD2' ' A' ' 71' ' ' PHE . 63.0 mt -64.22 -58.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.7 tm-20 -42.76 -39.72 2.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.529 -0.732 . . . . 0.0 109.407 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.34 -47.74 82.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.77 -56.53 5.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.212 -0.93 . . . . 0.0 110.129 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.813 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.5 tp -48.81 -30.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.49 -32.86 32.98 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -89.14 6.3 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -1.121 . . . . 0.0 110.05 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 30' ' ' ILE . 6.1 p -81.81 -18.73 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -161.35 -132.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 109.985 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -115.05 47.99 0.98 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 51' ' ' ILE . 9.9 p -45.77 135.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -1.156 . . . . 0.0 110.415 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.94 ' CE1' HG11 ' A' ' 7' ' ' VAL . 15.1 m-70 -105.63 -10.54 16.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.959 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.514 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 25.4 t60 -163.87 145.25 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.416 -0.802 . . . . 0.0 109.822 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.914 HD12 HG13 ' A' ' 50' ' ' ILE . 6.8 tt -162.27 124.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.049 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -145.23 140.1 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 110.399 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.947 HG21 HG21 ' A' ' 23' ' ' VAL . 4.6 p -131.9 148.03 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 m -126.88 168.47 14.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.07 -1.82 14.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 17.6 pt-20 -95.57 -34.12 12.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 9.6 mt-10 -102.04 4.97 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.559 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER 45.65 58.69 4.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.464 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.485 ' N ' HG12 ' A' ' 14' ' ' VAL . 9.3 p-10 -169.63 166.15 10.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.049 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.553 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -148.61 148.24 29.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.455 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.712 HG23 ' CG2' ' A' ' 11' ' ' THR . 3.4 m -109.89 152.82 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.791 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.914 HG13 HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.79 157.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.989 -1.069 . . . . 0.0 110.593 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.59 169.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.547 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.642 ' CE1' HG23 ' A' ' 10' ' ' VAL . 9.7 p90 -165.1 118.73 1.24 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.883 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.651 ' CG ' HG12 ' A' ' 7' ' ' VAL . 3.9 t0 -63.65 117.98 40.18 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.158 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.542 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.7 Cg_endo -70.68 -43.11 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.864 1.455 . . . . 0.0 109.841 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HD3' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.93 -26.04 0.37 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 tp -117.31 -34.89 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 110.07 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' HG23 ' A' ' 58' ' ' THR . 1.9 tp-100 -124.39 -150.95 0.46 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.955 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.56 HG22 ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.11 -179.36 0.35 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.294 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 58' ' ' THR . 41.7 Cg_endo -69.81 -30.43 22.04 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.917 1.483 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -36.2 83.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.863 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.411 HG21 ' CG ' ' A' ' 57' ' ' GLN . 97.2 m -57.75 -56.7 18.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.785 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.651 HD22 HG11 ' A' ' 10' ' ' VAL . 2.2 mp -50.16 -41.94 50.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.17 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.544 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.9 tt0 -61.49 -44.5 96.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.103 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -27.36 66.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.518 -0.739 . . . . 0.0 109.459 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -65.35 -62.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 109.942 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 73' ' ' ALA . 18.2 mm -51.63 -38.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.608 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -68.94 -26.15 64.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -70.88 -32.34 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.81 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.519 ' HE2' ' HA ' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -89.66 -50.49 6.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.266 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 121.72 -25.68 6.79 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 1.12 ' CD2' HD11 ' A' ' 26' ' ' ILE . 39.7 m-85 -43.01 116.7 0.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 110.281 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.03 83.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 110.398 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.006 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -129.26 137.04 50.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.4 p -117.93 133.93 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.226 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.544 HD11 ' HA ' ' A' ' 63' ' ' GLN . 6.1 mt -73.94 162.61 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.01 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.123 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.533 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 2.5 t -64.58 168.24 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -1.092 . . . . 0.0 110.805 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.4 m-20 -149.95 173.97 13.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.659 -0.651 . . . . 0.0 109.29 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 11.2 p -127.41 147.72 50.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.941 -1.099 . . . . 0.0 110.771 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.753 HG11 HD22 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -136.38 125.55 38.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.547 -0.72 . . . . 0.0 110.208 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.649 ' CG2' HG23 ' A' ' 49' ' ' THR . 0.9 OUTLIER -109.55 144.93 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.527 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.71 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.3 pp -144.1 169.65 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.551 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.44 ' N ' HD12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -114.34 138.24 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.393 -0.817 . . . . 0.0 109.809 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.85 146.68 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.528 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -145.94 27.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.868 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.36 80.42 0.12 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.603 ' O ' HG23 ' A' ' 18' ' ' THR . 0.0 OUTLIER -122.94 -138.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -1.141 . . . . 0.0 110.026 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 17' ' ' MET . 19.2 p -156.32 -94.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.346 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.5 p -142.51 -40.56 0.34 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.082 -1.011 . . . . 0.0 110.029 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 16.7 t-20 -145.34 -47.45 0.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.804 ' HA ' HG23 ' A' ' 25' ' ' THR . 0.8 OUTLIER -49.32 -20.47 0.66 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.925 -1.109 . . . . 0.0 110.325 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' O ' HD12 ' A' ' 26' ' ' ILE . 14.3 t -52.44 -81.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.939 -1.101 . . . . 0.0 111.381 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.768 ' CG1' HG21 ' A' ' 41' ' ' VAL . 7.5 p -81.16 -34.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.187 -0.946 . . . . 0.0 111.986 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.685 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.7 m-90 -60.2 -38.01 82.02 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 121.12 -0.988 . . . . 0.0 110.534 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.804 HG23 ' HA ' ' A' ' 21' ' ' SER . 16.4 p -80.49 -44.92 18.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.634 -1.291 . . . . 0.0 107.832 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 71' ' ' PHE . 50.4 mt -61.42 -56.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' VAL . 7.3 tt0 -43.22 -48.91 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.124 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -53.14 -41.8 65.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' HG23 ' A' ' 33' ' ' VAL . 18.6 tp60 -75.83 -51.87 11.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.799 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.832 ' O ' HG21 ' A' ' 36' ' ' VAL . 9.8 mm -51.24 -39.43 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.467 ' HA2' ' HB ' ' A' ' 36' ' ' VAL . . . -72.15 -30.95 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -82.89 -1.8 53.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -1.089 . . . . 0.0 110.126 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 29' ' ' GLN . 6.2 t -80.95 -47.31 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -155.66 -147.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.43 42.71 3.17 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.832 HG21 ' O ' ' A' ' 30' ' ' ILE . 41.4 t -46.73 100.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 110.109 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.523 ' HB2' HG12 ' A' ' 51' ' ' ILE . 50.9 m-70 -57.83 -85.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.293 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.552 ' CD2' HG13 ' A' ' 51' ' ' ILE . 14.0 p80 -111.54 161.64 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.095 -1.003 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.559 HD12 HG21 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -162.01 140.45 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.412 -0.805 . . . . 0.0 109.623 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.69 155.43 35.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.768 HG21 ' CG1' ' A' ' 23' ' ' VAL . 14.0 m -133.86 151.52 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.842 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 t -114.39 162.42 16.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 43' ' ' LEU . 2.1 mp -115.45 -18.08 11.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 110.342 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.86 -44.8 12.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.94 -5.32 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.355 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 54.68 79.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -168.07 -172.45 1.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.25 134.11 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.649 HG23 ' CG2' ' A' ' 11' ' ' THR . 32.2 m -122.31 118.04 27.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 109.563 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.11 HD11 ' CD2' ' A' ' 62' ' ' LEU . 1.3 pp -143.76 167.43 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.758 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.679 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.1 pp -115.57 -173.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.484 -0.76 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 20.5 p90 -175.5 152.18 1.31 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.875 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 4.6 t0 -92.85 105.23 14.02 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 42.6 Cg_endo -69.25 -10.07 27.97 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.0 1.526 . . . . 0.0 109.479 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.782 ' HB2' HD12 ' A' ' 56' ' ' LEU . 7.2 mtpt -57.01 -32.03 65.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.44 -0.787 . . . . 0.0 109.149 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.782 HD12 ' HB2' ' A' ' 55' ' ' LYS . 5.0 mp -118.35 -44.5 2.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.656 . . . . 0.0 109.381 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' A' ' 58' ' ' THR . 3.3 pt20 -107.84 -141.59 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 109.509 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.607 HG22 ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.33 -178.35 0.31 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.008 . . . . 0.0 110.279 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.607 ' HD2' HG22 ' A' ' 58' ' ' THR . 43.9 Cg_endo -70.9 -17.68 32.23 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.905 1.476 . . . . 0.0 110.11 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HE3' ' HG2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -73.07 -36.46 66.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.768 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.5 m -53.43 -52.81 58.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.536 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.11 ' CD2' HD11 ' A' ' 50' ' ' ILE . 2.0 mp -52.27 -41.23 62.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.026 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.402 ' HG3' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -65.42 -45.31 84.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 178.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -33.69 74.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.386 -0.821 . . . . 0.0 109.181 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.78 -52.1 66.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.52 -44.65 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.636 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.15 -17.65 58.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.86 -34.49 21.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.408 -0.807 . . . . 0.0 110.101 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 mmm -85.77 -57.79 2.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 128.61 -17.98 5.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 26' ' ' ILE . 33.7 m-85 -42.73 115.62 0.75 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -1.187 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.02 82.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.281 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -132.55 144.36 50.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.02 128.78 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.655 ' HA ' HG22 ' A' ' 12' ' ' ILE . 2.6 tt -54.52 161.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.53 ' N ' HG12 ' A' ' 75' ' ' ILE . 46.1 t-80 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.494 ' HA3' ' HD2' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.527 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 3.4 m -141.9 131.64 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.279 . . . . 0.0 110.583 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -96.9 -165.37 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.519 -0.738 . . . . 0.0 109.076 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.928 ' CB ' HG22 ' A' ' 51' ' ' ILE . 49.5 p -148.43 141.95 25.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.799 -1.188 . . . . 0.0 111.129 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.623 HG11 HD11 ' A' ' 62' ' ' LEU . 2.2 t -142.89 141.31 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.708 -0.62 . . . . 0.0 109.944 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.406 HG22 HG23 ' A' ' 49' ' ' THR . 66.9 p -117.89 156.31 28.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.776 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.6 pp -133.61 -175.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.267 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.501 ' N ' HD12 ' A' ' 12' ' ' ILE . 97.5 p -117.88 131.78 56.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 14' ' ' VAL . 3.4 p -116.98 125.56 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -134.05 -40.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.29 85.66 1.2 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.468 ' O ' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -110.75 -151.02 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.512 HG23 ' N ' ' A' ' 19' ' ' CYS . 8.9 t -179.06 -138.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.85 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.512 ' N ' HG23 ' A' ' 18' ' ' THR . 8.0 p -56.67 163.22 1.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.066 -1.021 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.496 ' OD1' ' HB2' ' A' ' 24' ' ' TRP . 5.4 t-20 -37.79 -30.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 110.846 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.555 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 0.1 OUTLIER -51.24 -20.74 1.72 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.809 -1.182 . . . . 0.0 110.056 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -46.31 -74.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 111.835 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.861 ' CG2' HG21 ' A' ' 41' ' ' VAL . 2.0 m -88.42 -38.68 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.646 ' CE3' HG22 ' A' ' 23' ' ' VAL . 25.9 m-90 -59.44 -31.73 69.57 Favored 'General case' 0 C--N 1.28 -2.438 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.278 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.555 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 7.6 m -84.42 -48.23 9.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 0.0 107.911 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.051 HD11 ' CD2' ' A' ' 71' ' ' PHE . 33.9 mt -59.9 -44.31 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.884 ' HG3' HD13 ' A' ' 39' ' ' ILE . 35.2 tt0 -57.55 -45.87 84.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.602 -0.686 . . . . 0.0 109.523 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 11.8 tt0 -54.84 -42.33 71.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.429 -0.795 . . . . 0.0 109.948 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -74.98 -63.62 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.645 ' O ' HG11 ' A' ' 36' ' ' VAL . 22.7 pt -50.44 -38.86 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.025 -1.047 . . . . 0.0 108.972 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.538 ' C ' HG11 ' A' ' 36' ' ' VAL . . . -69.18 -24.71 75.87 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -102.83 9.24 39.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.655 -0.909 . . . . 0.0 109.918 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.648 HG22 ' H ' ' A' ' 34' ' ' ASN . 1.2 p -66.13 -161.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.553 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.66 ' ND2' HD21 ' A' ' 56' ' ' LEU . 2.3 m-20 -61.74 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -118.13 87.73 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.29 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 36' ' ' VAL . 7.6 p -121.31 82.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.943 ' CD2' HD13 ' A' ' 51' ' ' ILE . 8.2 p80 -73.89 7.04 2.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 111.985 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.76 ' H ' HD11 ' A' ' 51' ' ' ILE . 15.9 t60 -173.34 149.81 1.79 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.773 -1.204 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.884 HD13 ' HG3' ' A' ' 27' ' ' GLU . 2.8 pp -157.8 158.01 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.457 -0.777 . . . . 0.0 109.575 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -154.35 163.69 39.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.832 -1.168 . . . . 0.0 111.11 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.861 HG21 ' CG2' ' A' ' 23' ' ' VAL . 73.4 t -136.96 138.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.483 -0.761 . . . . 0.0 110.019 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -124.85 76.2 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.21 -33.19 69.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -53.01 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.421 -0.8 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.54 58.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.315 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 60.51 70.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.38 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 14.6 t-20 -170.26 163.39 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB3' ' CG1' ' A' ' 12' ' ' ILE . . . -129.81 137.25 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 110.318 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 1.6 m -113.17 108.25 17.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.862 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.637 HD11 HD13 ' A' ' 62' ' ' LEU . 2.5 pp -136.77 154.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.943 HD13 ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -116.98 -166.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 22.5 p90 -174.52 155.13 2.19 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.292 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 3.0 p-10 -95.06 117.96 66.69 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 110.464 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 44.7 Cg_endo -70.89 -6.2 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.684 1.36 . . . . 0.0 109.305 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HD2' ' HA3' ' A' ' 6' ' ' GLY . 0.7 OUTLIER -66.73 -43.38 84.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.652 . . . . 0.0 109.544 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.66 HD21 ' ND2' ' A' ' 34' ' ' ASN . 1.2 tt -129.16 -8.28 4.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.37 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.61 -165.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.537 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.493 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -163.86 177.81 1.68 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 110.1 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HA ' HD21 ' A' ' 62' ' ' LEU . 45.6 Cg_endo -72.11 -7.98 22.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.017 1.535 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -33.96 21.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.348 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' LEU . 3.5 m -55.61 -68.16 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.831 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -45.45 -32.96 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 109.084 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -45.71 63.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 108.814 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -68.12 -29.9 68.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.2 -68.54 0.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.727 . . . . 0.0 110.153 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 67' ' ' ASP . 27.6 pt -50.56 -34.2 12.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.102 -0.999 . . . . 0.0 109.88 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 66' ' ' ILE . 11.4 t70 -74.25 -22.26 59.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.738 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.3 t0 -76.68 -34.82 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.512 ' CE ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -75.34 -46.22 34.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.78 9.97 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 1.051 ' CD2' HD11 ' A' ' 26' ' ' ILE . 9.3 m-85 -64.15 134.23 54.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 7.4 m-20 -69.29 58.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.377 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -109.94 143.88 39.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 110.008 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 t -139.6 146.7 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 0.0 110.288 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' A' ' 12' ' ' ILE . 9.4 tt -59.89 147.18 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 83.1 t60 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.477 -179.943 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 7' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.673 HG11 ' CD2' ' A' ' 37' ' ' HIS . 1.4 t -153.43 162.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -1.145 . . . . 0.0 110.318 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.59 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 5.9 m-20 -150.53 147.1 27.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -0.782 . . . . 0.0 109.872 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 t -106.56 138.31 42.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.325 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.726 HG21 HD23 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -124.76 131.21 72.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.571 -0.706 . . . . 0.0 110.381 -178.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.97 139.71 49.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 109.91 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.993 HD13 ' HB1' ' A' ' 73' ' ' ALA . 2.5 pp -141.07 167.2 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.674 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.562 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 4.6 m -90.08 140.85 29.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.348 -0.845 . . . . 0.0 108.803 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.692 HG12 ' SD ' ' A' ' 17' ' ' MET . 38.0 t -110.56 143.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.893 -1.13 . . . . 0.0 111.013 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -168.67 28.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 72' ' ' ASP . . . -153.08 57.64 0.42 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.692 ' SD ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.92 -153.91 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -1.206 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 19' ' ' CYS . 23.8 m -148.5 -83.59 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -0.918 . . . . 0.0 109.912 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.462 ' N ' HG22 ' A' ' 18' ' ' THR . 1.2 t -137.77 -141.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.496 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 5.1 m120 -46.41 -25.06 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.993 -1.067 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.543 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 67.9 p -57.84 -11.05 1.99 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.013 -1.055 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 93.9 m -52.9 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.846 -1.159 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.68 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 8.2 p -80.58 -30.09 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 111.252 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.68 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 18.2 m-90 -67.16 -43.34 82.55 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.671 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.651 HG22 ' SD ' ' A' ' 69' ' ' MET . 12.4 m -71.27 -45.22 63.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.496 -1.377 . . . . 0.0 107.867 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.944 ' CG2' HD11 ' A' ' 39' ' ' ILE . 1.1 mp -61.17 -58.52 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' ' 26' ' ' ILE . 82.4 tt0 -49.52 -32.89 13.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -68.95 -56.54 7.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' LYS . 5.8 tp60 -73.41 -61.62 1.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.962 HG21 HD13 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -49.13 -34.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.288 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.58 -27.45 67.41 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 29' ' ' GLN . 2.1 tttp -92.44 0.57 57.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -1.065 . . . . 0.0 110.088 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.804 HG13 ' N ' ' A' ' 34' ' ' ASN . 1.7 p -82.75 -146.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.351 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.804 ' N ' HG13 ' A' ' 33' ' ' VAL . 95.6 m-20 -49.06 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.32 61.75 0.33 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.145 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.953 HG11 HG23 ' A' ' 30' ' ' ILE . 25.8 m -59.92 135.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.128 -1.219 . . . . 0.0 109.818 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.673 ' CD2' HG11 ' A' ' 7' ' ' VAL . 31.0 m-70 -92.88 -24.44 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.136 -0.977 . . . . 0.0 111.017 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.406 ' CG ' ' C ' ' A' ' 37' ' ' HIS . 85.6 m-70 -147.04 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.952 -1.093 . . . . 0.0 110.778 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.962 HD13 HG21 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -167.07 123.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.133 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.95 140.09 24.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 23' ' ' VAL . 8.0 m -109.85 139.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.399 -0.813 . . . . 0.0 110.112 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.39 112.27 23.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.038 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 -16.46 38.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.301 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.77 -10.45 20.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.269 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -121.3 -1.53 9.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.215 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 50.75 67.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.648 ' HA ' HG23 ' A' ' 14' ' ' VAL . 1.2 t-20 -169.98 170.32 7.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 110.022 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.68 144.81 22.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.216 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.446 ' C ' ' CG2' ' A' ' 50' ' ' ILE . 88.1 m -120.31 129.76 54.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -0.821 . . . . 0.0 109.662 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.446 ' CG2' ' C ' ' A' ' 49' ' ' THR . 1.5 pp -147.33 161.27 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.07 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -114.49 170.72 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.902 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 10.6 p90 -168.45 126.52 1.11 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 20.4 p-10 -68.85 118.83 64.87 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 110.434 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 42.4 Cg_endo -69.73 -29.59 23.74 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.901 1.474 . . . . 0.0 110.058 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.37 -26.44 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.725 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.412 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.4 -57.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.871 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.68 ' C ' HG22 ' A' ' 58' ' ' THR . 2.5 tt0 -158.58 -178.64 7.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.732 HG23 ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -168.86 -60.19 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.791 -1.193 . . . . 0.0 111.603 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.732 ' CD ' HG23 ' A' ' 58' ' ' THR . 53.7 Cg_endo -75.59 -48.42 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.227 1.119 . . . . 0.0 111.745 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -76.22 -37.05 58.24 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.216 -0.927 . . . . 0.0 111.665 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 57' ' ' GLN . 12.7 m -64.19 -59.63 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 110.233 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.726 HD23 HG21 ' A' ' 10' ' ' VAL . 5.4 mp -52.28 -40.99 62.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -65.55 -46.09 80.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.272 -0.893 . . . . 0.0 109.087 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -66.96 -28.78 68.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.355 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.66 -53.2 58.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.499 -0.751 . . . . 0.0 109.666 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 71' ' ' PHE . 30.0 mt -58.37 -50.06 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.35 -22.62 32.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -79.23 -31.09 43.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 110.025 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.651 ' SD ' HG22 ' A' ' 25' ' ' THR . 26.2 mmt -106.27 12.46 29.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.0 22.15 5.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD13 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -72.52 78.43 1.06 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.723 -0.869 . . . . 0.0 110.422 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.038 . . . . 0.0 109.562 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 12' ' ' ILE . . . -125.68 167.95 14.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 111.062 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.66 120.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.753 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 12' ' ' ILE . 15.8 tt -80.95 140.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 0.0 110.764 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.7 p80 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.84 . . . . 0.0 109.98 179.636 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.487 ' CA ' ' HD2' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.582 ' CG2' ' N ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -167.61 170.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.168 -1.195 . . . . 0.0 111.056 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.582 ' N ' ' CG2' ' A' ' 7' ' ' VAL . 1.3 m-20 -155.17 163.19 40.55 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 p -104.15 161.59 13.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.82 -1.175 . . . . 0.0 110.848 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.926 HG21 ' CD2' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -151.99 126.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 110.18 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -116.19 161.63 18.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.32 -0.863 . . . . 0.0 109.574 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.801 ' CD1' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -150.35 162.59 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.479 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 3.1 m -97.7 126.37 43.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.888 HG12 ' HG2' ' A' ' 17' ' ' MET . 91.8 t -111.54 134.12 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.554 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.8 -40.61 0.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 17' ' ' MET . . . -50.73 -30.83 22.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.888 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -52.69 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -1.139 . . . . 0.0 110.102 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.461 HG22 ' SG ' ' A' ' 22' ' ' CYS . 2.4 t -164.21 -37.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.417 ' N ' HG23 ' A' ' 18' ' ' THR . 29.8 p -118.0 -138.89 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.59 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 7.1 m-20 -99.84 -57.3 2.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.523 ' O ' ' HB ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -45.72 -20.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 110.814 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' HD12 ' A' ' 26' ' ' ILE . 3.4 m -58.46 -87.25 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.816 -1.178 . . . . 0.0 111.336 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.079 HG21 HG21 ' A' ' 41' ' ' VAL . 12.1 p -70.56 -36.61 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.912 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.63 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.3 m-90 -63.69 -43.07 97.71 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.299 -0.876 . . . . 0.0 110.751 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 21' ' ' SER . 43.7 m -65.52 -38.82 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.449 -1.407 . . . . 0.0 107.914 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.959 HD11 ' CD2' ' A' ' 71' ' ' PHE . 52.1 mt -68.24 -48.66 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' OE2' ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -58.53 -27.42 64.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.596 179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -67.82 -54.16 21.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 109.936 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 33' ' ' VAL . 11.5 tt0 -64.11 -48.92 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.665 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.8 ' O ' HG21 ' A' ' 36' ' ' VAL . 56.8 mt -52.73 -38.91 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.564 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.909 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -69.97 -27.18 73.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.64 5.48 41.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.515 -0.991 . . . . 0.0 109.729 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 34' ' ' ASN . 1.3 t -51.84 -69.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.713 ' N ' HG12 ' A' ' 33' ' ' VAL . 2.5 m120 -142.76 -98.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.077 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . -106.04 62.63 0.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.909 HG11 ' HA2' ' A' ' 31' ' ' GLY . 42.1 t -89.12 118.34 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.26 . . . . 0.0 110.221 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.575 ' CD2' HG21 ' A' ' 7' ' ' VAL . 49.7 m-70 -65.91 -75.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 110.313 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.19 164.81 16.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.791 HD12 ' HB ' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -155.04 142.49 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -166.6 142.84 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.601 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.079 HG21 HG21 ' A' ' 23' ' ' VAL . 2.7 p -123.14 140.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.988 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.64 168.22 16.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mt -110.14 -28.91 8.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.226 -0.921 . . . . 0.0 109.979 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.23 -22.54 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.232 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.519 ' HB2' ' ND2' ' A' ' 47' ' ' ASN . 27.5 mt-10 -134.38 8.2 3.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mttt 46.92 74.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 0.0 110.507 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -170.26 -170.88 1.02 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.477 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.801 ' HB3' ' CD1' ' A' ' 12' ' ' ILE . . . -155.91 141.41 17.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.033 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 11' ' ' THR . 2.9 m -110.99 128.38 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -153.06 147.84 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -113.17 171.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.312 -0.868 . . . . 0.0 110.265 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.3 p90 -157.35 127.59 6.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.695 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.707 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 1.4 p30 -107.24 18.57 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.352 -0.842 . . . . 0.0 111.757 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 52.1 Cg_endo -79.62 65.42 8.88 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 N-CA-C 108.141 -1.523 . . . . 0.0 108.141 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HD2' ' CA ' ' A' ' 6' ' ' GLY . 0.9 OUTLIER -40.15 -27.15 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.636 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -54.07 -22.32 10.57 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.501 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 12.6 mm100 -154.77 178.17 10.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -175.05 -65.05 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 49.6 Cg_endo -73.09 -49.07 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.648 1.341 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HB3' ' NE2' ' A' ' 57' ' ' GLN . 2.5 tppp? -67.85 -32.6 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 110.781 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 57' ' ' GLN . 12.6 m -68.9 -58.35 4.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.926 ' CD2' HG21 ' A' ' 10' ' ' VAL . 4.0 mp -55.65 -46.79 77.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.296 -0.878 . . . . 0.0 109.117 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 1.4 tp60 -61.17 -41.21 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 108.83 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' ASP . 84.3 tt0 -68.62 -39.65 80.7 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.654 0.74 . . . . 0.0 109.093 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -47.88 -52.12 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.56 -0.713 . . . . 0.0 109.781 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 73' ' ' ALA . 34.3 mm -64.93 -55.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.581 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.53 -24.1 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 64' ' ' GLU . 2.7 t70 -75.89 -38.83 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.701 ' HG3' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -81.99 -65.95 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.19 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.12 41.38 0.76 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.959 ' CD2' HD11 ' A' ' 26' ' ' ILE . 19.9 m-85 -119.89 143.27 48.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -1.126 . . . . 0.0 110.243 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.409 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -65.62 74.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.456 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 66' ' ' ILE . . . -117.69 148.89 41.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.096 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 74' ' ' VAL . 27.1 m -132.55 120.15 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.351 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.5 tt -63.74 152.39 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.3 -0.875 . . . . 0.0 110.021 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 t60 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.262 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.441 ' HA3' ' CE ' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.542 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -141.79 135.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -1.168 . . . . 0.0 110.599 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -110.14 -177.78 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.817 ' OG ' HG22 ' A' ' 51' ' ' ILE . 57.9 m -131.6 135.08 46.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.761 -1.212 . . . . 0.0 110.776 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.8 HG11 HD23 ' A' ' 62' ' ' LEU . 2.1 t -127.91 145.23 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.91 173.35 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.089 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.024 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.2 130.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.279 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 8.5 t -84.5 135.65 34.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.221 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.675 HG12 ' C ' ' A' ' 46' ' ' LYS . 8.1 p -123.76 166.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.655 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -161.02 -39.27 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.437 -0.789 . . . . 0.0 109.927 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.83 97.85 2.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.545 ' HE1' ' HG3' ' A' ' 46' ' ' LYS . 0.9 OUTLIER -150.33 100.22 2.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.15 . . . . 0.0 110.238 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.538 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -42.0 -68.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.845 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 20' ' ' ASN . 6.0 m -154.68 -162.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.959 -1.088 . . . . 0.0 110.841 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.621 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.4 t30 -39.36 -50.13 2.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 110.806 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.516 ' O ' ' HB ' ' A' ' 25' ' ' THR . 42.7 m -43.69 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.601 ' C ' HD12 ' A' ' 26' ' ' ILE . 97.2 m -75.31 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.597 -1.315 . . . . 0.0 111.831 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.902 HG13 ' CE3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -43.1 -38.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.382 -0.824 . . . . 0.0 110.773 -178.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.902 ' CE3' HG13 ' A' ' 23' ' ' VAL . 21.4 m-90 -69.8 -50.18 45.5 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.141 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 21' ' ' SER . 49.4 m -60.06 -38.19 82.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.464 -1.398 . . . . 0.0 107.827 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 71' ' ' PHE . 17.0 mt -69.29 -54.23 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 3.7 tt0 -54.89 -20.76 9.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -57.77 3.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.435 ' OE1' ' CE ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -61.12 -52.07 66.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 109.721 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.51 ' CG2' ' HA ' ' A' ' 27' ' ' GLU . 11.8 tt -51.39 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.555 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.753 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -77.92 -15.69 80.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -116.78 18.82 14.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.852 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.536 HG13 ' N ' ' A' ' 34' ' ' ASN . 5.0 p -82.51 -42.6 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.725 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' N ' HG13 ' A' ' 33' ' ' VAL . 2.3 t30 -170.69 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.065 -1.022 . . . . 0.0 110.867 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 53' ' ' ASP . . . -67.91 55.31 0.38 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.163 -0.96 . . . . 0.0 110.841 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.753 HG11 ' HA2' ' A' ' 31' ' ' GLY . 5.7 p -95.39 151.55 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.914 -1.345 . . . . 0.0 108.476 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.649 ' NE2' ' HB ' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -115.32 -68.63 0.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.069 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.555 ' O ' ' CD1' ' A' ' 51' ' ' ILE . 9.4 p80 -124.66 168.76 12.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.593 -1.317 . . . . 0.0 111.091 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.477 HG23 ' HB ' ' A' ' 50' ' ' ILE . 1.8 mp -145.75 150.01 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 110.571 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.589 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -125.87 149.96 48.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 109.814 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.891 HG21 ' CG2' ' A' ' 23' ' ' VAL . 7.7 p -164.08 137.4 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.001 -1.062 . . . . 0.0 110.49 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.18 127.8 17.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.9 -3.45 51.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 110.45 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.45 -33.01 32.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 110.087 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.74 -1.41 21.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.068 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.675 ' C ' HG12 ' A' ' 14' ' ' VAL . 3.1 mptt 58.86 58.34 3.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.663 ' N ' HG12 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -170.38 167.81 8.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 109.69 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 40' ' ' LYS . . . -150.35 142.71 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.306 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 33.1 m -110.0 105.08 14.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 109.28 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -118.69 153.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.672 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.817 HG22 ' OG ' ' A' ' 9' ' ' SER . 0.9 OUTLIER -108.99 -177.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.438 -0.788 . . . . 0.0 110.591 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.642 ' CE1' HG23 ' A' ' 10' ' ' VAL . 20.3 p90 -178.34 141.51 0.23 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.618 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 6.3 p-10 -79.68 111.91 25.04 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.677 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 52' ' ' TYR . 46.5 Cg_endo -73.5 0.76 7.65 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.724 1.381 . . . . 0.0 110.477 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HA3' ' A' ' 6' ' ' GLY . 3.4 mttm -70.34 -19.39 63.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 0.0 110.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -139.05 3.1 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.955 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.685 ' C ' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -177.71 137.01 0.19 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 110.078 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.759 HG23 ' HD3' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -169.05 -60.34 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.948 -1.095 . . . . 0.0 112.054 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.759 ' HD3' HG23 ' A' ' 58' ' ' THR . 51.8 Cg_endo -74.45 -52.1 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.159 1.084 . . . . 0.0 111.499 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -86.92 -50.57 6.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 111.396 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 57' ' ' GLN . 63.9 m -46.15 -61.8 1.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.915 -1.116 . . . . 0.0 110.336 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.8 HD23 HG11 ' A' ' 10' ' ' VAL . 2.1 mp -52.23 -44.18 64.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.339 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -44.3 93.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.216 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -69.12 -19.95 64.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.544 -0.723 . . . . 0.0 109.329 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -69.93 -65.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.787 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 73' ' ' ALA . 1.3 tp -53.75 -35.3 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -78.59 -30.18 46.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 6.7 t0 -64.71 -36.11 83.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 109.929 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.435 ' CE ' ' OE1' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -89.64 -68.6 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.017 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.44 -9.06 10.96 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.165 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.826 ' CD2' HD11 ' A' ' 26' ' ' ILE . 30.6 m-85 -49.79 124.7 10.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.942 -1.328 . . . . 0.0 110.122 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.68 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.273 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -133.11 178.39 6.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.972 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' SER . 58.5 t -135.49 95.69 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 110.166 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.538 HG23 HD13 ' A' ' 66' ' ' ILE . 50.1 pt -56.62 162.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.227 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.962 HG11 ' NE2' ' A' ' 37' ' ' HIS . 11.4 m -66.87 143.32 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -1.214 . . . . 0.0 110.669 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -118.06 167.55 11.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.805 . . . . 0.0 109.927 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.3 t -112.11 136.81 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.063 -1.023 . . . . 0.0 110.287 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.103 ' CG1' HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -120.65 126.2 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.627 -0.671 . . . . 0.0 110.438 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.495 ' C ' ' CG2' ' A' ' 12' ' ' ILE . 12.3 p -116.88 161.01 19.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 0.0 109.603 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.823 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -152.38 166.98 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.411 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -98.21 159.99 14.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.683 HG11 ' SD ' ' A' ' 17' ' ' MET . 58.4 t -145.27 147.34 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.079 . . . . 0.0 110.705 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 3.3 tp10 -146.15 -41.36 0.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 109.706 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.05 88.81 1.49 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.683 ' SD ' HG11 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -114.5 -160.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -1.163 . . . . 0.0 110.614 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' C ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -167.04 -144.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.546 -0.721 . . . . 0.0 109.711 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -58.74 153.29 17.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 109.764 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -27.88 -44.26 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.65 0.738 . . . . 0.0 111.535 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.536 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 96.0 p -50.18 -15.9 0.27 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.745 -1.222 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 1.2 p -49.56 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.838 -1.164 . . . . 0.0 111.058 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.079 HG11 HG21 ' A' ' 41' ' ' VAL . 7.9 p -82.84 -23.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 111.374 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.643 ' CH2' HD21 ' A' ' 43' ' ' LEU . 14.4 m-90 -69.34 -28.46 66.24 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.264 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 28.4 m -82.29 -41.69 19.81 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.105 HD11 ' CD2' ' A' ' 71' ' ' PHE . 83.4 mt -65.1 -45.86 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.567 ' CG ' HD13 ' A' ' 39' ' ' ILE . 19.1 tt0 -60.32 -36.45 77.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.459 -0.776 . . . . 0.0 109.659 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -45.11 80.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.149 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.0 mm100 -54.23 -42.54 69.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.859 ' O ' HG21 ' A' ' 36' ' ' VAL . 75.2 mt -61.36 -46.93 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.466 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . -62.78 -14.65 52.3 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -107.26 -9.86 15.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -1.043 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' A' ' 30' ' ' ILE . 3.2 t -49.02 -64.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.743 HD21 HD22 ' A' ' 56' ' ' LEU . 48.1 t-20 -169.66 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.095 . . . . 0.0 110.812 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.13 34.84 4.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.859 HG21 ' O ' ' A' ' 30' ' ' ILE . 29.0 t -70.61 115.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.055 -1.262 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.962 ' NE2' HG11 ' A' ' 7' ' ' VAL . 52.3 m-70 -65.27 -87.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 110.691 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.58 ' CD2' HG13 ' A' ' 51' ' ' ILE . 19.5 p80 -120.52 163.07 18.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.89 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.031 ' O ' HD12 ' A' ' 39' ' ' ILE . 2.3 pp -148.42 153.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.449 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -164.83 141.54 5.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.95 -1.094 . . . . 0.0 111.096 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.079 HG21 HG11 ' A' ' 23' ' ' VAL . 1.2 p -124.32 135.34 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.813 ' C ' HD22 ' A' ' 43' ' ' LEU . 15.2 p -109.52 172.73 6.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 110.213 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.813 HD22 ' C ' ' A' ' 42' ' ' SER . 3.9 mm? -117.62 -29.06 5.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.998 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -66.04 -29.11 69.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 110.352 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 35.2 mt-10 -116.08 5.08 13.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.503 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER 43.01 65.61 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 45' ' ' GLU . 15.1 p-10 -155.59 171.89 19.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 12' ' ' ILE . . . -141.22 154.78 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 110.372 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 49' ' ' THR . 10.1 t -136.83 127.61 27.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 110.02 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.912 ' CB ' HG22 ' A' ' 39' ' ' ILE . 2.3 pp -144.62 161.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.138 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.58 HG13 ' CD2' ' A' ' 38' ' ' HIS . 0.5 OUTLIER -112.41 168.17 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 110.509 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.687 ' OH ' HG23 ' A' ' 10' ' ' VAL . 9.8 p90 -166.2 130.68 2.2 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.338 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.538 ' CB ' HG12 ' A' ' 7' ' ' VAL . 18.1 p-10 -77.34 125.85 85.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.368 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 42.2 Cg_endo -68.93 -30.16 26.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.87 1.458 . . . . 0.0 109.597 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -20.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.961 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.743 HD22 HD21 ' A' ' 34' ' ' ASN . 0.3 OUTLIER -135.86 -40.9 0.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.506 ' OE1' ' ND2' ' A' ' 34' ' ' ASN . 5.2 mp0 -106.77 -166.1 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 0.0 110.677 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.508 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.01 179.73 0.8 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 0.0 110.169 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 45.7 Cg_endo -73.44 -11.88 24.75 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.959 1.505 . . . . 0.0 110.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -76.29 -51.34 12.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 65' ' ' ALA . 54.3 m -44.37 -47.25 9.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.455 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.103 HD22 ' CG1' ' A' ' 10' ' ' VAL . 1.3 mp -57.32 -45.95 83.73 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.317 -0.865 . . . . 0.0 108.871 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HG3' HG21 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -62.74 -51.09 68.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.489 -0.757 . . . . 0.0 109.203 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.2 -34.66 78.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.389 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' THR . . . -56.5 -55.86 28.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 109.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 mm -55.2 -42.82 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -29.46 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.32 -23.96 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.945 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.78 -47.94 5.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.04 74.07 1.0 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 1.105 ' CD2' HD11 ' A' ' 26' ' ' ILE . 8.4 m-85 -146.48 135.52 22.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -1.139 . . . . 0.0 110.213 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.26 81.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.501 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -113.0 171.24 7.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' C ' ' A' ' 73' ' ' ALA . 71.3 t -147.51 79.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.383 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.427 HG21 ' HG3' ' A' ' 63' ' ' GLN . 8.2 tt -56.93 141.77 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.876 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.913 HG11 ' NE2' ' A' ' 37' ' ' HIS . 16.1 m -53.64 131.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.326 . . . . 0.0 110.698 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 51' ' ' ILE . 3.0 t-20 -118.77 -177.81 3.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.55 -0.719 . . . . 0.0 109.759 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -117.5 140.56 49.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.084 -1.01 . . . . 0.0 110.399 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.813 HG11 HD23 ' A' ' 62' ' ' LEU . 1.4 t -139.83 141.12 35.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.613 -0.68 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.3 p -114.35 159.39 20.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.233 -0.917 . . . . 0.0 110.186 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.843 ' O ' HD12 ' A' ' 12' ' ' ILE . 2.4 pp -135.99 136.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 110.196 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.425 ' HA ' ' CG ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -84.73 135.5 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 110.058 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.633 HG12 ' SD ' ' A' ' 17' ' ' MET . 71.1 t -117.33 142.42 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.26 52.77 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.2 51.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.633 ' SD ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -97.19 -139.79 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.392 -1.063 . . . . 0.0 110.15 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.716 HG22 ' SG ' ' A' ' 22' ' ' CYS . 1.4 t -179.43 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.203 -0.936 . . . . 0.0 110.42 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.8 OUTLIER -159.28 -139.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -89.32 -51.19 5.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 25' ' ' THR . 1.8 t -48.04 -17.75 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.667 -1.271 . . . . 0.0 110.619 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.757 ' O ' HD12 ' A' ' 26' ' ' ILE . 2.0 m -59.96 -87.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.73 -1.231 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.648 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 12.4 p -72.47 -17.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 112.044 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.648 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 8.0 m-90 -86.39 -40.87 14.96 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.02 -1.05 . . . . 0.0 110.522 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -68.41 -40.27 81.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.536 -1.353 . . . . 0.0 107.909 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.004 HD11 ' CD2' ' A' ' 71' ' ' PHE . 60.8 mt -60.7 -44.47 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.666 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -60.48 -28.8 68.64 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -42.87 88.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.527 ' HG3' ' CE ' ' A' ' 69' ' ' MET . 0.2 OUTLIER -67.09 -56.81 8.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.653 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 27' ' ' GLU . 1.5 tt -47.57 -28.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.23 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA2' ' CG2' ' A' ' 36' ' ' VAL . . . -83.6 -28.24 36.26 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -83.31 -0.26 48.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.015 . . . . 0.0 109.86 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.61 HG11 HG23 ' A' ' 61' ' ' THR . 13.2 t -102.49 -62.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -105.46 154.16 20.72 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -66.85 62.49 0.19 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 35.6 m -52.15 125.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.186 -1.185 . . . . 0.0 110.521 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.913 ' NE2' HG11 ' A' ' 7' ' ' VAL . 32.2 m-70 -93.24 -20.47 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.301 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.53 ' CD2' ' HA ' ' A' ' 50' ' ' ILE . 2.2 t60 -136.95 138.61 40.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.859 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.781 ' HA ' HG22 ' A' ' 50' ' ' ILE . 7.5 tt -139.27 123.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.58 148.19 35.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 110.417 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 23' ' ' VAL . 24.7 t -126.94 151.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.296 -0.877 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 47' ' ' ASN . 15.0 p -122.4 145.91 47.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -106.67 -66.09 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.372 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -15.19 4.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.649 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.61 -9.07 13.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 110.362 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 48.72 73.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.168 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -163.79 178.73 7.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB3' HG13 ' A' ' 12' ' ' ILE . . . -152.71 151.96 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.416 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 49' ' ' THR . 8.9 t -140.89 122.36 15.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.781 HG22 ' HA ' ' A' ' 39' ' ' ILE . 2.3 pp -145.64 172.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.687 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.36 170.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 109.755 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.905 ' HE2' HG22 ' A' ' 58' ' ' THR . 7.4 p90 -164.0 126.22 2.41 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.63 ' CA ' HG12 ' A' ' 7' ' ' VAL . 4.5 p-10 -68.31 121.08 79.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.568 -0.707 . . . . 0.0 110.017 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.588 ' HA ' HG23 ' A' ' 58' ' ' THR . 42.4 Cg_endo -67.77 -7.01 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.731 1.385 . . . . 0.0 110.084 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.9 -48.14 11.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.838 . . . . 0.0 109.81 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 8.9 mp -82.09 -63.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.907 ' O ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -156.76 -154.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 109.25 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -175.53 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 110.627 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 47.8 Cg_endo -73.02 -28.66 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.419 1.221 . . . . 0.0 109.159 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -91.34 -29.43 17.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.514 -0.741 . . . . 0.0 110.859 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 HG11 ' A' ' 33' ' ' VAL . 27.6 m -73.42 -63.41 1.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.738 -1.226 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.813 HD23 HG11 ' A' ' 10' ' ' VAL . 5.7 mp -46.84 -39.06 11.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 108.956 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -67.11 -48.0 69.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.533 -0.73 . . . . 0.0 109.272 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 68' ' ' ASP . 35.7 tt0 -66.75 -23.45 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.376 -0.828 . . . . 0.0 109.367 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -65.67 -69.56 0.29 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.802 . . . . 0.0 109.705 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.56 -30.43 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 109.158 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 10.7 t0 -78.58 -39.88 36.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 64' ' ' GLU . 18.0 t0 -53.15 -35.92 60.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.785 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.527 ' CE ' ' HG3' ' A' ' 29' ' ' GLN . 6.1 mmt -84.89 -68.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.193 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -12.42 7.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 1.004 ' CD2' HD11 ' A' ' 26' ' ' ILE . 15.4 m-85 -51.9 142.16 16.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.278 -1.13 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -68.62 70.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.71 164.36 27.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.414 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.49 152.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.126 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.725 HD13 ' HB3' ' A' ' 62' ' ' LEU . 1.7 pp -111.58 143.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.122 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 110.083 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.348 0.594 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -150.55 60.01 3.88 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.277 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 46.1 Cg_endo -73.86 -1.34 10.68 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.121 1.59 . . . . 0.0 109.812 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 5' ' ' MET . 0.2 OUTLIER 58.01 48.22 13.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.291 -0.88 . . . . 0.0 109.839 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.536 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 6.9 ttm 65.52 34.99 7.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.163 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.46 ' O ' ' OD1' ' A' ' 53' ' ' ASP . . . 44.51 67.66 1.07 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.551 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 1.9 t -143.92 165.81 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.054 -1.262 . . . . 0.0 110.079 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 6.5 m-20 -138.36 161.9 35.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.495 -0.753 . . . . 0.0 109.437 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 32.9 t -126.01 139.11 53.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.677 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.792 HG11 ' CD2' ' A' ' 62' ' ' LEU . 1.5 t -127.99 127.58 68.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.671 -0.643 . . . . 0.0 110.061 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.66 143.05 39.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.89 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.752 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.2 pp -138.59 154.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.624 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.401 ' C ' HG23 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -98.01 166.16 11.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.691 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 17' ' ' MET . 58.7 t -144.08 148.75 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -152.58 19.7 0.62 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 0.0 110.17 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.449 ' HA3' ' OD2' ' A' ' 72' ' ' ASP . . . -148.25 80.88 0.2 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.828 ' O ' HG23 ' A' ' 18' ' ' THR . 63.4 mtm -130.68 -143.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.402 -1.058 . . . . 0.0 110.096 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER 174.73 -71.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.321 -0.862 . . . . 0.0 109.735 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ASN . 33.5 m -112.76 160.66 17.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.348 -0.845 . . . . 0.0 109.885 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.53 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 14.5 p30 -42.73 -43.86 4.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 110.019 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.532 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 83.2 p -45.99 -21.7 0.16 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.904 -1.122 . . . . 0.0 110.694 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.745 ' O ' HD12 ' A' ' 26' ' ' ILE . 4.4 m -56.73 -86.17 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.917 -1.114 . . . . 0.0 111.375 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.831 HG22 HG11 ' A' ' 41' ' ' VAL . 12.0 p -72.34 -37.62 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.399 -0.813 . . . . 0.0 111.819 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.632 ' CZ2' ' CG2' ' A' ' 41' ' ' VAL . 9.2 m-90 -62.29 -47.43 84.35 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.517 -0.739 . . . . 0.0 110.485 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 14.7 m -64.67 -36.26 83.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.611 -1.306 . . . . 0.0 108.16 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.029 HD11 ' CD2' ' A' ' 71' ' ' PHE . 48.0 mt -68.0 -42.66 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.517 ' CA ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -66.13 -28.23 68.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.392 -0.818 . . . . 0.0 109.874 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -49.19 65.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -0.873 . . . . 0.0 109.713 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.37 -55.5 17.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.776 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.922 ' O ' HG21 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -52.8 -29.43 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.586 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.614 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -86.69 -21.29 51.42 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -101.75 10.98 39.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -1.108 . . . . 0.0 109.76 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 30' ' ' ILE . 6.3 p -83.03 -28.88 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.38 -0.825 . . . . 0.0 110.839 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.565 ' CB ' ' HG3' ' A' ' 57' ' ' GLN . 6.0 t-20 -165.88 -135.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.993 -1.067 . . . . 0.0 110.941 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.13 38.67 2.73 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.22 -0.991 . . . . 0.0 110.684 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.922 HG21 ' O ' ' A' ' 30' ' ' ILE . 3.5 t -67.33 115.19 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.926 -1.337 . . . . 0.0 109.446 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.565 ' H ' HD13 ' A' ' 51' ' ' ILE . 39.6 m-70 -64.07 -85.38 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.342 -0.849 . . . . 0.0 110.427 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.599 ' C ' HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -132.33 174.65 10.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.068 . . . . 0.0 110.907 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -157.66 173.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.531 -0.731 . . . . 0.0 109.44 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 39' ' ' ILE . 12.6 mttm -166.43 148.28 6.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.055 -1.028 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.831 HG11 HG22 ' A' ' 23' ' ' VAL . 4.2 m -123.23 159.23 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.296 -0.878 . . . . 0.0 109.965 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.03 85.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -25.21 4.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.79 -42.14 67.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.036 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.53 12.74 22.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.917 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? 49.53 69.19 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.34 -0.85 . . . . 0.0 110.268 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 18.3 p-10 -170.08 -177.68 2.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.43 137.85 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 110.106 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 49' ' ' THR . 15.0 t -109.98 130.33 55.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.833 HD11 HD21 ' A' ' 62' ' ' LEU . 2.0 pp -143.1 151.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 0.0 110.153 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.613 ' C ' HD12 ' A' ' 51' ' ' ILE . 1.1 pp -109.79 -177.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 23.5 p90 -174.33 133.26 0.39 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.122 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 6' ' ' GLY . 0.4 OUTLIER -71.3 117.34 55.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.326 -0.859 . . . . 0.0 110.34 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.551 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.6 Cg_endo -72.65 -26.66 16.07 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.901 1.474 . . . . 0.0 109.5 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HD3' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -70.7 -14.36 62.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.455 -0.778 . . . . 0.0 109.691 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.476 HD23 ' HD3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -121.99 -32.51 3.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.442 -0.786 . . . . 0.0 109.586 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.565 ' HG3' ' CB ' ' A' ' 34' ' ' ASN . 25.0 mm100 -134.72 -154.61 0.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.418 -0.802 . . . . 0.0 109.708 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.551 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.33 -179.17 0.64 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.013 -1.054 . . . . 0.0 110.306 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.735 ' HA ' HD13 ' A' ' 62' ' ' LEU . 42.3 Cg_endo -69.96 -17.9 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.796 1.419 . . . . 0.0 110.293 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -65.13 -49.04 71.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.543 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.1 m -50.19 -44.08 52.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 0.0 109.202 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.833 HD21 HD11 ' A' ' 50' ' ' ILE . 6.2 mp -57.07 -43.66 82.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 108.68 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -45.16 92.54 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.09 -31.6 70.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.475 -0.766 . . . . 0.0 109.543 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 68' ' ' ASP . . . -57.4 -59.42 5.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.485 -0.759 . . . . 0.0 110.087 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.18 -45.35 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.722 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -62.86 -16.83 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.818 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 63.6 t0 -81.08 -42.64 20.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.421 ' HE2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -86.43 -66.32 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 136.83 -26.03 3.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 1.029 ' CD2' HD11 ' A' ' 26' ' ' ILE . 92.3 m-85 -42.15 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.328 -1.101 . . . . 0.0 110.2 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.449 ' OD2' ' HA3' ' A' ' 16' ' ' GLY . 1.2 p30 -56.99 83.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.85 . . . . 0.0 110.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 12' ' ' ILE . . . -116.78 135.94 53.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 0.0 109.984 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.7 p -111.67 142.6 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 110.502 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.616 HG22 ' H ' ' A' ' 77' ' ' ASN . 5.8 mt -85.21 166.9 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.407 ' N ' HG22 ' A' ' 75' ' ' ILE . 0.4 OUTLIER -133.79 9.45 3.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.037 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.616 ' H ' HG22 ' A' ' 75' ' ' ILE . 1.6 m-20 -115.55 128.84 25.62 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 0.0 109.979 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.58 -38.23 4.64 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.811 1.427 . . . . 0.0 110.559 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.276 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 3' ' ' PRO . 6.9 mmm . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 120.93 0.395 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.475 ' C ' ' O ' ' A' ' 1' ' ' MET . 29.2 m-20 -33.08 94.49 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.827 -0.546 . . . . 0.0 111.37 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.481 ' N ' ' O ' ' A' ' 1' ' ' MET . 47.7 Cg_endo -75.52 -4.7 15.63 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.302 1.685 . . . . 0.0 108.606 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.575 ' HB2' HG22 ' A' ' 7' ' ' VAL . 2.2 p -80.82 -72.65 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.532 -0.73 . . . . 0.0 110.189 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 44.62 47.14 8.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 110.232 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.6 -41.23 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.054 HG21 ' CE1' ' A' ' 37' ' ' HIS . 27.8 m -64.42 132.47 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.235 . . . . 0.0 110.486 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 51' ' ' ILE . 4.9 m-20 -95.5 -174.42 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.42 -0.8 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 95.5 p -131.28 132.14 44.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.942 -1.099 . . . . 0.0 111.153 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.519 HG23 ' CE1' ' A' ' 52' ' ' TYR . 2.1 t -128.66 129.12 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.765 -0.584 . . . . 0.0 109.546 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.638 HG22 HG23 ' A' ' 49' ' ' THR . 82.5 p -112.01 159.32 18.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.221 -0.925 . . . . 0.0 110.646 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.845 ' O ' HD12 ' A' ' 12' ' ' ILE . 2.7 pp -139.8 157.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 110.359 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -88.61 168.14 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 109.694 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.917 HG11 ' SD ' ' A' ' 17' ' ' MET . 70.5 t -140.11 147.49 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.991 -1.068 . . . . 0.0 110.585 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -170.61 42.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 17' ' ' MET . . . -171.69 -34.06 0.03 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.917 ' SD ' HG11 ' A' ' 14' ' ' VAL . 19.3 ptt? -42.88 151.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -1.118 . . . . 0.0 110.516 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.532 ' N ' ' HB3' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -72.01 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -0.825 . . . . 0.0 110.716 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' C ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -107.24 -31.48 8.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 0.0 110.423 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -125.31 -67.19 0.91 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.192 -0.943 . . . . 0.0 109.974 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.539 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 2.7 t -49.96 -19.44 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.834 -1.166 . . . . 0.0 109.971 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.893 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -46.04 -85.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.952 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.946 HG21 HG11 ' A' ' 41' ' ' VAL . 7.3 p -85.32 -31.64 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 111.461 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.665 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 17.1 m-90 -60.84 -32.18 71.59 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.165 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 14.7 m -80.4 -44.93 18.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.939 HD11 ' CD2' ' A' ' 71' ' ' PHE . 9.0 mt -63.64 -59.24 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.687 ' HG3' HG21 ' A' ' 39' ' ' ILE . 42.9 tt0 -42.91 -41.93 3.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.487 -0.758 . . . . 0.0 109.292 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -57.27 -43.79 83.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' A' ' 32' ' ' LYS . 1.9 mt-30 -74.98 -63.0 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.08 -1.012 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.852 ' O ' HG21 ' A' ' 36' ' ' VAL . 24.3 pt -51.45 -34.57 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.976 . . . . 0.0 109.473 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' N ' HG13 ' A' ' 30' ' ' ILE . . . -77.19 -22.33 71.23 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.409 -1.877 . . . . 0.0 108.409 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 12.3 tttm -101.02 3.17 41.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.488 -1.007 . . . . 0.0 110.013 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.794 HG12 ' N ' ' A' ' 34' ' ' ASN . 1.8 t -59.94 -76.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 0.0 109.902 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.794 ' N ' HG12 ' A' ' 33' ' ' VAL . 2.3 t30 -177.25 -75.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.941 -1.099 . . . . 0.0 110.95 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.61 -26.73 74.26 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.852 HG21 ' O ' ' A' ' 30' ' ' ILE . 35.9 m -50.81 123.77 2.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -1.146 . . . . 0.0 110.54 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 1.054 ' CE1' HG21 ' A' ' 7' ' ' VAL . 5.2 p80 -129.54 10.89 5.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.832 ' N ' HD11 ' A' ' 51' ' ' ILE . 14.9 t60 -171.85 143.66 1.66 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 109.934 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.687 HG21 ' HG3' ' A' ' 27' ' ' GLU . 3.9 mp -141.2 149.59 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.118 -0.989 . . . . 0.0 110.642 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.41 108.51 4.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 0.0 109.989 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.946 HG11 HG21 ' A' ' 23' ' ' VAL . 4.8 p -125.89 140.4 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.158 -0.964 . . . . 0.0 110.476 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 p -112.54 150.94 30.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.987 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 -2.91 22.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 110.136 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -102.51 -32.55 9.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.3 -3.08 37.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -0.911 . . . . 0.0 110.104 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' C ' ' HB ' ' A' ' 14' ' ' VAL . 4.8 mttp 53.75 65.06 1.62 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.337 -0.852 . . . . 0.0 110.321 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.55 176.01 12.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 0.0 109.707 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.63 146.56 25.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.012 . . . . 0.0 110.781 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.638 HG23 HG22 ' A' ' 11' ' ' THR . 88.3 m -132.8 100.34 4.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.742 . . . . 0.0 109.435 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -119.23 156.5 21.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 110.231 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 1.014 HD13 ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -109.86 174.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 8.1 p90 -159.28 128.71 5.44 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.583 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.631 ' CA ' HG12 ' A' ' 7' ' ' VAL . 6.6 t0 -68.52 115.13 26.91 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 0.0 110.014 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 42.9 Cg_endo -69.44 -44.89 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.906 1.477 . . . . 0.0 110.138 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' A' ' 53' ' ' ASP . 11.1 ptmt -42.56 -26.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.176 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 34' ' ' ASN . 0.2 OUTLIER -123.93 -22.69 4.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.372 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 49.3 mm-40 -131.01 -158.64 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 110.293 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.536 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -170.72 179.42 0.71 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HA ' HD12 ' A' ' 62' ' ' LEU . 43.1 Cg_endo -69.46 -12.27 33.1 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.719 1.379 . . . . 0.0 110.291 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 61' ' ' THR . 11.1 mttt -74.14 -51.97 13.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.649 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' LYS . 7.4 m -45.2 -48.63 12.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 109.227 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.666 HD12 ' HA ' ' A' ' 59' ' ' PRO . 2.1 mt -57.91 -48.88 78.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 109.263 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.9 -37.99 72.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.854 . . . . 0.0 109.001 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 68' ' ' ASP . 47.1 tt0 -73.53 -31.76 63.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.501 -0.749 . . . . 0.0 109.251 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -55.78 -58.22 8.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.485 -0.759 . . . . 0.0 109.548 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 12' ' ' ILE . 56.7 mt -61.37 -37.62 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.489 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -74.89 -12.24 60.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 64' ' ' GLU . 25.0 t70 -85.59 -39.82 16.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.4 mmt -87.59 -56.13 3.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.14 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 123.56 -10.16 8.61 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.939 ' CD2' HD11 ' A' ' 26' ' ' ILE . 8.0 m-85 -42.76 143.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -1.179 . . . . 0.0 110.347 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.14 74.09 2.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -119.81 162.15 19.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.645 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.433 ' HB ' ' OG ' ' A' ' 13' ' ' SER . 40.8 t -144.07 108.59 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.877 . . . . 0.0 110.177 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.771 ' HA ' HG22 ' A' ' 12' ' ' ILE . 14.4 pt -46.26 146.38 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -122.34 45.99 2.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 10' ' ' VAL . 32.7 m-80 -109.88 108.85 59.39 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.251 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.25 -44.67 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.012 1.533 . . . . 0.0 110.437 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.231 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.249 0.547 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.56 61.22 36.05 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' O ' ' CB ' ' A' ' 4' ' ' SER . 49.4 Cg_endo -75.92 2.81 6.66 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.17 1.616 . . . . 0.0 109.822 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.537 ' O ' HG22 ' A' ' 7' ' ' VAL . 1.1 m 71.29 30.61 2.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.26 -0.9 . . . . 0.0 110.172 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.468 ' O ' ' HG3' ' A' ' 5' ' ' MET . 6.5 ptm -68.7 100.36 1.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 110.276 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 137.96 -19.43 3.29 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.94 HG11 ' CE1' ' A' ' 37' ' ' HIS . 6.2 m -82.14 142.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.4 m-20 -108.09 166.64 10.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.073 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.3 p -114.37 131.64 56.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.651 HG11 HD22 ' A' ' 62' ' ' LEU . 1.3 t -117.8 137.38 51.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.642 -0.661 . . . . 0.0 110.351 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.712 ' CG2' HG23 ' A' ' 49' ' ' THR . 0.8 OUTLIER -114.64 152.67 31.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 109.573 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.006 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -145.35 139.83 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.003 -1.06 . . . . 0.0 110.764 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.7 m -90.55 122.28 33.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG12 ' C ' ' A' ' 46' ' ' LYS . 10.2 p -111.45 153.84 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 110.494 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -139.98 -59.74 0.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.48 75.77 0.52 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.459 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -98.36 -146.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -1.11 . . . . 0.0 110.205 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 m -156.93 -67.11 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 110.208 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.7 -55.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.21 -0.931 . . . . 0.0 110.12 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.595 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 0.1 OUTLIER -140.8 -68.92 0.4 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.841 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.513 ' O ' ' CB ' ' A' ' 25' ' ' THR . 0.3 OUTLIER -45.38 -22.73 0.15 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.103 -0.998 . . . . 0.0 109.975 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 16.0 t -49.83 -83.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.796 -1.19 . . . . 0.0 110.398 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.947 HG21 HG21 ' A' ' 41' ' ' VAL . 15.0 p -81.13 -42.22 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 111.531 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.622 ' N ' HG13 ' A' ' 23' ' ' VAL . 9.8 m-90 -52.55 -33.75 47.07 Favored 'General case' 0 C--N 1.285 -2.223 0 O-C-N 121.127 -0.983 . . . . 0.0 109.725 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.513 ' CB ' ' O ' ' A' ' 21' ' ' SER . 25.7 m -77.8 -43.04 31.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.12 HD11 ' CD2' ' A' ' 71' ' ' PHE . 63.0 mt -64.22 -58.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.7 tm-20 -42.76 -39.72 2.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.529 -0.732 . . . . 0.0 109.407 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.34 -47.74 82.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.561 -0.712 . . . . 0.0 110.192 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.77 -56.53 5.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.212 -0.93 . . . . 0.0 110.129 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.813 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.5 tp -48.81 -30.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.49 -32.86 32.98 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -89.14 6.3 40.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -1.121 . . . . 0.0 110.05 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' O ' ' A' ' 30' ' ' ILE . 6.1 p -81.81 -18.73 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -161.35 -132.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 109.985 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.572 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -115.05 47.99 0.98 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 51' ' ' ILE . 9.9 p -45.77 135.03 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.234 -1.156 . . . . 0.0 110.415 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.94 ' CE1' HG11 ' A' ' 7' ' ' VAL . 15.1 m-70 -105.63 -10.54 16.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.959 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.514 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 25.4 t60 -163.87 145.25 8.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.416 -0.802 . . . . 0.0 109.822 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.914 HD12 HG13 ' A' ' 50' ' ' ILE . 6.8 tt -162.27 124.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.049 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -145.23 140.1 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 0.0 110.399 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.947 HG21 HG21 ' A' ' 23' ' ' VAL . 4.6 p -131.9 148.03 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 0.0 110.089 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 m -126.88 168.47 14.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.947 . . . . 0.0 110.325 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.07 -1.82 14.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 17.6 pt-20 -95.57 -34.12 12.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.928 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 44' ' ' GLU . 9.6 mt-10 -102.04 4.97 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.559 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER 45.65 58.69 4.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 110.464 179.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.485 ' N ' HG12 ' A' ' 14' ' ' VAL . 9.3 p-10 -169.63 166.15 10.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 110.049 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.553 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -148.61 148.24 29.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -0.933 . . . . 0.0 110.455 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.712 HG23 ' CG2' ' A' ' 11' ' ' THR . 3.4 m -109.89 152.82 25.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.791 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.914 HG13 HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.79 157.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.989 -1.069 . . . . 0.0 110.593 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.59 169.95 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.935 . . . . 0.0 110.547 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.642 ' CE1' HG23 ' A' ' 10' ' ' VAL . 9.7 p90 -165.1 118.73 1.24 Allowed 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.883 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.651 ' CG ' HG12 ' A' ' 7' ' ' VAL . 3.9 t0 -63.65 117.98 40.18 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.158 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.542 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 43.7 Cg_endo -70.68 -43.11 2.04 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.864 1.455 . . . . 0.0 109.841 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HD3' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.93 -26.04 0.37 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 tp -117.31 -34.89 4.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 110.07 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' HG23 ' A' ' 58' ' ' THR . 1.9 tp-100 -124.39 -150.95 0.46 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.955 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.56 HG22 ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.11 -179.36 0.35 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.26 -0.9 . . . . 0.0 110.294 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 58' ' ' THR . 41.7 Cg_endo -69.81 -30.43 22.04 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.917 1.483 . . . . 0.0 110.273 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -36.2 83.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.863 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.411 HG21 ' CG ' ' A' ' 57' ' ' GLN . 97.2 m -57.75 -56.7 18.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 0.0 109.785 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.651 HD22 HG11 ' A' ' 10' ' ' VAL . 2.2 mp -50.16 -41.94 50.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 109.17 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.544 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.9 tt0 -61.49 -44.5 96.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -0.797 . . . . 0.0 109.103 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -27.36 66.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.518 -0.739 . . . . 0.0 109.459 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -65.35 -62.05 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 109.942 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 73' ' ' ALA . 18.2 mm -51.63 -38.71 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.608 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -68.94 -26.15 64.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.743 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -70.88 -32.34 69.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.405 -0.81 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.519 ' HE2' ' HA ' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -89.66 -50.49 6.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.266 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 121.72 -25.68 6.79 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 1.12 ' CD2' HD11 ' A' ' 26' ' ' ILE . 39.7 m-85 -43.01 116.7 0.93 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.316 -1.108 . . . . 0.0 110.281 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.03 83.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 110.398 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.006 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -129.26 137.04 50.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 74' ' ' VAL . 11.4 p -117.93 133.93 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.226 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 77' ' ' ASN . 6.1 mt -73.94 162.61 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 110.01 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.22 23.75 5.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 110.123 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.552 ' H ' HG22 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -166.93 85.7 0.84 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.65 -90.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.084 1.571 . . . . 0.0 110.347 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t0 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.085 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.5 mtt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.241 0.543 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -158.37 60.35 1.77 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.966 . . . . 0.0 110.491 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.92 -3.3 13.36 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.114 1.586 . . . . 0.0 109.526 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m -159.61 79.38 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.49 -0.756 . . . . 0.0 109.842 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.06 62.59 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.321 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 54' ' ' PRO . . . 172.45 -64.8 0.13 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.533 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 2.5 t -64.58 168.24 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.343 -1.092 . . . . 0.0 110.805 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.4 m-20 -149.95 173.97 13.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.659 -0.651 . . . . 0.0 109.29 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 11.2 p -127.41 147.72 50.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.941 -1.099 . . . . 0.0 110.771 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.753 HG11 HD22 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -136.38 125.55 38.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.547 -0.72 . . . . 0.0 110.208 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.649 ' CG2' HG23 ' A' ' 49' ' ' THR . 0.9 OUTLIER -109.55 144.93 37.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.527 179.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.71 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.3 pp -144.1 169.65 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.108 -0.995 . . . . 0.0 110.551 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.44 ' N ' HD12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -114.34 138.24 50.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.393 -0.817 . . . . 0.0 109.809 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.85 146.68 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 110.528 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -145.94 27.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.868 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.36 80.42 0.12 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.603 ' O ' HG23 ' A' ' 18' ' ' THR . 0.0 OUTLIER -122.94 -138.11 0.31 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -1.141 . . . . 0.0 110.026 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 17' ' ' MET . 19.2 p -156.32 -94.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.098 -1.001 . . . . 0.0 110.346 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.5 p -142.51 -40.56 0.34 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.082 -1.011 . . . . 0.0 110.029 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 16.7 t-20 -145.34 -47.45 0.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.804 ' HA ' HG23 ' A' ' 25' ' ' THR . 0.8 OUTLIER -49.32 -20.47 0.66 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.925 -1.109 . . . . 0.0 110.325 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' O ' HD12 ' A' ' 26' ' ' ILE . 14.3 t -52.44 -81.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.939 -1.101 . . . . 0.0 111.381 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.768 ' CG1' HG21 ' A' ' 41' ' ' VAL . 7.5 p -81.16 -34.38 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.187 -0.946 . . . . 0.0 111.986 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.685 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.7 m-90 -60.2 -38.01 82.02 Favored 'General case' 0 C--N 1.282 -2.35 0 O-C-N 121.12 -0.988 . . . . 0.0 110.534 -178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.804 HG23 ' HA ' ' A' ' 21' ' ' SER . 16.4 p -80.49 -44.92 18.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.634 -1.291 . . . . 0.0 107.832 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.835 HD11 ' CD2' ' A' ' 71' ' ' PHE . 50.4 mt -61.42 -56.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' VAL . 7.3 tt0 -43.22 -48.91 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.124 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -53.14 -41.8 65.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.582 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' HG23 ' A' ' 33' ' ' VAL . 18.6 tp60 -75.83 -51.87 11.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.383 -0.823 . . . . 0.0 109.799 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.832 ' O ' HG21 ' A' ' 36' ' ' VAL . 9.8 mm -51.24 -39.43 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.467 ' HA2' ' HB ' ' A' ' 36' ' ' VAL . . . -72.15 -30.95 64.5 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -82.89 -1.8 53.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -1.089 . . . . 0.0 110.126 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 29' ' ' GLN . 6.2 t -80.95 -47.31 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 110.196 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -155.66 -147.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -86.43 42.71 3.17 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.832 HG21 ' O ' ' A' ' 30' ' ' ILE . 41.4 t -46.73 100.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 110.109 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.523 ' HB2' HG12 ' A' ' 51' ' ' ILE . 50.9 m-70 -57.83 -85.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.293 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.552 ' CD2' HG13 ' A' ' 51' ' ' ILE . 14.0 p80 -111.54 161.64 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.095 -1.003 . . . . 0.0 110.626 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.559 HD12 HG21 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -162.01 140.45 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.412 -0.805 . . . . 0.0 109.623 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.69 155.43 35.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.033 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.768 HG21 ' CG1' ' A' ' 23' ' ' VAL . 14.0 m -133.86 151.52 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.842 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 t -114.39 162.42 16.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.309 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 43' ' ' LEU . 2.1 mp -115.45 -18.08 11.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 110.342 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.86 -44.8 12.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.94 -5.32 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.355 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptt 54.68 79.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.198 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -168.07 -172.45 1.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.25 134.11 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.065 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.649 HG23 ' CG2' ' A' ' 11' ' ' THR . 32.2 m -122.31 118.04 27.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.86 . . . . 0.0 109.563 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.11 HD11 ' CD2' ' A' ' 62' ' ' LEU . 1.3 pp -143.76 167.43 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.758 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.679 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.1 pp -115.57 -173.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.484 -0.76 . . . . 0.0 111.125 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 20.5 p90 -175.5 152.18 1.31 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.875 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 4.6 t0 -92.85 105.23 14.02 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 42.6 Cg_endo -69.25 -10.07 27.97 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.0 1.526 . . . . 0.0 109.479 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.782 ' HB2' HD12 ' A' ' 56' ' ' LEU . 7.2 mtpt -57.01 -32.03 65.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.44 -0.787 . . . . 0.0 109.149 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.782 HD12 ' HB2' ' A' ' 55' ' ' LYS . 5.0 mp -118.35 -44.5 2.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.656 . . . . 0.0 109.381 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' A' ' 58' ' ' THR . 3.3 pt20 -107.84 -141.59 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.31 -0.869 . . . . 0.0 109.509 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.607 HG22 ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -176.33 -178.35 0.31 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.008 . . . . 0.0 110.279 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.607 ' HD2' HG22 ' A' ' 58' ' ' THR . 43.9 Cg_endo -70.9 -17.68 32.23 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.905 1.476 . . . . 0.0 110.11 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HE3' ' HG2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -73.07 -36.46 66.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 109.768 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.5 m -53.43 -52.81 58.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.536 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.11 ' CD2' HD11 ' A' ' 50' ' ' ILE . 2.0 mp -52.27 -41.23 62.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.026 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.402 ' HG3' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -65.42 -45.31 84.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 178.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -33.69 74.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.386 -0.821 . . . . 0.0 109.181 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.78 -52.1 66.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.2 mt -58.52 -44.65 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 109.636 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.15 -17.65 58.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.875 . . . . 0.0 109.707 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.86 -34.49 21.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.408 -0.807 . . . . 0.0 110.101 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 7.3 mmm -85.77 -57.79 2.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 71' ' ' PHE . . . 128.61 -17.98 5.75 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.835 ' CD2' HD11 ' A' ' 26' ' ' ILE . 33.7 m-85 -42.73 115.62 0.75 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -1.187 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.02 82.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.281 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 71' ' ' PHE . . . -132.55 144.36 50.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -112.02 128.78 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.655 ' HA ' HG22 ' A' ' 12' ' ' ILE . 2.6 tt -54.52 161.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.53 ' N ' HG12 ' A' ' 75' ' ' ILE . 46.1 t-80 -158.96 59.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.414 ' CG ' ' O ' ' A' ' 77' ' ' ASN . 25.1 p-10 -117.66 109.41 41.69 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.305 -0.872 . . . . 0.0 110.24 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -75.15 -81.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.987 1.52 . . . . 0.0 110.528 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.216 179.888 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.247 0.546 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.453 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.7 p30 -161.45 54.9 0.56 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.278 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 44.9 Cg_endo -73.42 -2.69 12.49 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 124.039 1.547 . . . . 0.0 109.557 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.41 ' OG ' ' C ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER 174.04 63.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.453 -0.779 . . . . 0.0 109.724 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.49 65.85 9.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 110.62 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.494 ' HA3' ' HD2' ' A' ' 55' ' ' LYS . . . 120.96 47.17 0.31 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.527 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 3.4 m -141.9 131.64 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.279 . . . . 0.0 110.583 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -96.9 -165.37 1.26 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.519 -0.738 . . . . 0.0 109.076 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.928 ' CB ' HG22 ' A' ' 51' ' ' ILE . 49.5 p -148.43 141.95 25.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.799 -1.188 . . . . 0.0 111.129 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.623 HG11 HD11 ' A' ' 62' ' ' LEU . 2.2 t -142.89 141.31 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.708 -0.62 . . . . 0.0 109.944 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.406 HG22 HG23 ' A' ' 49' ' ' THR . 66.9 p -117.89 156.31 28.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 109.977 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.776 HD12 ' C ' ' A' ' 12' ' ' ILE . 2.6 pp -133.61 -175.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.267 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.501 ' N ' HD12 ' A' ' 12' ' ' ILE . 97.5 p -117.88 131.78 56.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 14' ' ' VAL . 3.4 p -116.98 125.56 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -134.05 -40.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 110.28 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.29 85.66 1.2 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.468 ' O ' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -110.75 -151.02 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.215 -1.168 . . . . 0.0 110.09 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.512 HG23 ' N ' ' A' ' 19' ' ' CYS . 8.9 t -179.06 -138.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 109.85 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.512 ' N ' HG23 ' A' ' 18' ' ' THR . 8.0 p -56.67 163.22 1.93 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.066 -1.021 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.496 ' OD1' ' HB2' ' A' ' 24' ' ' TRP . 5.4 t-20 -37.79 -30.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.509 -0.744 . . . . 0.0 110.846 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.555 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 0.1 OUTLIER -51.24 -20.74 1.72 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.809 -1.182 . . . . 0.0 110.056 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -46.31 -74.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.232 -0.918 . . . . 0.0 111.835 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.861 ' CG2' HG21 ' A' ' 41' ' ' VAL . 2.0 m -88.42 -38.68 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.079 -1.013 . . . . 0.0 110.23 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.646 ' CE3' HG22 ' A' ' 23' ' ' VAL . 25.9 m-90 -59.44 -31.73 69.57 Favored 'General case' 0 C--N 1.28 -2.438 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.278 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.555 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 7.6 m -84.42 -48.23 9.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 0.0 107.911 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.051 HD11 ' CD2' ' A' ' 71' ' ' PHE . 33.9 mt -59.9 -44.31 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.884 ' HG3' HD13 ' A' ' 39' ' ' ILE . 35.2 tt0 -57.55 -45.87 84.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.602 -0.686 . . . . 0.0 109.523 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 11.8 tt0 -54.84 -42.33 71.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.429 -0.795 . . . . 0.0 109.948 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -74.98 -63.62 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 110.226 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.645 ' O ' HG11 ' A' ' 36' ' ' VAL . 22.7 pt -50.44 -38.86 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.025 -1.047 . . . . 0.0 108.972 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.538 ' C ' HG11 ' A' ' 36' ' ' VAL . . . -69.18 -24.71 75.87 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.4 OUTLIER -102.83 9.24 39.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.655 -0.909 . . . . 0.0 109.918 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.648 HG22 ' H ' ' A' ' 34' ' ' ASN . 1.2 p -66.13 -161.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.553 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.66 ' ND2' HD21 ' A' ' 56' ' ' LEU . 2.3 m-20 -61.74 -80.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 110.878 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -118.13 87.73 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.29 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 36' ' ' VAL . 7.6 p -121.31 82.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -1.118 . . . . 0.0 109.184 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.943 ' CD2' HD13 ' A' ' 51' ' ' ILE . 8.2 p80 -73.89 7.04 2.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.0 111.985 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.76 ' H ' HD11 ' A' ' 51' ' ' ILE . 15.9 t60 -173.34 149.81 1.79 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.773 -1.204 . . . . 0.0 110.766 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.884 HD13 ' HG3' ' A' ' 27' ' ' GLU . 2.8 pp -157.8 158.01 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.457 -0.777 . . . . 0.0 109.575 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -154.35 163.69 39.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.832 -1.168 . . . . 0.0 111.11 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.861 HG21 ' CG2' ' A' ' 23' ' ' VAL . 73.4 t -136.96 138.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.483 -0.761 . . . . 0.0 110.019 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -124.85 76.2 1.5 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -58.21 -33.19 69.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -53.01 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.421 -0.8 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.54 58.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.343 -0.848 . . . . 0.0 110.315 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' SER . 0.1 OUTLIER 60.51 70.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.38 179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 14.6 t-20 -170.26 163.39 8.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 109.999 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB3' ' CG1' ' A' ' 12' ' ' ILE . . . -129.81 137.25 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 110.318 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 40' ' ' LYS . 1.6 m -113.17 108.25 17.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.862 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.637 HD11 HD13 ' A' ' 62' ' ' LEU . 2.5 pp -136.77 154.43 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.316 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.943 HD13 ' CD2' ' A' ' 37' ' ' HIS . 1.2 pp -116.98 -166.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.646 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 22.5 p90 -174.52 155.13 2.19 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.292 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 3.0 p-10 -95.06 117.96 66.69 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 110.464 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 44.7 Cg_endo -70.89 -6.2 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.684 1.36 . . . . 0.0 109.305 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HD2' ' HA3' ' A' ' 6' ' ' GLY . 0.7 OUTLIER -66.73 -43.38 84.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.656 -0.652 . . . . 0.0 109.544 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.66 HD21 ' ND2' ' A' ' 34' ' ' ASN . 1.2 tt -129.16 -8.28 4.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.37 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.61 -165.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 110.537 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.493 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -163.86 177.81 1.68 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 110.1 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.666 ' HA ' HD21 ' A' ' 62' ' ' LEU . 45.6 Cg_endo -72.11 -7.98 22.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.017 1.535 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -33.96 21.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.348 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' LEU . 3.5 m -55.61 -68.16 0.22 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.831 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -45.45 -32.96 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 109.084 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -45.71 63.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 108.814 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -68.12 -29.9 68.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.2 -68.54 0.33 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.727 . . . . 0.0 110.153 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 67' ' ' ASP . 27.6 pt -50.56 -34.2 12.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.102 -0.999 . . . . 0.0 109.88 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' HG13 ' A' ' 66' ' ' ILE . 11.4 t70 -74.25 -22.26 59.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.738 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 1.3 t0 -76.68 -34.82 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.817 . . . . 0.0 110.092 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.512 ' CE ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -75.34 -46.22 34.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 0.0 110.242 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.88 -0.78 9.97 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 1.051 ' CD2' HD11 ' A' ' 26' ' ' ILE . 9.3 m-85 -64.15 134.23 54.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.13 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 7.4 m-20 -69.29 58.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.377 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -109.94 143.88 39.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 110.008 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 t -139.6 146.7 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 0.0 110.288 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' A' ' 12' ' ' ILE . 9.4 tt -59.89 147.18 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 0.0 110.025 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -122.03 -43.27 2.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.477 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -129.11 95.6 30.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 110.325 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.36 -159.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.017 1.536 . . . . 0.0 110.258 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.258 0.551 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -132.3 54.34 13.67 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.288 -0.882 . . . . 0.0 110.16 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 46.8 Cg_endo -73.45 -1.61 10.92 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.1 1.579 . . . . 0.0 109.818 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -165.87 -62.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.383 -0.823 . . . . 0.0 109.961 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 45.65 72.06 0.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -0.865 . . . . 0.0 110.591 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 7' ' ' VAL . . . 124.43 5.32 7.24 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.673 HG11 ' CD2' ' A' ' 37' ' ' HIS . 1.4 t -153.43 162.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -1.145 . . . . 0.0 110.318 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.59 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 5.9 m-20 -150.53 147.1 27.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -0.782 . . . . 0.0 109.872 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 t -106.56 138.31 42.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.325 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.726 HG21 HD23 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -124.76 131.21 72.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.571 -0.706 . . . . 0.0 110.381 -178.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.97 139.71 49.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 109.91 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.993 HD13 ' HB1' ' A' ' 73' ' ' ALA . 2.5 pp -141.07 167.2 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 110.674 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.562 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 4.6 m -90.08 140.85 29.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.348 -0.845 . . . . 0.0 108.803 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.692 HG12 ' SD ' ' A' ' 17' ' ' MET . 38.0 t -110.56 143.54 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.893 -1.13 . . . . 0.0 111.013 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -168.67 28.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 72' ' ' ASP . . . -153.08 57.64 0.42 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.692 ' SD ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -111.92 -153.91 0.53 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -1.206 . . . . 0.0 109.917 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 19' ' ' CYS . 23.8 m -148.5 -83.59 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -0.918 . . . . 0.0 109.912 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.462 ' N ' HG22 ' A' ' 18' ' ' THR . 1.2 t -137.77 -141.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 109.496 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 5.1 m120 -46.41 -25.06 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.993 -1.067 . . . . 0.0 109.496 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.543 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 67.9 p -57.84 -11.05 1.99 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.013 -1.055 . . . . 0.0 110.688 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 93.9 m -52.9 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.846 -1.159 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.68 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 8.2 p -80.58 -30.09 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 0.0 111.252 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.68 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 18.2 m-90 -67.16 -43.34 82.55 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.214 -0.995 . . . . 0.0 110.671 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.651 HG22 ' SD ' ' A' ' 69' ' ' MET . 12.4 m -71.27 -45.22 63.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.496 -1.377 . . . . 0.0 107.867 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.944 ' CG2' HD11 ' A' ' 39' ' ' ILE . 1.1 mp -61.17 -58.52 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' ' 26' ' ' ILE . 82.4 tt0 -49.52 -32.89 13.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 109.977 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -68.95 -56.54 7.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' LYS . 5.8 tp60 -73.41 -61.62 1.76 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.962 HG21 HD13 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -49.13 -34.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.227 -0.92 . . . . 0.0 109.288 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.58 -27.45 67.41 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 29' ' ' GLN . 2.1 tttp -92.44 0.57 57.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -1.065 . . . . 0.0 110.088 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.804 HG13 ' N ' ' A' ' 34' ' ' ASN . 1.7 p -82.75 -146.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 110.351 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.804 ' N ' HG13 ' A' ' 33' ' ' VAL . 95.6 m-20 -49.06 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.32 61.75 0.33 Allowed Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.145 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.953 HG11 HG23 ' A' ' 30' ' ' ILE . 25.8 m -59.92 135.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.128 -1.219 . . . . 0.0 109.818 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.673 ' CD2' HG11 ' A' ' 7' ' ' VAL . 31.0 m-70 -92.88 -24.44 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.136 -0.977 . . . . 0.0 111.017 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.406 ' CG ' ' C ' ' A' ' 37' ' ' HIS . 85.6 m-70 -147.04 157.88 43.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.952 -1.093 . . . . 0.0 110.778 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.962 HD13 HG21 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -167.07 123.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 0.0 110.133 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.95 140.09 24.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 23' ' ' VAL . 8.0 m -109.85 139.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.399 -0.813 . . . . 0.0 110.112 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.39 112.27 23.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.038 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.88 -16.46 38.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 110.301 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -100.77 -10.45 20.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.269 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -121.3 -1.53 9.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.215 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 50.75 67.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.648 ' HA ' HG23 ' A' ' 14' ' ' VAL . 1.2 t-20 -169.98 170.32 7.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 110.022 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.68 144.81 22.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 110.216 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.446 ' C ' ' CG2' ' A' ' 50' ' ' ILE . 88.1 m -120.31 129.76 54.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.387 -0.821 . . . . 0.0 109.662 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.446 ' CG2' ' C ' ' A' ' 49' ' ' THR . 1.5 pp -147.33 161.27 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.07 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -114.49 170.72 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.446 -0.784 . . . . 0.0 109.902 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 10.6 p90 -168.45 126.52 1.11 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.249 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 20.4 p-10 -68.85 118.83 64.87 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.419 -0.801 . . . . 0.0 110.434 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' CD ' ' HA ' ' A' ' 7' ' ' VAL . 42.4 Cg_endo -69.73 -29.59 23.74 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.901 1.474 . . . . 0.0 110.058 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.37 -26.44 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.725 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.4 -57.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.871 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.68 ' C ' HG22 ' A' ' 58' ' ' THR . 2.5 tt0 -158.58 -178.64 7.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.522 -0.736 . . . . 0.0 109.348 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.732 HG23 ' CD ' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -168.86 -60.19 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.791 -1.193 . . . . 0.0 111.603 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.732 ' CD ' HG23 ' A' ' 58' ' ' THR . 53.7 Cg_endo -75.59 -48.42 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.227 1.119 . . . . 0.0 111.745 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -76.22 -37.05 58.24 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.216 -0.927 . . . . 0.0 111.665 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 57' ' ' GLN . 12.7 m -64.19 -59.63 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 110.233 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.726 HD23 HG21 ' A' ' 10' ' ' VAL . 5.4 mp -52.28 -40.99 62.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 109.223 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -65.55 -46.09 80.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.272 -0.893 . . . . 0.0 109.087 179.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -66.96 -28.78 68.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.428 -0.795 . . . . 0.0 109.355 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.66 -53.2 58.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.499 -0.751 . . . . 0.0 109.666 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 71' ' ' PHE . 30.0 mt -58.37 -50.06 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.35 -22.62 32.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -79.23 -31.09 43.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 110.025 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.651 ' SD ' HG22 ' A' ' 25' ' ' THR . 26.2 mmt -106.27 12.46 29.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.37 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.0 22.15 5.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.885 ' CZ ' HD13 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -72.52 78.43 1.06 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.723 -0.869 . . . . 0.0 110.422 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.493 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -52.88 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.04 -1.038 . . . . 0.0 109.562 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 12' ' ' ILE . . . -125.68 167.95 14.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 111.062 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.66 120.11 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.753 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.966 ' HA ' HG22 ' A' ' 12' ' ' ILE . 15.8 tt -80.95 140.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 0.0 110.764 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -127.53 20.04 6.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.357 -0.84 . . . . 0.0 109.98 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.98 102.42 34.58 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.291 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.13 -89.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.013 1.533 . . . . 0.0 110.309 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 p30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.189 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 tpt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.347 0.594 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 20.5 p30 -147.46 54.18 1.84 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.28 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 45.3 Cg_endo -73.15 -2.74 12.5 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.078 1.567 . . . . 0.0 109.684 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 6' ' ' GLY . 50.6 m -148.4 70.43 1.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.136 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.2 59.22 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 4' ' ' SER . . . 83.72 71.13 1.32 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.582 ' CG2' ' N ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -167.61 170.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.168 -1.195 . . . . 0.0 111.056 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.582 ' N ' ' CG2' ' A' ' 7' ' ' VAL . 1.3 m-20 -155.17 163.19 40.55 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.5 p -104.15 161.59 13.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.82 -1.175 . . . . 0.0 110.848 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.926 HG21 ' CD2' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -151.99 126.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 110.18 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 49' ' ' THR . 0.1 OUTLIER -116.19 161.63 18.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.32 -0.863 . . . . 0.0 109.574 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.801 ' CD1' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -150.35 162.59 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.479 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 3.1 m -97.7 126.37 43.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.888 HG12 ' HG2' ' A' ' 17' ' ' MET . 91.8 t -111.54 134.12 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.554 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.8 -40.61 0.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 110.191 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 17' ' ' MET . . . -50.73 -30.83 22.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.888 ' HG2' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -52.69 -175.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -1.139 . . . . 0.0 110.102 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.461 HG22 ' SG ' ' A' ' 22' ' ' CYS . 2.4 t -164.21 -37.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' N ' HG23 ' A' ' 18' ' ' THR . 29.8 p -118.0 -138.89 0.36 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.303 -0.873 . . . . 0.0 110.061 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.59 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 7.1 m-20 -99.84 -57.3 2.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.16 -0.962 . . . . 0.0 110.297 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.523 ' O ' ' HB ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -45.72 -20.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 110.814 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' O ' HD12 ' A' ' 26' ' ' ILE . 3.4 m -58.46 -87.25 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.816 -1.178 . . . . 0.0 111.336 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.079 HG21 HG21 ' A' ' 41' ' ' VAL . 12.1 p -70.56 -36.61 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 0.0 111.912 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.63 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 10.3 m-90 -63.69 -43.07 97.71 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.299 -0.876 . . . . 0.0 110.751 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 21' ' ' SER . 43.7 m -65.52 -38.82 90.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.449 -1.407 . . . . 0.0 107.914 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.959 HD11 ' CD2' ' A' ' 71' ' ' PHE . 52.1 mt -68.24 -48.66 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' OE2' ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -58.53 -27.42 64.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.247 -0.908 . . . . 0.0 109.596 179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -67.82 -54.16 21.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.406 -0.809 . . . . 0.0 109.936 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 33' ' ' VAL . 11.5 tt0 -64.11 -48.92 74.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.665 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.8 ' O ' HG21 ' A' ' 36' ' ' VAL . 56.8 mt -52.73 -38.91 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.564 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.909 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -69.97 -27.18 73.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.64 5.48 41.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.515 -0.991 . . . . 0.0 109.729 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 34' ' ' ASN . 1.3 t -51.84 -69.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 0.0 109.548 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.713 ' N ' HG12 ' A' ' 33' ' ' VAL . 2.5 m120 -142.76 -98.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.077 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . -106.04 62.63 0.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.909 HG11 ' HA2' ' A' ' 31' ' ' GLY . 42.1 t -89.12 118.34 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.059 -1.26 . . . . 0.0 110.221 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.575 ' CD2' HG21 ' A' ' 7' ' ' VAL . 49.7 m-70 -65.91 -75.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 110.313 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -121.19 164.81 16.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 110.489 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.791 HD12 ' HB ' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -155.04 142.49 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.359 -0.838 . . . . 0.0 109.734 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -166.6 142.84 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.113 -0.992 . . . . 0.0 110.601 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.079 HG21 HG21 ' A' ' 23' ' ' VAL . 2.7 p -123.14 140.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.988 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.64 168.22 16.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mt -110.14 -28.91 8.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.226 -0.921 . . . . 0.0 109.979 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.23 -22.54 1.06 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.232 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.519 ' HB2' ' ND2' ' A' ' 47' ' ' ASN . 27.5 mt-10 -134.38 8.2 3.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mttt 46.92 74.01 0.17 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 0.0 110.507 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -170.26 -170.88 1.02 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 110.477 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.801 ' HB3' ' CD1' ' A' ' 12' ' ' ILE . . . -155.91 141.41 17.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.033 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 11' ' ' THR . 2.9 m -110.99 128.38 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 110.065 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -153.06 147.84 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.323 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -113.17 171.87 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.312 -0.868 . . . . 0.0 110.265 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.3 p90 -157.35 127.59 6.35 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.695 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.707 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 1.4 p30 -107.24 18.57 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.352 -0.842 . . . . 0.0 111.757 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 53' ' ' ASP . 52.1 Cg_endo -79.62 65.42 8.88 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 N-CA-C 108.141 -1.523 . . . . 0.0 108.141 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' HD2' ' CA ' ' A' ' 6' ' ' GLY . 0.9 OUTLIER -40.15 -27.15 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.636 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -54.07 -22.32 10.57 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.263 -0.898 . . . . 0.0 109.398 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.501 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 12.6 mm100 -154.77 178.17 10.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.2 m -175.05 -65.05 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 49.6 Cg_endo -73.09 -49.07 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.648 1.341 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HB3' ' NE2' ' A' ' 57' ' ' GLN . 2.5 tppp? -67.85 -32.6 73.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 110.781 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 57' ' ' GLN . 12.6 m -68.9 -58.35 4.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 109.619 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.926 ' CD2' HG21 ' A' ' 10' ' ' VAL . 4.0 mp -55.65 -46.79 77.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.296 -0.878 . . . . 0.0 109.117 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 1.4 tp60 -61.17 -41.21 96.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 108.83 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 68' ' ' ASP . 84.3 tt0 -68.62 -39.65 80.7 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.654 0.74 . . . . 0.0 109.093 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -47.88 -52.12 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.56 -0.713 . . . . 0.0 109.781 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 73' ' ' ALA . 34.3 mm -64.93 -55.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.581 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -57.53 -24.1 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 64' ' ' GLU . 2.7 t70 -75.89 -38.83 57.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.701 ' HG3' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -81.99 -65.95 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.511 -0.743 . . . . 0.0 110.19 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.12 41.38 0.76 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.959 ' CD2' HD11 ' A' ' 26' ' ' ILE . 19.9 m-85 -119.89 143.27 48.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -1.126 . . . . 0.0 110.243 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.409 ' HB2' ' HA3' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -65.62 74.38 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.456 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB3' HD12 ' A' ' 66' ' ' ILE . . . -117.69 148.89 41.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.096 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 74' ' ' VAL . 27.1 m -132.55 120.15 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.351 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.438 HG12 ' OD1' ' A' ' 77' ' ' ASN . 18.5 tt -63.74 152.39 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.3 -0.875 . . . . 0.0 110.021 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -148.99 61.32 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.975 . . . . 0.0 110.262 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.438 ' OD1' HG12 ' A' ' 75' ' ' ILE . 15.7 p-10 -112.13 110.67 53.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.999 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -5.24 16.85 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.018 1.536 . . . . 0.0 110.513 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 27.4 p-10 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.192 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.251 0.548 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 47.45 61.17 14.15 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 110.287 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.5 -3.22 13.34 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.129 1.594 . . . . 0.0 109.534 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' GLY . 60.0 p -166.34 74.91 0.18 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.094 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.439 ' C ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -59.96 83.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.434 -0.791 . . . . 0.0 110.21 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 4' ' ' SER . . . 54.19 51.4 50.88 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.542 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -141.79 135.13 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -1.168 . . . . 0.0 110.599 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -110.14 -177.78 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.817 ' OG ' HG22 ' A' ' 51' ' ' ILE . 57.9 m -131.6 135.08 46.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.761 -1.212 . . . . 0.0 110.776 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.8 HG11 HD23 ' A' ' 62' ' ' LEU . 2.1 t -127.91 145.23 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.604 -0.685 . . . . 0.0 109.925 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.91 173.35 6.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.089 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.024 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.2 130.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.279 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 8.5 t -84.5 135.65 34.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.221 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.675 HG12 ' C ' ' A' ' 46' ' ' LYS . 8.1 p -123.76 166.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.655 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -161.02 -39.27 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.437 -0.789 . . . . 0.0 109.927 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.83 97.85 2.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.545 ' HE1' ' HG3' ' A' ' 46' ' ' LYS . 0.9 OUTLIER -150.33 100.22 2.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.15 . . . . 0.0 110.238 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.538 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 0.2 OUTLIER -42.0 -68.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.883 . . . . 0.0 110.845 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 20' ' ' ASN . 6.0 m -154.68 -162.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.959 -1.088 . . . . 0.0 110.841 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.621 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.4 t30 -39.36 -50.13 2.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.441 -0.787 . . . . 0.0 110.806 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.516 ' O ' ' HB ' ' A' ' 25' ' ' THR . 42.7 m -43.69 -19.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.763 -1.211 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.601 ' C ' HD12 ' A' ' 26' ' ' ILE . 97.2 m -75.31 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.597 -1.315 . . . . 0.0 111.831 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.902 HG13 ' CE3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -43.1 -38.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.382 -0.824 . . . . 0.0 110.773 -178.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.902 ' CE3' HG13 ' A' ' 23' ' ' VAL . 21.4 m-90 -69.8 -50.18 45.5 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.141 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 21' ' ' SER . 49.4 m -60.06 -38.19 82.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.464 -1.398 . . . . 0.0 107.827 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 71' ' ' PHE . 17.0 mt -69.29 -54.23 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 3.7 tt0 -54.89 -20.76 9.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -57.77 3.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.385 -0.822 . . . . 0.0 109.956 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.435 ' OE1' ' CE ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -61.12 -52.07 66.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 109.721 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.51 ' CG2' ' HA ' ' A' ' 27' ' ' GLU . 11.8 tt -51.39 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.555 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.753 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . -77.92 -15.69 80.86 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -116.78 18.82 14.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.852 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.536 HG13 ' N ' ' A' ' 34' ' ' ASN . 5.0 p -82.51 -42.6 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.725 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' N ' HG13 ' A' ' 33' ' ' VAL . 2.3 t30 -170.69 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.065 -1.022 . . . . 0.0 110.867 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 53' ' ' ASP . . . -67.91 55.31 0.38 Allowed Glycine 0 N--CA 1.491 2.316 0 O-C-N 121.163 -0.96 . . . . 0.0 110.841 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.753 HG11 ' HA2' ' A' ' 31' ' ' GLY . 5.7 p -95.39 151.55 3.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.914 -1.345 . . . . 0.0 108.476 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.649 ' NE2' ' HB ' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -115.32 -68.63 0.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.069 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.555 ' O ' ' CD1' ' A' ' 51' ' ' ILE . 9.4 p80 -124.66 168.76 12.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.593 -1.317 . . . . 0.0 111.091 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.477 HG23 ' HB ' ' A' ' 50' ' ' ILE . 1.8 mp -145.75 150.01 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.068 -1.02 . . . . 0.0 110.571 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.589 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -125.87 149.96 48.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 109.814 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.891 HG21 ' CG2' ' A' ' 23' ' ' VAL . 7.7 p -164.08 137.4 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.001 -1.062 . . . . 0.0 110.49 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.18 127.8 17.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.086 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.9 -3.45 51.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 110.45 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.45 -33.01 32.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 110.087 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -107.74 -1.41 21.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.068 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.675 ' C ' HG12 ' A' ' 14' ' ' VAL . 3.1 mptt 58.86 58.34 3.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.994 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.663 ' N ' HG12 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -170.38 167.81 8.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 109.69 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 40' ' ' LYS . . . -150.35 142.71 24.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.306 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 40' ' ' LYS . 33.1 m -110.0 105.08 14.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.442 -0.786 . . . . 0.0 109.28 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -118.69 153.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.277 -0.889 . . . . 0.0 110.672 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.817 HG22 ' OG ' ' A' ' 9' ' ' SER . 0.9 OUTLIER -108.99 -177.87 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.438 -0.788 . . . . 0.0 110.591 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.642 ' CE1' HG23 ' A' ' 10' ' ' VAL . 20.3 p90 -178.34 141.51 0.23 Allowed 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.618 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 6.3 p-10 -79.68 111.91 25.04 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 0.0 109.677 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 52' ' ' TYR . 46.5 Cg_endo -73.5 0.76 7.65 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.724 1.381 . . . . 0.0 110.477 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' CE ' ' HA3' ' A' ' 6' ' ' GLY . 3.4 mttm -70.34 -19.39 63.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 0.0 110.556 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -139.05 3.1 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.078 -1.014 . . . . 0.0 110.955 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.685 ' C ' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -177.71 137.01 0.19 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.007 -1.058 . . . . 0.0 110.078 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.759 HG23 ' HD3' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -169.05 -60.34 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.948 -1.095 . . . . 0.0 112.054 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.759 ' HD3' HG23 ' A' ' 58' ' ' THR . 51.8 Cg_endo -74.45 -52.1 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.159 1.084 . . . . 0.0 111.499 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -86.92 -50.57 6.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 111.396 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 57' ' ' GLN . 63.9 m -46.15 -61.8 1.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.915 -1.116 . . . . 0.0 110.336 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.8 HD23 HG11 ' A' ' 10' ' ' VAL . 2.1 mp -52.23 -44.18 64.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.339 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -44.3 93.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.216 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -69.12 -19.95 64.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.544 -0.723 . . . . 0.0 109.329 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -69.93 -65.51 0.71 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.525 -0.734 . . . . 0.0 109.787 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 73' ' ' ALA . 1.3 tp -53.75 -35.3 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -78.59 -30.18 46.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.392 -0.817 . . . . 0.0 109.851 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 6.7 t0 -64.71 -36.11 83.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 109.929 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.435 ' CE ' ' OE1' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -89.64 -68.6 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.017 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.44 -9.06 10.96 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.165 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.826 ' CD2' HD11 ' A' ' 26' ' ' ILE . 30.6 m-85 -49.79 124.7 10.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.942 -1.328 . . . . 0.0 110.122 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.68 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.273 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -133.11 178.39 6.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.972 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' SER . 58.5 t -135.49 95.69 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 110.166 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.538 HG23 HD13 ' A' ' 66' ' ' ILE . 50.1 pt -56.62 162.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.227 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -145.17 87.75 1.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.215 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -117.93 137.46 24.43 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.047 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.57 -9.38 23.95 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.945 1.497 . . . . 0.0 110.84 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.201 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.278 0.561 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.9 65.86 6.11 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.508 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 4' ' ' SER . 47.0 Cg_endo -74.38 -0.5 9.76 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.036 1.545 . . . . 0.0 109.581 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 0.7 OUTLIER 65.37 58.07 0.87 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.333 -0.854 . . . . 0.0 110.278 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.18 85.31 3.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.72 -33.81 0.05 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.962 HG11 ' NE2' ' A' ' 37' ' ' HIS . 11.4 m -66.87 143.32 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -1.214 . . . . 0.0 110.669 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -118.06 167.55 11.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.413 -0.805 . . . . 0.0 109.927 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.3 t -112.11 136.81 51.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.063 -1.023 . . . . 0.0 110.287 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.103 ' CG1' HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -120.65 126.2 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.627 -0.671 . . . . 0.0 110.438 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.495 ' C ' ' CG2' ' A' ' 12' ' ' ILE . 12.3 p -116.88 161.01 19.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 0.0 109.603 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.823 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -152.38 166.98 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.025 -1.047 . . . . 0.0 110.411 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -98.21 159.99 14.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.683 HG11 ' SD ' ' A' ' 17' ' ' MET . 58.4 t -145.27 147.34 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.079 . . . . 0.0 110.705 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' HA ' ' OE1' ' A' ' 15' ' ' GLU . 3.3 tp10 -146.15 -41.36 0.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 109.706 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.05 88.81 1.49 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.683 ' SD ' HG11 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -114.5 -160.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -1.163 . . . . 0.0 110.614 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' C ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -167.04 -144.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.546 -0.721 . . . . 0.0 109.711 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -58.74 153.29 17.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 109.764 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -27.88 -44.26 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.65 0.738 . . . . 0.0 111.535 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.536 ' HA ' ' OG1' ' A' ' 25' ' ' THR . 96.0 p -50.18 -15.9 0.27 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.745 -1.222 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 1.2 p -49.56 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.838 -1.164 . . . . 0.0 111.058 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.079 HG11 HG21 ' A' ' 41' ' ' VAL . 7.9 p -82.84 -23.53 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 111.374 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.643 ' CH2' HD21 ' A' ' 43' ' ' LEU . 14.4 m-90 -69.34 -28.46 66.24 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.264 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 21' ' ' SER . 28.4 m -82.29 -41.69 19.81 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.105 HD11 ' CD2' ' A' ' 71' ' ' PHE . 83.4 mt -65.1 -45.86 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.567 ' CG ' HD13 ' A' ' 39' ' ' ILE . 19.1 tt0 -60.32 -36.45 77.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.459 -0.776 . . . . 0.0 109.659 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -45.11 80.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.469 -0.77 . . . . 0.0 110.149 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.0 mm100 -54.23 -42.54 69.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.859 ' O ' HG21 ' A' ' 36' ' ' VAL . 75.2 mt -61.36 -46.93 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.466 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . -62.78 -14.65 52.3 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -107.26 -9.86 15.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.427 -1.043 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' A' ' 30' ' ' ILE . 3.2 t -49.02 -64.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 110.206 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.743 HD21 HD22 ' A' ' 56' ' ' LEU . 48.1 t-20 -169.66 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.095 . . . . 0.0 110.812 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.13 34.84 4.56 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.859 HG21 ' O ' ' A' ' 30' ' ' ILE . 29.0 t -70.61 115.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.055 -1.262 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.962 ' NE2' HG11 ' A' ' 7' ' ' VAL . 52.3 m-70 -65.27 -87.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 110.691 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.58 ' CD2' HG13 ' A' ' 51' ' ' ILE . 19.5 p80 -120.52 163.07 18.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.89 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.031 ' O ' HD12 ' A' ' 39' ' ' ILE . 2.3 pp -148.42 153.37 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.449 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -164.83 141.54 5.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.95 -1.094 . . . . 0.0 111.096 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.079 HG21 HG11 ' A' ' 23' ' ' VAL . 1.2 p -124.32 135.34 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.813 ' C ' HD22 ' A' ' 43' ' ' LEU . 15.2 p -109.52 172.73 6.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 110.213 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.813 HD22 ' C ' ' A' ' 42' ' ' SER . 3.9 mm? -117.62 -29.06 5.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.998 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -66.04 -29.11 69.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 110.352 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HB2' ' OD1' ' A' ' 47' ' ' ASN . 35.2 mt-10 -116.08 5.08 13.77 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.19 -0.944 . . . . 0.0 110.503 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER 43.01 65.61 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 45' ' ' GLU . 15.1 p-10 -155.59 171.89 19.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 110.178 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 12' ' ' ILE . . . -141.22 154.78 45.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 110.372 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 49' ' ' THR . 10.1 t -136.83 127.61 27.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 110.02 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.912 ' CB ' HG22 ' A' ' 39' ' ' ILE . 2.3 pp -144.62 161.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.138 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.58 HG13 ' CD2' ' A' ' 38' ' ' HIS . 0.5 OUTLIER -112.41 168.17 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 110.509 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.687 ' OH ' HG23 ' A' ' 10' ' ' VAL . 9.8 p90 -166.2 130.68 2.2 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.338 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.538 ' CB ' HG12 ' A' ' 7' ' ' VAL . 18.1 p-10 -77.34 125.85 85.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.368 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD3' ' HA ' ' A' ' 7' ' ' VAL . 42.2 Cg_endo -68.93 -30.16 26.73 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.87 1.458 . . . . 0.0 109.597 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -20.16 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.803 . . . . 0.0 109.961 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.743 HD22 HD21 ' A' ' 34' ' ' ASN . 0.3 OUTLIER -135.86 -40.9 0.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.506 ' OE1' ' ND2' ' A' ' 34' ' ' ASN . 5.2 mp0 -106.77 -166.1 1.14 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.166 -0.959 . . . . 0.0 110.677 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.508 ' CB ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -169.01 179.73 0.8 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 0.0 110.169 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 58' ' ' THR . 45.7 Cg_endo -73.44 -11.88 24.75 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.959 1.505 . . . . 0.0 110.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -76.29 -51.34 12.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 65' ' ' ALA . 54.3 m -44.37 -47.25 9.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.455 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.103 HD22 ' CG1' ' A' ' 10' ' ' VAL . 1.3 mp -57.32 -45.95 83.73 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.317 -0.865 . . . . 0.0 108.871 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HG3' HG21 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -62.74 -51.09 68.51 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.489 -0.757 . . . . 0.0 109.203 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -64.2 -34.66 78.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.389 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' THR . . . -56.5 -55.86 28.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 109.607 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 19.9 mm -55.2 -42.82 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -29.46 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.32 -23.96 50.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.945 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.78 -47.94 5.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.04 74.07 1.0 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 1.105 ' CD2' HD11 ' A' ' 26' ' ' ILE . 8.4 m-85 -146.48 135.52 22.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -1.139 . . . . 0.0 110.213 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.26 81.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.501 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -113.0 171.24 7.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.019 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' C ' ' A' ' 73' ' ' ALA . 71.3 t -147.51 79.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.383 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.427 HG21 ' HG3' ' A' ' 63' ' ' GLN . 8.2 tt -56.93 141.77 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.105 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -159.72 92.89 1.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 110.281 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.536 ' CG ' HG22 ' A' ' 10' ' ' VAL . 1.1 p30 -157.25 57.01 1.22 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 45.8 Cg_endo -73.43 162.15 40.84 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.998 1.525 . . . . 0.0 110.37 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.265 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.207 0.527 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.436 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 58.1 t0 -165.81 56.35 0.42 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.955 . . . . 0.0 110.415 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 46.3 Cg_endo -73.97 -1.58 11.06 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.069 1.562 . . . . 0.0 109.742 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.917 ' O ' HG22 ' A' ' 7' ' ' VAL . 5.8 m -67.17 -8.85 34.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.957 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER 70.12 41.8 1.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.486 -0.758 . . . . 0.0 110.612 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.46 -46.56 3.0 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.605 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.917 HG22 ' O ' ' A' ' 4' ' ' SER . 16.1 m -53.64 131.97 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.946 -1.326 . . . . 0.0 110.698 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 51' ' ' ILE . 3.0 t-20 -118.77 -177.81 3.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.55 -0.719 . . . . 0.0 109.759 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -117.5 140.56 49.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.084 -1.01 . . . . 0.0 110.399 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.813 HG11 HD23 ' A' ' 62' ' ' LEU . 1.4 t -139.83 141.12 35.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.613 -0.68 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.3 p -114.35 159.39 20.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.233 -0.917 . . . . 0.0 110.186 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.843 ' O ' HD12 ' A' ' 12' ' ' ILE . 2.4 pp -135.99 136.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 110.196 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.425 ' HA ' ' CG ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -84.73 135.5 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 110.058 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.633 HG12 ' SD ' ' A' ' 17' ' ' MET . 71.1 t -117.33 142.42 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.198 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.26 52.77 0.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.2 51.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.633 ' SD ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -97.19 -139.79 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.392 -1.063 . . . . 0.0 110.15 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.716 HG22 ' SG ' ' A' ' 22' ' ' CYS . 1.4 t -179.43 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.203 -0.936 . . . . 0.0 110.42 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HB2' HG23 ' A' ' 18' ' ' THR . 0.8 OUTLIER -159.28 -139.92 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.188 -0.945 . . . . 0.0 110.215 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' TRP . 0.4 OUTLIER -89.32 -51.19 5.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 25' ' ' THR . 1.8 t -48.04 -17.75 0.15 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.667 -1.271 . . . . 0.0 110.619 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.757 ' O ' HD12 ' A' ' 26' ' ' ILE . 2.0 m -59.96 -87.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.73 -1.231 . . . . 0.0 111.577 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.648 ' CG1' ' CE3' ' A' ' 24' ' ' TRP . 12.4 p -72.47 -17.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 112.044 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.648 ' CE3' ' CG1' ' A' ' 23' ' ' VAL . 8.0 m-90 -86.39 -40.87 14.96 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.02 -1.05 . . . . 0.0 110.522 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 21' ' ' SER . 19.5 m -68.41 -40.27 81.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.536 -1.353 . . . . 0.0 107.909 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.004 HD11 ' CD2' ' A' ' 71' ' ' PHE . 60.8 mt -60.7 -44.47 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.666 ' O ' HG22 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -60.48 -28.8 68.64 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -42.87 88.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.527 ' HG3' ' CE ' ' A' ' 69' ' ' MET . 0.2 OUTLIER -67.09 -56.81 8.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.653 179.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 27' ' ' GLU . 1.5 tt -47.57 -28.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.23 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA2' ' CG2' ' A' ' 36' ' ' VAL . . . -83.6 -28.24 36.26 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.704 -1.758 . . . . 0.0 108.704 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -83.31 -0.26 48.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.015 . . . . 0.0 109.86 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.61 HG11 HG23 ' A' ' 61' ' ' THR . 13.2 t -102.49 -62.21 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -105.46 154.16 20.72 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 37' ' ' HIS . . . -66.85 62.49 0.19 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 35.6 m -52.15 125.75 6.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.186 -1.185 . . . . 0.0 110.521 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.913 ' NE2' HG11 ' A' ' 7' ' ' VAL . 32.2 m-70 -93.24 -20.47 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.301 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.53 ' CD2' ' HA ' ' A' ' 50' ' ' ILE . 2.2 t60 -136.95 138.61 40.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.859 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.781 ' HA ' HG22 ' A' ' 50' ' ' ILE . 7.5 tt -139.27 123.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.26 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.58 148.19 35.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 110.417 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 23' ' ' VAL . 24.7 t -126.94 151.45 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.296 -0.877 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 47' ' ' ASN . 15.0 p -122.4 145.91 47.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.215 -0.928 . . . . 0.0 110.157 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -106.67 -66.09 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 0.0 110.372 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.65 -15.19 4.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.649 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.61 -9.07 13.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.047 -1.033 . . . . 0.0 110.362 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 48.72 73.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.168 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -163.79 178.73 7.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.182 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB3' HG13 ' A' ' 12' ' ' ILE . . . -152.71 151.96 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 110.416 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 49' ' ' THR . 8.9 t -140.89 122.36 15.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.781 HG22 ' HA ' ' A' ' 39' ' ' ILE . 2.3 pp -145.64 172.83 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.687 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -109.36 170.46 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 109.755 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.905 ' HE2' HG22 ' A' ' 58' ' ' THR . 7.4 p90 -164.0 126.22 2.41 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.63 ' CA ' HG12 ' A' ' 7' ' ' VAL . 4.5 p-10 -68.31 121.08 79.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.568 -0.707 . . . . 0.0 110.017 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.588 ' HA ' HG23 ' A' ' 58' ' ' THR . 42.4 Cg_endo -67.77 -7.01 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.731 1.385 . . . . 0.0 110.084 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -44.9 -48.14 11.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.838 . . . . 0.0 109.81 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 8.9 mp -82.09 -63.26 1.42 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.907 ' O ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -156.76 -154.56 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.079 -1.013 . . . . 0.0 109.25 179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -175.53 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.108 -0.995 . . . . 0.0 110.627 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.601 ' CD ' ' CB ' ' A' ' 58' ' ' THR . 47.8 Cg_endo -73.02 -28.66 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.419 1.221 . . . . 0.0 109.159 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -91.34 -29.43 17.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.514 -0.741 . . . . 0.0 110.859 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 HG11 ' A' ' 33' ' ' VAL . 27.6 m -73.42 -63.41 1.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.738 -1.226 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.813 HD23 HG11 ' A' ' 10' ' ' VAL . 5.7 mp -46.84 -39.06 11.27 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 108.956 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -67.11 -48.0 69.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.533 -0.73 . . . . 0.0 109.272 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 68' ' ' ASP . 35.7 tt0 -66.75 -23.45 66.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.376 -0.828 . . . . 0.0 109.367 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 62' ' ' LEU . . . -65.67 -69.56 0.29 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.416 -0.802 . . . . 0.0 109.705 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 mp -53.56 -30.43 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 109.158 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 10.7 t0 -78.58 -39.88 36.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.757 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 64' ' ' GLU . 18.0 t0 -53.15 -35.92 60.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.785 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.527 ' CE ' ' HG3' ' A' ' 29' ' ' GLN . 6.1 mmt -84.89 -68.44 0.72 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.193 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.35 -12.42 7.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 1.004 ' CD2' HD11 ' A' ' 26' ' ' ILE . 15.4 m-85 -51.9 142.16 16.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.278 -1.13 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -68.62 70.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.71 164.36 27.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.414 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.49 152.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 110.126 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.725 HD13 ' HB3' ' A' ' 62' ' ' LEU . 1.7 pp -111.58 143.19 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.122 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.407 ' C ' ' CG ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -129.24 -171.82 2.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.224 -0.923 . . . . 0.0 110.083 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.536 ' OD1' ' CD ' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -164.27 -61.2 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.199 -0.938 . . . . 0.0 110.275 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.536 ' CD ' ' OD1' ' A' ' 77' ' ' ASN . 46.6 Cg_endo -72.98 57.64 3.26 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.449 1.237 . . . . 0.0 110.151 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.235 -179.936 . . . . . . . . 0 0 . 1 stop_ save_